dipyridamole has been researched along with Cardiovascular Stroke in 560 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The trial did not meet the predefined criteria for noninferiority but showed similar rates of recurrent stroke with ASA-ERDP and with clopidogrel." | 9.13 | Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. ( Albers, GW; Bath, P; Bornstein, N; Chan, BP; Chen, ST; Cotton, D; Cunha, L; Dahlöf, B; De Keyser, J; Diener, HC; Donnan, GA; Estol, C; Gorelick, P; Gu, V; Hermansson, K; Hilbrich, L; Kaste, M; Lawton, WA; Lu, C; Machnig, T; Martin, RH; Ounpuu, S; Pais, P; Palesch, Y; Roberts, R; Sacco, RL; Skvortsova, V; Teal, P; Toni, D; Vandermaelen, C; Voigt, T; Weber, M; Yoon, BW; Yusuf, S, 2008) |
| "To investigate whether biphasic response during dipyridamole echocardiography test (DET), which represents viable but potentially ischemic myocardium in the infarcted region, affects prognosis of patients after uncomplicated acute myocardial infarction, we performed high-dose DET in 80 consecutive patients younger than 65 years with first acute myocardial infarction and preserved left ventricular function." | 9.11 | Predictive value of biphasic response during dipyridamole echocardiography test in the low-risk group of patients after acute myocardial infarction. ( Beleslin, B; Karadzic, A; Kostic, J; Marinkovic, J; Mitrovic, P; Ostojic, M; Pokrajcic, ZV; Radosavljevic-Radovanovic, M; Radovanovic, N; Stankovic, G; Stefanovic, B, 2005) |
| "These results indicate that administration of dipyridamole can prevent and terminate reperfusion arrhythmias such as AIVR and VT." | 9.09 | Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias : evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias. ( Akahoshi, M; Hirai, M; Hirayama, H; Inden, Y; Ito, T; Kondo, T; Murakami, Y; Okamoto, M; Saito, H; Toyama, J; Tsuboi, N; Tsuda, M; Tsuji, Y; Yamada, T; Yoshida, Y, 2000) |
| "To compare the ability of dobutamine and dipyridamole stress echocardiography to detect functional recovery of stunned but viable myocardial regions early after acute myocardial infarction, and to predict late functional recovery of the reperfusion salvaged myocardium within the infarct area." | 9.08 | Comparison of dobutamine stress echocardiography with dipyridamole stress echocardiography for detection of viable myocardium after myocardial infarction treated with thrombolysis. ( Diotallevi, P; Ferrario, M; Fetiveau, R; Lanzarini, L; Montemartini, C; Mussini, A; Poli, A; Previtali, M; Specchia, G, 1996) |
| "The efficacy of combining antiplatelet agents with low doses of aspirin to prevent cardiac events in patients with myocardial infarction was examined." | 9.08 | Aspirin plus either dipyridamole or ticlopidine is effective in preventing recurrent myocardial infarction. Secondary Prevention Group. ( Hama, J; Ishikawa, K; Kanamasa, K; Katori, R; Kimura, A; Naito, T; Nakai, S; Ogawa, I; Oyaizu, M; Takenaka, T; Yamamoto, K; Yamamoto, T, 1997) |
| "The aim of this study was to assess the safety and prognostic value of dipyridamole 201T1 imaging very early after acute myocardial infarction in patients treated with thrombolytic therapy." | 9.08 | Dipyridamole thallium-201 imaging very early after uncomplicated acute myocardial infarction in patients treated with thrombolytic therapy. ( Corato, A; Corrada, E; Danzi, GB; De Vita, C; Massa, D; Moreo, A; Piccalo, G; Pirelli, S; Sara, R, 1997) |
| " The aim of the present study was to assess in a clinically realistic fashion the relative prognostic value of exercise electrocardiography test (EET) and dipyridamole-echocardiography test (DET) early after first acute uncomplicated myocardial infarction." | 9.08 | The relative value of exercise-electrocardiography and dipyridamole stress echocardiography for risk stratification early after uncomplicated myocardial infarction. The EPIC (Echo Persantine International Cooperative) Study Group. ( Baroni, M; Bianchi, F; Chiarandà, G; Del Negro, B; Gandolfo, N; Landi, P; Magaia, O; Margaria, F; Michelassi, C; Minardi, G; Picano, E; Pirelli, S; Previtali, M; Raciti, M; Severi, S; Seveso, G; Sicari, R; Vassalle, C, 1997) |
| "We assessed the safety of early (2 to 4 days) intravenous dipyridamole infusion in conjunction with technetium 99m sestamibi tomographic myocardial perfusion imaging in patients with first myocardial infarction (MI)." | 9.08 | Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS). ( Brown, KA; Haber, SB; Heller, GV; Landin, RJ, 1997) |
| "The aim of this study was to compare dipyridamole and dobutamine stress echocardiography, performed early in patients with acute myocardial infarction (AMI) to evaluate residual ischemia, viability, and prognosis." | 9.08 | Diagnostic and prognostic value of dipyridamole and dobutamine stress echocardiography in patients with Q-wave acute myocardial infarction. ( Armiento, G; Chiantera, A; De Santis, F; Di Segni, M; Giovannini, E; Manzara, CC; Minardi, G; Pulignano, G; Vajola, FS, 1997) |
| "This study was conducted to assess the feasibility, safety and prognostic value of dipyridamole echocardiography in elderly patients recovering from an uncomplicated acute myocardial infarction in a subset analysis performed on the patients entered in the subproject "residual ischemia" of the Echo Persantine Italian Cooperative Study (EPIC)." | 9.07 | Prognostic value of dipyridamole echocardiography early after myocardial infarction in elderly patients. Echo Persantine Italian Cooperative (EPIC) Study Group. ( Bolognese, L; Camerieri, A; Chiarella, F; Gandolfo, N; Landi, P; Michelassi, C; Minardi, G; Picano, E; Pingitore, A; Seveso, G, 1993) |
| "To determine the prognostic capability of the dipyridamole echocardiography test (DET) early after an acute myocardial infarction." | 9.07 | Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large-scale, multicenter trial. The EPIC Study Group. ( Bolognese, L; Chiarandà, G; Chiarella, F; Gandolfo, N; Landi, P; Orlandini, A; Picano, E; Previtali, M; Sclavo, MG; Seveso, G, 1993) |
| "A controlled trial of oral dipyridamole in 103 patients with acute myocardial infarction showed no difference in the number of complications or deaths in either the control or the treated groups." | 9.03 | Dipyridamole: a controlled trial of its effect in acute myocardial infarction. ( Brook, CG; Foley, TH; Gent, AE; Miller, TN, 1968) |
| "Results from randomized controlled trials of dipyridamole, given with or without aspirin, for secondary prevention after ischemic stroke or transient ischemic attack (TIA) have given conflicting results." | 8.82 | Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. ( Bath, PM; Bousser, MG; Davalos, A; Dewey, ME; Diener, HC; Guiraud-Chaumeil, B; Leonardi-Bee, J; Sivenius, J; Yatsu, F, 2005) |
| "Combination therapy with dipyridamole and clopidogrel in stroke prevention and long-term outcomes in aspirin-intolerant patients with acute myocardial infarction (AMI) and previous stroke are unknown." | 7.91 | Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study. ( Chiang, CH; Huang, WC; Hung, CC; Kuo, FY; Liang, HL; Lin, KC; Liu, CP; Mar, GY; Tang, PL; Wang, MT; Yang, JS, 2019) |
| "Seven hundred and ninety-three consecutive patients symptomatic for chest pain underwent dipyridamole stress-CMR and were followed up for 810 ± 665 days." | 7.83 | Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a mid-term follow-up study. ( Agostoni, P; Andreini, D; Aquaro, GD; Baggiano, A; Bartorelli, AL; Beltrama, V; Bertella, E; Conte, E; Giovannardi, M; Gripari, P; Guaricci, AI; Guglielmo, M; Loguercio, M; Masci, PG; Mushtaq, S; Pepi, M; Pontone, G; Rossi, C; Salerni, S; Segurini, C; Veglia, F, 2016) |
| "Stress-induced ST-segment elevation following myocardial infarction (MI) has been correlated with myocardial ischemia, viability and wall motion abnormality, but its mechanism is still unclear, so the present study compared ST-segment elevation and wall motion response during exercise, dobutamine and dipyridamole stresses." | 7.71 | Stress-induced ST-segment elevation following myocardial infarction and its role in wall motion abnormality, myocardial ischemia and viability: comparison of response to exercise, dobutamine and dipyridamole. ( Hirano, Y; Ishikawa, K; Miyazaki, T; Yamamoto, T, 2001) |
| "To assess the prognostic value of dipyridamole stress echocardiography in survivors of a first uncomplicated acute myocardial infarction." | 7.70 | [Prognostic value of dipyridamole echocardiography in 1st acute uncomplicated myocardial infarction]. ( Azqueta, M; Paré, JC; Sánchez, P; Sanz, GA, 1998) |
| "Dipyridamole-thallium SPECT is safely performed and is useful and important for risk stratification in the long-term follow-up of patients with Kawasaki disease." | 7.70 | Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease. ( Hamamoto, K; Ikezoe, J; Matsumoto, S; Miyagawa, M; Mochizuki, T; Murase, K; Niino, M; Sekiya, M; Tanada, S, 1998) |
| "Ninety patients underwent dipyridamole stress echo and exercise testing at a mean +/- SD of 9 +/- 4 days after admission for acute uncomplicated first myocardial infarction." | 7.70 | Dipyridamole stress echocardiography and exercise testing for risk stratification after uncomplicated myocardial infarction. ( Canel, F; Celegon, L; Cernetti, C; Desideri, A; Suzzi, GL; Terlizzi, R, 1998) |
| "To assess the utility of intravenous dipyridamole thallium testing for predicting major cardiac events following acute myocardial infarction in older patients." | 7.70 | Prognostic value of dipyridamole thallium imaging after acute myocardial infarction in older patients. ( Baird, JB; Fischer, KC; Jain, S; Rich, MW, 1999) |
| "We evaluated the usefulness of preoperative dipyridamole myocardial scintigraphy (DMS) under low-level exercise in predicting postoperative cardiac problems in patients undergoing elective abdominal aortic aneurysm (AAA) repair." | 7.70 | Role of dipyridamole myocardial scintigraphy in abdominal aortic aneurysm repair. ( Harada, H; Hayashi, S; Kitajima, M; Matsumoto, K; Nakamaru, M; Obara, H, 1999) |
| "To demonstrate that the administration of dipyridamole at the end of an insufficient maximal subjective exercise test can improve the diagnostic accuracy of single-photon emission computed tomography in patients with previous myocardial infarction, 209 consecutive patients were studied with technetium-99m methoxyisobutyl isonitrile single-photon emission computed tomography and coronary angiography." | 7.70 | Dipyridamole administration at the end of an insufficient exercise Tc-99m MIBI SPECT improves detection of multivessel coronary artery disease in patients with previous myocardial infarction. ( Aguadé-Bruix, S; Bermejo-Fraile, B; Candell-Riera, J; Castell-Conesa, J; Santana-Boado, C; Soler-Soler, J, 2000) |
| "Thirty-eight patients with coronary arterial involvement of Kawasaki disease and 18 control subjects received cardiac ultrafast CT with intravenous long-bolus iodinated contrast injection; dipyridamole was loaded in 40 examinations." | 7.69 | Significance of dipyridamole loading in ultrafast x-ray computed tomography for detection of myocardial ischemia. A study in patients with Kawasaki disease. ( Hamada, S; Kamiya, T; Naito, H; Takamiya, M; Tamura, S; Yoshibayashi, M, 1995) |
| "84 mg/kg over a 10-minute period) dipyridamole echocardiography test (DET) after a first acute myocardial infarction (AMI) in comparison with clinical, electrocardiographic, echocardiographic, and angiographic variables, follow-up data over an average period of 16 months were obtained in 93 consecutive patients." | 7.69 | Positive high-dose dipyridamole echocardiography test after acute myocardial infarction is an excellent predictor of cardiac events. ( Babić, R; Marinković, J; Nesković, AN; Obradović, V; Popović, AD, 1995) |
| "In recent years, increasing evidence has pointed to the potential of dipyridamole stress echocardiography as a fast, effective, inexpensive method of risk stratification after an acute myocardial infarction." | 7.69 | Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: feasibility, tolerability, safety and in-hospital prognostic value. ( Bellone, P; Bellotti, P; Chiarella, F; Domenicucci, S; Scarsi, G; Vecchio, C, 1994) |
| "To assess the diagnostic and prognostic value of dipyridamole thallium-201 scintigraphy in the "thrombolytic era", we studied 110 consecutive patients younger than 75 recovering from first uncomplicated acute myocardial infarction treated with thrombolytic agents." | 7.69 | [Thallium-dipyridamole in acute myocardial infarction treated by thrombolysis: diagnostic and prognostic value]. ( Cafiero, F; Cammelli, F; D'Urbano, M; Romano, S; Spreafico, GL, 1994) |
| "This study assessed and compared the diagnostic potential of submaximal exercise, transesophageal atrial pacing, dipyridamole, and dobutamine-atropine stress echocardiography tests shortly after acute myocardial infarction." | 7.69 | Comparison of the diagnostic potential of four echocardiographic stress tests shortly after acute myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyridamole, and dobutamine-atropine. ( Dingerkus, H; Dissmann, R; Linderer, T; Münzberg, H; Schröder, K; Schultheiss, HP; Völler, H, 1996) |
| "Intravenous dipyridamole-thallium-scintigraphy performed very early after myocardial infarction is safe and useful to predict in-hospital ischemic events." | 7.69 | Prediction of in-hospital cardiac events using dipyridamole-thallium scintigraphy performed very early after acute myocardial infarction. ( Betriu, A; Bosch, X; García, A; Magriñá, J; March, R; Navarro-López, F; Sanz, G, 1996) |
| "High-dose dipyridamole transesophageal stress echocardiography has recently been proposed as a useful and safe method to assess myocardial ischemia in patients with poor transthoracic acoustic window." | 7.69 | Usefulness of dipyridamole transesophageal echocardiography in the evaluation of myocardial ischemia and coronary artery flow. ( Ceci, V; Galati, A; Goletta, C; Greco, G; Ricci, R; Richichi, G; Serdoz, R, 1996) |
| "We have recently shown that in patients with single vessel disease and no myocardial infarction, a complex plaque morphology makes myocardium more vulnerable to ischaemia during dipyridamole echocardiography testing." | 7.69 | Impact of culprit lesion morphology on prevalence of provoked myocardial ischaemia in patients with old myocardial infarction. A dipyridamole stress echocardiography, exercise electrocardiography and angiographic study. ( Biagini, A; DeNes, M; Distante, A; L'Abbate, A; Lu, C; Marzilli, M; Wang, Y, 1997) |
| "Fifty-one patients underwent simultaneous dipyridamole stress echocardiography and scintigraphy at a mean +/- SD of 12 +/- 3 days after admission for acute uncomplicated myocardial infarction." | 7.69 | [Echocardiography or stress scintigraphy with dipyridamole for the stratification of risk after acute myocardial infarction?]. ( Candelpergher, G; Celegon, L; Colangeli, G; Desideri, A; Favero, A; Ferlin, G; Suzzi, GL; Terlizzi, R; Zanco, P, 1997) |
| "To determine the safety and prognostic value of dipyridamole thallium-201 scintigraphy performed in patients within three to five days of acute myocardial infarction, including those receiving thrombolytic treatment." | 7.69 | Dipyridamole thallium-201 scintigraphy for early risk stratification of patients after uncomplicated myocardial infarction. ( Groom, GN; Hands, ME; Hung, J; Moshiri, M; Parsons, RW; Van der Schaaf, AA, 1997) |
| "The prevalence and prognostic significance of silent myocardial ischemia were prospectively assessed in 217 patients (mean age 57 +/- 9 years, 83% male) recovering from a first uncomplicated acute myocardial infarction and undergoing a dipyridamole echocardiography test before hospital discharge." | 7.68 | Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: clinical and prognostic significance. ( Bolognese, L; Bongo, AS; Dellavesa, P; Prando, MD; Rossi, L; Rossi, P; Sarasso, G, 1992) |
| "A case of myocardial infarction secondary to dipyridamole overdose is described in a 62-year-old woman with longstanding angina." | 7.68 | Myocardial infarction secondary to dipyridamole overdose. ( Holdright, DR; Jahangiri, M, 1992) |
| "To examine the incidence of arrhythmias in dipyridamole infusion and the relation between dipyridamole-induced arrhythmias and ST-segment depression, dipyridamole electrocardiography tests were performed on 100 patients with coronary artery disease." | 7.68 | Relation between the incidence of arrhythmias and ischemic ST-segment depression during dipyridamole electrocardiography test in patients with coronary artery disease. ( Hanashima, K; Ikeda, K; Kubota, I; Shibata, T; Tsuiki, K; Yamaki, M; Yasui, S, 1991) |
| "Fifty three patients were studied with dipyridamole thallium myocardial scintigraphy, 4 to 6 days after a first episode of myocardial infarction." | 7.68 | [Early test of thallium dipyridamole after myocardial infarction: prognostic value and correlation with coronarography]. ( Corbalán, R; Galleguillos, CG; Kunstmann, S; Marchant, E; Olea, E; Orellana, P; Puschel, K, 1991) |
| "Dipyridamole 201Tl imaging has been proposed as an alternative to exercise ECG testing for the prehospital discharge evaluation of patients recovering from myocardial infarction." | 7.68 | Dipyridamole 201Tl scintigraphy in the evaluation of prognosis after myocardial infarction. ( Glover, DK; Leppo, JA; Okada, RD, 1991) |
| "84 mg/kg over 10 minutes) dipyridamole 2D echocardiography test (DET) were evaluated in 78 asymptomatic patients 10 to 14 days after uncomplicated acute myocardial infarction and the results were compared with those of exercise stress test (EST)." | 7.68 | [Prognostic value of echocardiography with high-dose dipyridamole after recent uncomplicated myocardial infarction]. ( Belli, R; Bosco, M; Gandolfo, N; Parigi, A; Schon, W, 1991) |
| "To evaluate safety and usefulness of dipyridamole-radionuclide ventriculography (D-RVG), soon after acute myocardial infarction (MI), in the prediction of future cardiac events." | 7.68 | [Cineventriculography with radionuclides and intravenous dipyridamole in the prognostic evaluation after acute myocardial infarction]. ( de Almeida, LA; Escosteguy, CC; Esteves, RN; Futuro, DO; Pantoja, MR; Pinto, JC; Saad, EA, 1990) |
| "We evaluated 50 consecutive patients who received thrombolytic therapy for acute myocardial infarction using thallium-201 single photon emission computed tomography in combination with oral dipyridamole (300 mg) to assess the frequency of residual myocardial ischemia." | 7.68 | Comparison of coronary angiography and early oral dipyridamole thallium-201 scintigraphy in patients receiving thrombolytic therapy for acute myocardial infarction. ( Adams, KF; Hicks, RR; Jain, A; McCarthy, JJ; Myers, GH; Perry, JR, 1990) |
| "The ability of dipyridamole-thallium-201 imaging to predict in-hospital and late cardiac events when performed very early (62 +/- 21 hours, range 23 to 102) after acute myocardial infarction (AMI) was tested in 50 patients." | 7.68 | Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. ( Brown, KA; Chambers, CE; O'Meara, J; Plante, DA, 1990) |
| "This report describes the occurrence of chest pain and electrocardiographic features of acute myocardial infarction following intravenous dipyridamole-handgrip stress." | 7.68 | Acute myocardial infarction associated with intravenous dipyridamole for rubidium-82 PET imaging. ( Hollman, J; Marwick, TH, 1990) |
| "To evaluate the safety and usefulness of serial thallium scanning immediately after intravenous dipyridamole, we studied 51 patients recovering from acute myocardial infarction." | 7.67 | Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. ( Getchell, JD; Lee, VW; Leppo, JA; O'Brien, J; Rothendler, JA, 1984) |
| "In the present study 27 post-myocardial infarction patients were treated with Persantin capsules (Depot-Kapseln, sustained release form), containing 200 mg dipyridamole, b." | 7.67 | Plasma concentrations of platelet-specific proteins and serum thromboxane B2 production in response to treatment with dipyridamole. A pilot study of 27 post-myocardial infarction patients. ( Kutti, J; Safai-Kutti, S; Vedin, A; Wilhelmsson, C, 1985) |
| "The prognostic value of predischarge dipyridamole-thallium scanning after uncomplicated myocardial infarction was determined by comparison with submaximal exercise electrocardiography and 6-week maximal exercise thallium imaging and by correlation with clinical events." | 7.67 | Prognostic utility of predischarge dipyridamole-thallium imaging compared to predischarge submaximal exercise electrocardiography and maximal exercise thallium imaging after uncomplicated acute myocardial infarction. ( Boucher, CA; Gimple, LW; Guiney, TE; Hutter, AM, 1989) |
| "To evaluate the safety and usefulness of myocardial thallium-201 scintigraphy after intravenous dipyridamole during the early post-infarction period, 35 patients under 60 years of age and with recent first transmural uncomplicated myocardial infarction (27 inferior, 8 anterior) were examined between the 5th and 13th day of hospitalization." | 7.67 | Dipyridamole-thallium 201 scintigraphy in the early post-infarction period. (Safety and accuracy in predicting the extent of coronary disease and future recurrence of angina in patients suffering from their first myocardial infarction). ( Campolo, L; Corrada, E; Inglese, E; Pirelli, S; Suppa, M, 1988) |
| "The investigations concerning the significance of the systolic time intervals in the dipyridamole test for the diagnosis of the coronary heart disease were carried out in 15 healthy test persons and 40 patients with coronary heart disease." | 7.67 | [The significance of systolic time intervals in the dipyridamole test for the diagnosis of coronary disease]. ( Cholewa, M; Gawor, Z; Markiewicz, K, 1988) |
| "The effects on an acute myocardial infarction of equipotent hypotensive doses of nitroglycerin and dipyridamole were studied using the thermographic technique in open-chest dogs." | 7.66 | Effects of nitroglycerin and dipyridamole on acute myocardial infarction: a thermographic study in the dog. ( Arborelius, M; Bornmyr, S; Gil, RL; Lilja, B; Malm, A, 1979) |
| " At 24 hours, 202 patients were randomized to continue intravenous heparin therapy (n = 99) in full dosage or to discontinue heparin therapy and begin an oral antiplatelet regimen of aspirin (300 mg/day) and dipyridamole (300 mg/day) (n = 103)." | 6.67 | A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group. ( Aylward, PE; Federman, J; Giles, RW; Harris, PJ; Hodge, RL; Nelson, GI; Thompson, PL; Thomson, A; Tonkin, AM; Walsh, WF, 1991) |
| "Following elective abdominal aortic aneurysm (AAA) repair the commonest cause for perioperative death is cardiac-related." | 6.42 | Abdominal aortic aneurysms and concomitant coronary artery disease. Is routine dipyridamole thallium scintigraphy still justified? ( Galland, RB, 2003) |
| " Conditions characterized by a reduction in platelet survival and where dipyridamole has been used include heart valve replacement, arterial grafting, cerebrovascular disorders, and disorders of peripheral circulation." | 6.15 | Dipyridamole: a critical evaluation. ( Alexander, MR; Rivey, MP; Taylor, JW, 1984) |
| "Large-scale clinical trials of the use of aspirin in post-myocardial infarction patients were based on the assumption that inhibition of platelet activity would reduce thromboembolism associated with atherosclerosis, and that thromboembolism is a major cause of the clinical complications of atherosclerosis." | 6.15 | Aspirin in the treatment of cardiovascular disease: a review. ( Kinlough-Rathbone, RL; Mustard, JF; Packham, MA, 1983) |
| "Aspirin has been convincingly shown to reduce stroke and death in men with transient ischemic attacks (it may possibly be beneficial to women also), myocardial infarction and death in patients with unstable angina, thromboembolic complications associated with artificial heart valves in patients receiving oral anticoagulants (although gastrointestinal bleeding is prohibitive with this combination), and thrombotic occlusion of silicone rubber arteriovenous cannulae in uremic patients undergoing hemodialysis." | 6.15 | Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis. ( Harker, LA, 1986) |
| " This case shows that, in such particular conditions, a change in dipyridamole dosage can induce a myocardial infarction even if its blood level remains in the therapeutic range." | 5.36 | [Myocardial infarction after voluntary intoxication by drug interaction between dipyridamole and aspirin]. ( Amat, G; Brahic, H; Eschalier, A; Eschalier, R; Marcaggi, X; Ravan, R, 2010) |
| "Dipyridamole (DIP) is a powerful antioxidant and increases adenosine concentration." | 5.33 | The beneficial effect of insulin, glucose, and dipyridamole on regional left ventricular function early after acute myocardial infarction. ( Bedetti, G; Bugiardini, R; Gabrieli, L; Pasanisi, E; Picano, E; Pizzi, C; Varga, A, 2005) |
| "Thirty-eight patients with Kawasaki disease and 11 age-matched controls participated in the study." | 5.30 | Noninvasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing. ( Akagi, T; Fukuda, T; Inoue, O; Ishibashi, M; Kato, H; Sugimura, T, 1998) |
| "Furthermore." | 5.30 | Valsartan and coronary haemodynamics in early post-myocardial infarction in rats. ( De Gasparo, M; Fornes, P; Gervais, M; Giudicelli, JF; Richer, C, 1999) |
| "Dipyridamole 0." | 5.28 | Atrial fibrillation after intravenous dipyridamole for thallium imaging. ( Ell, PJ; Pennell, DJ, 1992) |
| "1 The effects of propranolol and practolol, at equivalent myocardial beta-adrenoceptor blocking doses, (as assessed by the degree of shift of isoprenaline dose-response curves) were investigated in anaesthetized greyhounds before and after acute coronary artery ligation." | 5.26 | Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction. ( Marshall, RJ; Parratt, JR, 1976) |
| "The addition of myocardial perfusion (MP) imaging during dipyridamole real-time contrast echocardiography improves the sensitivity to detect coronary artery disease, but its prognostic value to predict hard cardiac events in large numbers of patients with known or suspected coronary artery disease remains unknown." | 5.16 | Prognostic value of high-dose dipyridamole stress myocardial contrast perfusion echocardiography. ( Gaibazzi, N; Lorenzoni, V; Molinaro, S; Porter, TR; Reverberi, C, 2012) |
| "No previous study has assessed the possible role of dipyridamole for treatment of no-reflow during acute myocardial infarction (AMI)." | 5.14 | Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty. ( Arrivi, A; Greco, C; Mangieri, E; Pasceri, V; Pelliccia, F; Placanica, A; Tanzilli, G, 2010) |
| "The trial did not meet the predefined criteria for noninferiority but showed similar rates of recurrent stroke with ASA-ERDP and with clopidogrel." | 5.13 | Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. ( Albers, GW; Bath, P; Bornstein, N; Chan, BP; Chen, ST; Cotton, D; Cunha, L; Dahlöf, B; De Keyser, J; Diener, HC; Donnan, GA; Estol, C; Gorelick, P; Gu, V; Hermansson, K; Hilbrich, L; Kaste, M; Lawton, WA; Lu, C; Machnig, T; Martin, RH; Ounpuu, S; Pais, P; Palesch, Y; Roberts, R; Sacco, RL; Skvortsova, V; Teal, P; Toni, D; Vandermaelen, C; Voigt, T; Weber, M; Yoon, BW; Yusuf, S, 2008) |
| " The recently published European/Australasian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT), an open-label randomised controlled study, compared long-term treatment of patients randomised to aspirin 30-325 mg daily with (n = 1363) or without (n = 1376) dipyridamole 200 mg twice daily." | 5.12 | ESPRIT study design and outcomes--a critical appraisal. ( Einhäupl, K, 2007) |
| "To investigate whether biphasic response during dipyridamole echocardiography test (DET), which represents viable but potentially ischemic myocardium in the infarcted region, affects prognosis of patients after uncomplicated acute myocardial infarction, we performed high-dose DET in 80 consecutive patients younger than 65 years with first acute myocardial infarction and preserved left ventricular function." | 5.11 | Predictive value of biphasic response during dipyridamole echocardiography test in the low-risk group of patients after acute myocardial infarction. ( Beleslin, B; Karadzic, A; Kostic, J; Marinkovic, J; Mitrovic, P; Ostojic, M; Pokrajcic, ZV; Radosavljevic-Radovanovic, M; Radovanovic, N; Stankovic, G; Stefanovic, B, 2005) |
| "These results indicate that administration of dipyridamole can prevent and terminate reperfusion arrhythmias such as AIVR and VT." | 5.09 | Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias : evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias. ( Akahoshi, M; Hirai, M; Hirayama, H; Inden, Y; Ito, T; Kondo, T; Murakami, Y; Okamoto, M; Saito, H; Toyama, J; Tsuboi, N; Tsuda, M; Tsuji, Y; Yamada, T; Yoshida, Y, 2000) |
| "The second European Stroke Prevention Study investigated the prevention of stroke and/or death in 6602 patients with transient ischaemic attack or stroke with aspirin (25 mg b." | 5.09 | Cardiac safety in the European Stroke Prevention Study 2 (ESPS2). ( Bertrand-Hardy, JM; Darius, H; Diener, HC; Humphreys, M, 2001) |
| "This study sought to assess the value of dipyridamole echocardiography in predicting reinfarction in patients evaluated early after uncomplicated acute myocardial infarction." | 5.08 | Stress echocardiographic results predict risk of reinfarction early after uncomplicated acute myocardial infarction: large-scale multicenter study. Echo Persantine International Cooperative (EPIC) Study Group. ( Bolognese, L; Chiaranda, G; Chiarella, F; Gandolfo, N; Minardi, G; Picano, E; Pingitore, A; Sclavo, MG; Seveso, G; Sicari, R, 1995) |
| "This study assessed the effect of the combination of aspirin and dipyridamole on patency of the infarct-related artery between 4 weeks and 1 year after myocardial infarction." | 5.08 | Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. ( Brown, MA; Cross, DB; French, JK; Hamer, AW; Ormiston, JA; White, HD; Williams, BF, 1995) |
| "To compare the ability of dobutamine and dipyridamole stress echocardiography to detect functional recovery of stunned but viable myocardial regions early after acute myocardial infarction, and to predict late functional recovery of the reperfusion salvaged myocardium within the infarct area." | 5.08 | Comparison of dobutamine stress echocardiography with dipyridamole stress echocardiography for detection of viable myocardium after myocardial infarction treated with thrombolysis. ( Diotallevi, P; Ferrario, M; Fetiveau, R; Lanzarini, L; Montemartini, C; Mussini, A; Poli, A; Previtali, M; Specchia, G, 1996) |
| "The efficacy of combining antiplatelet agents with low doses of aspirin to prevent cardiac events in patients with myocardial infarction was examined." | 5.08 | Aspirin plus either dipyridamole or ticlopidine is effective in preventing recurrent myocardial infarction. Secondary Prevention Group. ( Hama, J; Ishikawa, K; Kanamasa, K; Katori, R; Kimura, A; Naito, T; Nakai, S; Ogawa, I; Oyaizu, M; Takenaka, T; Yamamoto, K; Yamamoto, T, 1997) |
| "Dipyridamole echocardiography test was performed in 55 consecutive patients after a first acute myocardial infarction before hospital discharge." | 5.08 | Detection of significant residual stenosis of the infarct-related artery after thrombolysis by high-dose dipyridamole echocardiography test: is it detected often enough? ( Bojić, M; Nesković, AN; Popović, AD, 1997) |
| "The aim of this study was to assess the safety and prognostic value of dipyridamole 201T1 imaging very early after acute myocardial infarction in patients treated with thrombolytic therapy." | 5.08 | Dipyridamole thallium-201 imaging very early after uncomplicated acute myocardial infarction in patients treated with thrombolytic therapy. ( Corato, A; Corrada, E; Danzi, GB; De Vita, C; Massa, D; Moreo, A; Piccalo, G; Pirelli, S; Sara, R, 1997) |
| " The aim of the present study was to assess in a clinically realistic fashion the relative prognostic value of exercise electrocardiography test (EET) and dipyridamole-echocardiography test (DET) early after first acute uncomplicated myocardial infarction." | 5.08 | The relative value of exercise-electrocardiography and dipyridamole stress echocardiography for risk stratification early after uncomplicated myocardial infarction. The EPIC (Echo Persantine International Cooperative) Study Group. ( Baroni, M; Bianchi, F; Chiarandà, G; Del Negro, B; Gandolfo, N; Landi, P; Magaia, O; Margaria, F; Michelassi, C; Minardi, G; Picano, E; Pirelli, S; Previtali, M; Raciti, M; Severi, S; Seveso, G; Sicari, R; Vassalle, C, 1997) |
| "We assessed the safety of early (2 to 4 days) intravenous dipyridamole infusion in conjunction with technetium 99m sestamibi tomographic myocardial perfusion imaging in patients with first myocardial infarction (MI)." | 5.08 | Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS). ( Brown, KA; Haber, SB; Heller, GV; Landin, RJ, 1997) |
| "The aim of this study was to compare dipyridamole and dobutamine stress echocardiography, performed early in patients with acute myocardial infarction (AMI) to evaluate residual ischemia, viability, and prognosis." | 5.08 | Diagnostic and prognostic value of dipyridamole and dobutamine stress echocardiography in patients with Q-wave acute myocardial infarction. ( Armiento, G; Chiantera, A; De Santis, F; Di Segni, M; Giovannini, E; Manzara, CC; Minardi, G; Pulignano, G; Vajola, FS, 1997) |
| "The aim of the study was to compare the ability of dobutamine and dipyridamole echocardiography to detect stunned but viable myocardium early after acute myocardial infarction, to predict spontaneous functional recovery of the reperfused myocardium at 2 months and to detect myocardial ischemia in the infarcted area." | 5.07 | [The echo-dobutamine and echo-dipyridamole tests in assessing vital myocardium and residual ischemia in myocardial infarct after thrombolysis]. ( Diotallevi, P; Ferrario, M; Fetiveau, R; Lanzarini, L; Montemartini, C; Mussini, A; Poli, A; Previtali, M, 1994) |
| "This study was conducted to assess the feasibility, safety and prognostic value of dipyridamole echocardiography in elderly patients recovering from an uncomplicated acute myocardial infarction in a subset analysis performed on the patients entered in the subproject "residual ischemia" of the Echo Persantine Italian Cooperative Study (EPIC)." | 5.07 | Prognostic value of dipyridamole echocardiography early after myocardial infarction in elderly patients. Echo Persantine Italian Cooperative (EPIC) Study Group. ( Bolognese, L; Camerieri, A; Chiarella, F; Gandolfo, N; Landi, P; Michelassi, C; Minardi, G; Picano, E; Pingitore, A; Seveso, G, 1993) |
| "To determine the prognostic capability of the dipyridamole echocardiography test (DET) early after an acute myocardial infarction." | 5.07 | Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large-scale, multicenter trial. The EPIC Study Group. ( Bolognese, L; Chiarandà, G; Chiarella, F; Gandolfo, N; Landi, P; Orlandini, A; Picano, E; Previtali, M; Sclavo, MG; Seveso, G, 1993) |
| "Combination therapy with dipyridamole and aspirin reduces not only the risk of cerebrovascular ischemic events but also the risk of myocardial infarction." | 5.07 | Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event. ( Laakso, M; Lowenthal, A; Riekkinen, PJ; Sivenius, J; Smets, P, 1993) |
| "84 mg/kg over 10') dipyridamole-echocardiography test (DET) early after an acute myocardial infarction in a "phase IV" study, based upon 11 different echocardiographic laboratories, all with established experience in stress echo and fulfilling quality control requirements for stress echo readings." | 5.07 | [Prognostic value of the dipyridamole-echocardiography test immediately after a non-complicated myocardial infarct: a large scale multicenter study. Echo Persantine Italian Cooperative Study]. ( Bolognese, L; Chiarandà, G; Chiarella, F; Gandolfo, N; Landi, P; Michelassi, C; Picano, E; Previtali, M; Sclavo, MG; Seveso, G, 1992) |
| " The present study was undertaken to assess the value of 18 clinical parameters, of 7 clinical scoring systems, and of quantitative dipyridamole-thallium imaging for predicting the occurrence of postoperative myocardial infarction or cardiac death." | 5.07 | Multivariate clinical models and quantitative dipyridamole-thallium imaging to predict cardiac morbidity and death after vascular reconstruction. ( Cerino, M; Lassonde, J; Laurendeau, F; Lette, J; Levy, R; Nattel, S; Picard, M; René, P; Waters, D, 1991) |
| "In the Persantine-Aspirin Reinfarction Study, Part II (PARIS II), 3,128 persons who had recovered from myocardial infarction, suffered from 4 weeks to 4 months previously, were randomized into two groups: dipyridamole (Persantine) plus aspirin (n = 1,563) and placebo (n = 1,565)." | 5.06 | Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. ( Klimt, CR; Knatterud, GL; Meier, P; Stamler, J, 1986) |
| "The efficacy and safety of a combination of Persantine and aspirin, of aspirin alone and of a placebo as a regimen for preventing reinfarction were compared in 2026 patients who had recovered from a documented acute myocardial infarction (MI) that had occurred 8 weeks to 5 years previously." | 5.05 | The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group. ( , 1980) |
| " These trials were prompted by earlier observations that aspirin takers seemed to fare better after acute myocardial infarction and were further stimulated by the recent growth of knowledge about the role of vascular and platelet prostaglandins." | 5.05 | Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials. ( Castaldi, PA, 1981) |
| "The Persantine-Aspirin Reinfarction Study (PARIS) was a randomized, controlled, double-blind study of dipyridamole (Persantine) and aspirin in secondary prevention of coronary heart disease." | 5.05 | Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group. ( , 1980) |
| "Aspirin, sulfinpyrazone and the combination of aspirin/dipyridamole, which inhibit some aspects of platelet function, have been evaluated in large-scale clinical trials in secondary prevention of myocardial infarction." | 5.05 | Secondary prevention of myocardial infarction. ( Davies, JA, 1985) |
| " centers, 231 male diabetic patients who had either a recent amputation for gangrene (N = 207) or active gangrene (N = 24) were randomly assigned to a group which received aspirin (325 mg t." | 5.05 | V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics. ( Abraira, C; Anderson, JW; Bingham, SF; Colwell, JA; Kwaan, HC, 1985) |
| "A controlled trial of oral dipyridamole in 103 patients with acute myocardial infarction showed no difference in the number of complications or deaths in either the control or the treated groups." | 5.03 | Dipyridamole: a controlled trial of its effect in acute myocardial infarction. ( Brook, CG; Foley, TH; Gent, AE; Miller, TN, 1968) |
| "To assess the clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole (MRD) alone or with aspirin (ASA) compared with ASA (and each other where appropriate) in the prevention of occlusive vascular events in patients with a history of MI, ischaemic stroke/TIA or established peripheral arterial disease." | 4.87 | Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis. ( Bagust, A; Blundell, M; Boland, A; Dickson, R; Dundar, Y; Fisher, M; Greenhalgh, J; Martin Saborido, C; Oyee, J; Proudlove, C, 2011) |
| "Results from randomized controlled trials of dipyridamole, given with or without aspirin, for secondary prevention after ischemic stroke or transient ischemic attack (TIA) have given conflicting results." | 4.82 | Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. ( Bath, PM; Bousser, MG; Davalos, A; Dewey, ME; Diener, HC; Guiraud-Chaumeil, B; Leonardi-Bee, J; Sivenius, J; Yatsu, F, 2005) |
| "The purpose of this study was to conduct a metaanalysis of semiquantitive dipyridamole myocardial perfusion scintigraphy for the prediction of perioperative myocardial infarction and cardiac death in patients undergoing noncardiac vascular surgery." | 4.81 | Semiquantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a meta-analysis. ( Cook, D; Etchells, E; Meade, M; Tomlinson, G, 2002) |
| " To achieve this goal, investigators have focused on several areas including imaging technique, in which the accuracy of single-photon emission CT has been compared with that of positron emission tomography; radiopharmaceuticals, in which 201Tl has been compared with 99mTc-sestamibi and 99mTc-teboroxime; stress modalities, in which dipyridamole and adenosine stress have been compared with exercise; myocardial viability, as determined by delayed and reinjection 201Tl imaging or by measurement of cellular integrity using 82Rb compared with 18fluorodeoxyglucose metabolic PET imaging; and assessment of myocardial salvage and prognosis by exercise or dipyridamole 201Tl imaging in acute myocardial infarction." | 4.78 | Myocardial perfusion imaging in the diagnosis of coronary artery disease. ( Cook, SA; Go, RT; MacIntyre, WJ; Neumann, DR, 1992) |
| "Combination therapy with dipyridamole and clopidogrel in stroke prevention and long-term outcomes in aspirin-intolerant patients with acute myocardial infarction (AMI) and previous stroke are unknown." | 3.91 | Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study. ( Chiang, CH; Huang, WC; Hung, CC; Kuo, FY; Liang, HL; Lin, KC; Liu, CP; Mar, GY; Tang, PL; Wang, MT; Yang, JS, 2019) |
| "Seven hundred and ninety-three consecutive patients symptomatic for chest pain underwent dipyridamole stress-CMR and were followed up for 810 ± 665 days." | 3.83 | Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a mid-term follow-up study. ( Agostoni, P; Andreini, D; Aquaro, GD; Baggiano, A; Bartorelli, AL; Beltrama, V; Bertella, E; Conte, E; Giovannardi, M; Gripari, P; Guaricci, AI; Guglielmo, M; Loguercio, M; Masci, PG; Mushtaq, S; Pepi, M; Pontone, G; Rossi, C; Salerni, S; Segurini, C; Veglia, F, 2016) |
| "This study followed a multicenter cohort of 718 patients for 16 months after high-dose dipyridamole contrast SE for evaluation of known or suspected coronary artery disease." | 3.79 | Comparative prediction of cardiac events by wall motion, wall motion plus coronary flow reserve, or myocardial perfusion analysis: a multicenter study of contrast stress echocardiography. ( Bartolomucci, F; Gaibazzi, N; Lorenzoni, V; Marwick, TH; Molinaro, S; Reverberi, C; Rigo, F, 2013) |
| "To evaluate dipyridamole cardiac magnetic resonance (MR) imaging in the prediction of major events (MEs) in patients with ischemic chest pain in a large multicenter registry." | 3.78 | Prognostic implications of dipyridamole cardiac MR imaging: a prospective multicenter registry. ( Aguilar, J; Bodi, V; Bosch, MJ; Chaustre, F; Chorro, FJ; Diago, JL; García, C; Gómez, C; Husser, O; Llacer, A; López-Lereu, MP; Miñana, G; Monmeneu, JV; Moratal, D; Núñez, J; Rumiz, E; Sanchis, J, 2012) |
| "The aim of the study was to evaluate the prognostic value of Doppler echocardiographic-derived coronary flow reserve (CFR) over regional wall motion in patients with known or suspected coronary artery disease (CAD) undergoing dipyridamole echocardiography test (DET)." | 3.74 | The additive prognostic value of wall motion abnormalities and coronary flow reserve during dipyridamole stress echo. ( Cortigiani, L; Djordjevic-Dikic, A; Gherardi, S; Picano, E; Rigo, F; Sicari, R, 2008) |
| "A total of 5,456 patients (749 diabetics) undergoing dipyridamole (n = 3,306) or dobutamine (n = 2,150) SE were prospectively followed up for the occurrence of hard events (death and/or nonfatal myocardial infarction)." | 3.73 | Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. ( Bigi, R; Bovenzi, F; Cortigiani, L; Landi, P; Picano, E; Sicari, R, 2006) |
| " In 48 patients who had coronary angiography, the positive predictive value of exercise (+dipyridamole) myocardial SPECT for the diagnosis of left anterior descending coronary artery stenosis was 93%, for left circumflex coronary artery stenosis, 96%, and for right coronary artery stenosis, 89%." | 3.72 | Usefulness of myocardial perfusion SPECT in patients with left bundle branch block and previous myocardial infarction. ( Aguadé-Bruix, S; Candell-Riera, J; Castell-Conesa, J; Oller-Martínez, G; Pereztol-Valdés, O; Santana-Boado, C; Simó, M; Soler-Peter, M; Soler-Soler, J, 2003) |
| "Among patients with medically stabilized unstable angina and a negative dipyridamole stress echocardiogram, male gender and previous myocardial infarction are associated with a non-favourable outcome." | 3.72 | Identifying patients without favourable long-term outcome among those with medically stabilized unstable angina and a negative dipyridamole stress echocardiogram. ( Almería, C; Macaya, C; Mataix, L; Moreno, R; Perez de Isla, L; Pérez-González, JA; Rodrigo, JL; Villate, A; Zamorano, J, 2004) |
| "496 patients underwent a maximum exercise ECG and pharmacological stress echocardiography (406 dobutamine and 90 dipyridamole) within 15 days of uncomplicated acute myocardial infarction and were followed for a mean of 25 months (range 1-74 months) for reinfarction, unstable angina, and cardiac death." | 3.71 | Incremental prognostic value of stress echocardiography as an adjunct to exercise electrocardiography after uncomplicated myocardial infarction. ( Bax, JJ; Bigi, R; Coletta, C; Desideri, A; Fiorentini, C; Fioretti, PM; Galati, A, 2001) |
| " On multivariate analysis, increased age, previous myocardial infarction, aortic surgery, impaired heart rate variability and a positive thallium scan were independent predictors of primary end-points." | 3.71 | The role of myocardial perfusion scanning, heart rate variability and D-dimers in predicting the risk of perioperative cardiac complications after peripheral vascular surgery. ( Cobbe, SM; Docherty, G; Lowe, GD; Macfarlane, PW; Mamode, N; Martin, W; Pollock, JG, 2001) |
| "Stress-induced ST-segment elevation following myocardial infarction (MI) has been correlated with myocardial ischemia, viability and wall motion abnormality, but its mechanism is still unclear, so the present study compared ST-segment elevation and wall motion response during exercise, dobutamine and dipyridamole stresses." | 3.71 | Stress-induced ST-segment elevation following myocardial infarction and its role in wall motion abnormality, myocardial ischemia and viability: comparison of response to exercise, dobutamine and dipyridamole. ( Hirano, Y; Ishikawa, K; Miyazaki, T; Yamamoto, T, 2001) |
| "The aim of the present study was to assess the relative prognostic value of clinical variables, the exercise electrocardiography test and the pharmacological stress echocardiography test either with dipyridamole or dobutamine early after a first uncomplicated acute myocardial infarction in a large, multicentre, prospective study." | 3.71 | Exercise-electrocardiography and/or pharmacological stress echocardiography for non-invasive risk stratification early after uncomplicated myocardial infarction. A prospective international large scale multicentre study. ( Chiarandà, G; Gandolfo, N; Landi, P; Magaia, O; Margaria, F; Mathias, W; Minardi, G; Picano, E; Pirelli, S; Previtali, M; Seveso, G; Sicari, R, 2002) |
| "To assess the prognostic value of dipyridamole stress echocardiography in survivors of a first uncomplicated acute myocardial infarction." | 3.70 | [Prognostic value of dipyridamole echocardiography in 1st acute uncomplicated myocardial infarction]. ( Azqueta, M; Paré, JC; Sánchez, P; Sanz, GA, 1998) |
| "Dipyridamole-thallium SPECT is safely performed and is useful and important for risk stratification in the long-term follow-up of patients with Kawasaki disease." | 3.70 | Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease. ( Hamamoto, K; Ikezoe, J; Matsumoto, S; Miyagawa, M; Mochizuki, T; Murase, K; Niino, M; Sekiya, M; Tanada, S, 1998) |
| "Ninety patients underwent dipyridamole stress echo and exercise testing at a mean +/- SD of 9 +/- 4 days after admission for acute uncomplicated first myocardial infarction." | 3.70 | Dipyridamole stress echocardiography and exercise testing for risk stratification after uncomplicated myocardial infarction. ( Canel, F; Celegon, L; Cernetti, C; Desideri, A; Suzzi, GL; Terlizzi, R, 1998) |
| "To assess the utility of intravenous dipyridamole thallium testing for predicting major cardiac events following acute myocardial infarction in older patients." | 3.70 | Prognostic value of dipyridamole thallium imaging after acute myocardial infarction in older patients. ( Baird, JB; Fischer, KC; Jain, S; Rich, MW, 1999) |
| "We evaluated the usefulness of preoperative dipyridamole myocardial scintigraphy (DMS) under low-level exercise in predicting postoperative cardiac problems in patients undergoing elective abdominal aortic aneurysm (AAA) repair." | 3.70 | Role of dipyridamole myocardial scintigraphy in abdominal aortic aneurysm repair. ( Harada, H; Hayashi, S; Kitajima, M; Matsumoto, K; Nakamaru, M; Obara, H, 1999) |
| "The aim of this study was to evaluate if dipyridamole-atropine stress echocardiography (DASE) performed between the third-fifth day in uncomplicated acute myocardial infarction allows for an effective risk stratification with an early discharge in some cases." | 3.70 | [The echo-stress test with dipyridamole-atropine on the 3rd-5th day of an uncomplicated acute myocardial infarct for risk stratification and early discharge]. ( Astarita, C; Caso, P; Gambardella, S; Liguori, E; Maresca, FS; Rumolo, S; Severino, S; Stella, P, 2000) |
| "To demonstrate that the administration of dipyridamole at the end of an insufficient maximal subjective exercise test can improve the diagnostic accuracy of single-photon emission computed tomography in patients with previous myocardial infarction, 209 consecutive patients were studied with technetium-99m methoxyisobutyl isonitrile single-photon emission computed tomography and coronary angiography." | 3.70 | Dipyridamole administration at the end of an insufficient exercise Tc-99m MIBI SPECT improves detection of multivessel coronary artery disease in patients with previous myocardial infarction. ( Aguadé-Bruix, S; Bermejo-Fraile, B; Candell-Riera, J; Castell-Conesa, J; Santana-Boado, C; Soler-Soler, J, 2000) |
| "Ninety patients with old myocardial infarction were studied to evaluate the efficacy of intravenous dipyridamole 201Tl imaging for the detection of myocardial ischaemia in post-infarction patients, and to compare the prevalence of ischaemia in 63 patients with post-infarction angina (group I) and 27 patients without angina (group II)." | 3.69 | Comparison of myocardial ischaemia in post-infarction patients with and without angina: assessment by dipyridamole 201T1 imaging. ( Chen, UW; Huang, YF; Jong, SB; Lee, BF; Yang, CC, 1995) |
| "Thirty-eight patients with coronary arterial involvement of Kawasaki disease and 18 control subjects received cardiac ultrafast CT with intravenous long-bolus iodinated contrast injection; dipyridamole was loaded in 40 examinations." | 3.69 | Significance of dipyridamole loading in ultrafast x-ray computed tomography for detection of myocardial ischemia. A study in patients with Kawasaki disease. ( Hamada, S; Kamiya, T; Naito, H; Takamiya, M; Tamura, S; Yoshibayashi, M, 1995) |
| "This study was undertaken to assess the reliability of clinical parameters and dipyridamole-thallium 201 images for predicting the occurrence of future cardiac events (nonfatal myocardial infarction or cardiac death)." | 3.69 | Long-term risk stratification with dipyridamole imaging. ( Bertrand, C; Cerino, M; Eybalin, MC; Gossard, D; Lette, J; Levasseur, A; McNamara, D; Nattel, S; Picard, M; Ruscito, O, 1995) |
| "84 mg/kg over a 10-minute period) dipyridamole echocardiography test (DET) after a first acute myocardial infarction (AMI) in comparison with clinical, electrocardiographic, echocardiographic, and angiographic variables, follow-up data over an average period of 16 months were obtained in 93 consecutive patients." | 3.69 | Positive high-dose dipyridamole echocardiography test after acute myocardial infarction is an excellent predictor of cardiac events. ( Babić, R; Marinković, J; Nesković, AN; Obradović, V; Popović, AD, 1995) |
| " The current study was performed to examine whether sex-specific differences exist in these outcomes in a large population of vascular surgery patients and to determine the value of clinical and dipyridamole thallium variables in predicting myocardial infarction and cardiac death." | 3.69 | Sex differences in perioperative and long-term cardiac event-free survival in vascular surgery patients. An analysis of clinical and scintigraphic variables. ( Chen, MH; Eagle, KA; Hendel, RC; L'Italien, GJ; Leppo, JA; Newell, JB; Paul, SD, 1995) |
| "In recent years, increasing evidence has pointed to the potential of dipyridamole stress echocardiography as a fast, effective, inexpensive method of risk stratification after an acute myocardial infarction." | 3.69 | Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: feasibility, tolerability, safety and in-hospital prognostic value. ( Bellone, P; Bellotti, P; Chiarella, F; Domenicucci, S; Scarsi, G; Vecchio, C, 1994) |
| "To assess the diagnostic and prognostic value of dipyridamole thallium-201 scintigraphy in the "thrombolytic era", we studied 110 consecutive patients younger than 75 recovering from first uncomplicated acute myocardial infarction treated with thrombolytic agents." | 3.69 | [Thallium-dipyridamole in acute myocardial infarction treated by thrombolysis: diagnostic and prognostic value]. ( Cafiero, F; Cammelli, F; D'Urbano, M; Romano, S; Spreafico, GL, 1994) |
| "We hypothesized that left ventricular (LV) cavity size measured on dipyridamole thallium scintigraphy identifies patients at risk for late nonfatal myocardial infarction and cardiovascular death." | 3.69 | Left ventricular cavity size determined by preoperative dipyridamole thallium scintigraphy as a predictor of late cardiac events in vascular surgery patients. ( Dahlberg, S; Emlein, G; Leppo, J; Villegas, B, 1996) |
| "This study assessed and compared the diagnostic potential of submaximal exercise, transesophageal atrial pacing, dipyridamole, and dobutamine-atropine stress echocardiography tests shortly after acute myocardial infarction." | 3.69 | Comparison of the diagnostic potential of four echocardiographic stress tests shortly after acute myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyridamole, and dobutamine-atropine. ( Dingerkus, H; Dissmann, R; Linderer, T; Münzberg, H; Schröder, K; Schultheiss, HP; Völler, H, 1996) |
| "Intravenous dipyridamole-thallium-scintigraphy performed very early after myocardial infarction is safe and useful to predict in-hospital ischemic events." | 3.69 | Prediction of in-hospital cardiac events using dipyridamole-thallium scintigraphy performed very early after acute myocardial infarction. ( Betriu, A; Bosch, X; García, A; Magriñá, J; March, R; Navarro-López, F; Sanz, G, 1996) |
| "In patients with previous myocardial infarction and left ventricular asynergy, dipyridamole infusion may have the capacity to unmask myocardial viability through transient recovery of contractile function in asynergic segments." | 3.69 | Residual myocardial perfusion in reversibly damaged myocardium by dipyridamole contrast echocardiography. ( Chella, P; Distante, A; Ferdeghini, M; L'Abbate, A; Lombardi, M; Magagnini, E; Morris, H; Picano, E; Pieroni, A; Rovai, D; Zanchi, M, 1996) |
| "Seventy-three survivors of an uncomplicated anterior myocardial infarction, 67 men and 7 women, with a mean age of 56 +/- 9 years (34-70 range), underwent T1-SPECT after stress test (62 exercise test and 11 pharmacological Dipyridamole test) as well as coronarographic studies before discharge." | 3.69 | [Detection of residual ischemia after acute anterior myocardial infarction using Thallium-201 SPECT]. ( Campos, JV; Contreras, J; Martínez, A; Martínez, J; Nuno de la Rosa, JA; Picó, F; Ruipérez, JA; Ruiz, JA; Salas, J; Valentí, JA, 1996) |
| "The aim of this study was to assess the incidence of myocardial infarction among persistent perfusion defects in dipyridamole-stress thallium scintigraphy by inspecting autopsied hearts and to evaluate whether the regional thallium activity of a scintigraphic defect can predict the presence of infarction." | 3.69 | Myocardial viability in cases with persistent perfusion defects on the dipyridamole thallium-201 scintigram. A comparative study with autopsy findings. ( Mashima, S; Nakayama, M; Ohkawa, S; Tanno, M; Yamada, H, 1996) |
| "High-dose dipyridamole transesophageal stress echocardiography has recently been proposed as a useful and safe method to assess myocardial ischemia in patients with poor transthoracic acoustic window." | 3.69 | Usefulness of dipyridamole transesophageal echocardiography in the evaluation of myocardial ischemia and coronary artery flow. ( Ceci, V; Galati, A; Goletta, C; Greco, G; Ricci, R; Richichi, G; Serdoz, R, 1996) |
| "Verify the value of the combined use of Dipyridamole Stress Echocardiography (DSE) and Exercise Testing (ET) for predicting cardiac events after Thrombolysed Myocardial Infarction (TMI)." | 3.69 | [Combined use of bicycle ergometry test and echo-dipyridamole in stratification of risk after thrombolysed myocardial infarct]. ( Candelpergher, G; Canel, F; Celegon, L; Cisotto, P; Colangeli, G; Desideri, A; Maggiolo, G; Suzzi, G; Terlizzi, R, 1996) |
| "We have recently shown that in patients with single vessel disease and no myocardial infarction, a complex plaque morphology makes myocardium more vulnerable to ischaemia during dipyridamole echocardiography testing." | 3.69 | Impact of culprit lesion morphology on prevalence of provoked myocardial ischaemia in patients with old myocardial infarction. A dipyridamole stress echocardiography, exercise electrocardiography and angiographic study. ( Biagini, A; DeNes, M; Distante, A; L'Abbate, A; Lu, C; Marzilli, M; Wang, Y, 1997) |
| "We evaluate 1,271 patients from the Thrombolysis in Myocardial Infarction (TIMI)-IIIB trial (86% of TIMI-IIIB cohort) with unstable angina or non-Q wave myocardial infarction, who underwent predischarge exercise (92%) or dipyridamole stress (8%) Tl-201 imaging." | 3.69 | Relevance of increased lung thallium uptake on stress imaging in patients with unstable angina and non-Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI)-IIIB Study. ( Jain, D; Thompson, B; Wackers, FJ; Zaret, BL, 1997) |
| "Echocardiographically recognized resting function, myocardial viability (by low-dose dobutamine) and stress-induced ischemia (by high-dose dipyridamole) are potent predictors of subsequent events, but their relative value in patients evaluated very early after acute myocardial infarction remains to be established." | 3.69 | Ultra-early risk stratification after myocardial infarction via pharmacological stress echocardiography: the relative value of resting function, viability and myocardial ischemia. ( Aruta, E; Presbitero, P; Sclavo, M, 1997) |
| "Fifty-one patients underwent simultaneous dipyridamole stress echocardiography and scintigraphy at a mean +/- SD of 12 +/- 3 days after admission for acute uncomplicated myocardial infarction." | 3.69 | [Echocardiography or stress scintigraphy with dipyridamole for the stratification of risk after acute myocardial infarction?]. ( Candelpergher, G; Celegon, L; Colangeli, G; Desideri, A; Favero, A; Ferlin, G; Suzzi, GL; Terlizzi, R; Zanco, P, 1997) |
| "To determine the safety and prognostic value of dipyridamole thallium-201 scintigraphy performed in patients within three to five days of acute myocardial infarction, including those receiving thrombolytic treatment." | 3.69 | Dipyridamole thallium-201 scintigraphy for early risk stratification of patients after uncomplicated myocardial infarction. ( Groom, GN; Hands, ME; Hung, J; Moshiri, M; Parsons, RW; Van der Schaaf, AA, 1997) |
| "We evaluated the usefulness of a decrease in the average peak velocity from 4 to 10 minutes after infusion of dipyridamole for detecting myocardial ischemia in 50 patients, including patients with a prior myocardial infarction." | 3.69 | Mechanisms of limited maximum coronary flow in severe single-vessel coronary artery disease in humans due to vertical steal. ( Arima, S; Fukumoto, N; Hamasaki, S; Kamekou, M; Kihara, K; Nakano, F; Nakao, S; Shono, H; Tanaka, H; Yamaguchi, T, 1997) |
| "The aim of this study was to evaluate a circumferential profile method of analysis (CPA) of the Fourier image of amplitude (FA), obtained by equilibrium gated radionuclide angiocardiography (EGRA) in the assessment of the response to the dipyridamole (DIP) test in patients with previous myocardial infarction." | 3.68 | Fourier amplitude image circumferential profile analysis in the evaluation of the dipyridamole test. ( Bestetti, A; Castellani, M; Chiti, A; Giovanella, L; Lomuscio, A; Pedrazzini, L; Tarolo, GL, 1993) |
| "The aim of this study was to examine the ability of Dipyridamole Echocardiography Test (DET)--performed early after an acute myocardial infarction (AMI)--to assess: a) the presence of induced ischemia and its relation with coronary artery stenoses; b) the presence of myocardial viability and the comparison with late wall motion; c) the appearance of cardiac events during hospitalization and in the following period." | 3.68 | [The usefulness of the echo-dipyridamole test in the early period after an uncomplicated acute myocardial infarct]. ( Biffani, G; Boccardi, L; Di Segni, M; Lioy, E; Loschiavo, P; Milazzotto, F; Minardi, G; Natale, E; Pucci, E; Tubaro, M, 1993) |
| " The alterations of flow documented a horizontal epicardial steal induced during dipyridamole hyperemia, hyperemic flow reversal by intravenous aminophylline, and subsequent normalization of distal hyperemia after endoluminal enlargement by successful angioplasty." | 3.68 | Quantitative demonstration of dipyridamole-induced coronary steal and alteration by angioplasty in man: analysis by simultaneous, continuous dual Doppler spectral flow velocity. ( Aguirre, FV; Bach, RG; Caracciolo, EA; Donohue, TJ; Flynn, MS; Kern, MJ; Wolford, T, 1993) |
| "Exercise stress test, 24-hour-ambulatory electrocardiographic monitoring and myocardial perfusion 201-Thallium single photon emission computerized tomography (SPECT) with dipyridamole pharmacological stress probably have different sensitivities and specificities for the identification of residual ischemia after an acute myocardial infarction." | 3.68 | [Determination of myocardial risk on basis of the outcome of previous myocardial infarcts. Advantages of myocardial tomoscintigraphy using thallium with dipyridamole]. ( Baroffio, R; Palagi, B, 1993) |
| "To assess the usefulness of radionuclide tests in detecting coronary occlusive lesions in children with Kawasaki disease, we compared the results of stress thallium-201 myocardial single photon emission computed tomography with dipyridamole infusion and coronary angiography in 34 patients (19 males and 15 females)." | 3.68 | Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram. ( Fukazawa, M; Fukushige, J; Hijii, T; Ichiya, Y; Igarashi, H; Kuwabara, Y; Narabayashi, H; Otsuka, M; Takeuchi, T; Ueda, K, 1993) |
| "In an attempt to predict high risk myocardial infarction, we studied 201 patients with Q wave infarction with dipyridamole-loading thallium-201 myocardial perfusion scintigraphy (D-MPS), left ventriculography, coronary angiography and treadmill exercise testing." | 3.68 | [Assessment of prognosis of old myocardial infarction]. ( Doi, Y; Hamashige, N; Kuzume, O; Murai, T; Odawara, H; Ozawa, T; Takata, J; Yamada, M; Yonezawa, Y, 1992) |
| "Three cases of postoperative myocardial infarction are reported in patients with normal or fixed defects on preoperative dipyridamole thallium scans (interpreted as "negative" for active cardiac ischaemic risk)." | 3.68 | Failure of negative dipyridamole thallium scans to predict perioperative myocardial ischaemia and infarction. ( Fleisher, LA; Nelson, AH; Rosenbaum, SH, 1992) |
| "The prevalence and prognostic significance of silent myocardial ischemia were prospectively assessed in 217 patients (mean age 57 +/- 9 years, 83% male) recovering from a first uncomplicated acute myocardial infarction and undergoing a dipyridamole echocardiography test before hospital discharge." | 3.68 | Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: clinical and prognostic significance. ( Bolognese, L; Bongo, AS; Dellavesa, P; Prando, MD; Rossi, L; Rossi, P; Sarasso, G, 1992) |
| "A case of myocardial infarction secondary to dipyridamole overdose is described in a 62-year-old woman with longstanding angina." | 3.68 | Myocardial infarction secondary to dipyridamole overdose. ( Holdright, DR; Jahangiri, M, 1992) |
| " Dipyridamole echocardiography test (DET, 67 patients) and exercise electrocardiography test (EET, 104 patients) were performed to assess sensitivity and specificity in identifying patients at risk for an unfavorable clinical outcome and subsequent cardiac events: 67 patients underwent coronary arteriography within 4 weeks after AMI." | 3.68 | [The usefulness of the echo-dipyridamole and exercise tests in risk stratification in patients with acute uncomplicated myocardial infarct after systemic thrombolysis]. ( Morselli, L; Noussan, P; Presbitero, P; Sclavo, M, 1991) |
| "To examine the incidence of arrhythmias in dipyridamole infusion and the relation between dipyridamole-induced arrhythmias and ST-segment depression, dipyridamole electrocardiography tests were performed on 100 patients with coronary artery disease." | 3.68 | Relation between the incidence of arrhythmias and ischemic ST-segment depression during dipyridamole electrocardiography test in patients with coronary artery disease. ( Hanashima, K; Ikeda, K; Kubota, I; Shibata, T; Tsuiki, K; Yamaki, M; Yasui, S, 1991) |
| "Fifty three patients were studied with dipyridamole thallium myocardial scintigraphy, 4 to 6 days after a first episode of myocardial infarction." | 3.68 | [Early test of thallium dipyridamole after myocardial infarction: prognostic value and correlation with coronarography]. ( Corbalán, R; Galleguillos, CG; Kunstmann, S; Marchant, E; Olea, E; Orellana, P; Puschel, K, 1991) |
| "Dipyridamole 201Tl imaging has been proposed as an alternative to exercise ECG testing for the prehospital discharge evaluation of patients recovering from myocardial infarction." | 3.68 | Dipyridamole 201Tl scintigraphy in the evaluation of prognosis after myocardial infarction. ( Glover, DK; Leppo, JA; Okada, RD, 1991) |
| "To assess whether the different mechanical effects of intravenous dipyridamole were correlated with the location and distribution of the coronary arteries stenosis, 98 patients underwent high dose DET 8-10 days after an acute myocardial infarction." | 3.68 | [The echo-dipyridamole test early after acute myocardial infarct: echocardiographic aspects and angiographic correlations]. ( Aralda, D; Bolognese, L; Bongo, AS; Francalacci, G; Piccinino, C; Prando, ME; Rossi, L; Rossi, P; Sarasso, G, 1991) |
| "84 patients (pts) with recent first uncomplicated myocardial infarction underwent during the early post-infarction period, dipyridamole (D) test (EKG-ECHO-THALLIUM) and coronary arteriography in order to verify its feasibility, safety and usefulness in the detection of residual jeopardized but viable myocardium and in the diagnosis of multivessel disease." | 3.68 | [Prognostic stratification of non complicated acute myocardial infarct. Usefulness of the dipyridamole test with ecg-echo-thallium 201]. ( Cafiero, F; Cammelli, F; Castelli, C; D'Urbano, M; Passoni, F; Romano, S; Seveso, G; Spaziani, D, 1991) |
| "84 mg/kg over 10 minutes) dipyridamole 2D echocardiography test (DET) were evaluated in 78 asymptomatic patients 10 to 14 days after uncomplicated acute myocardial infarction and the results were compared with those of exercise stress test (EST)." | 3.68 | [Prognostic value of echocardiography with high-dose dipyridamole after recent uncomplicated myocardial infarction]. ( Belli, R; Bosco, M; Gandolfo, N; Parigi, A; Schon, W, 1991) |
| "To assess the value and safety of echo-dipyridamole test in risk stratification soon after an uncomplicated acute myocardial infarction, 56 consecutive patients were enrolled in a prospective study with a 1-year follow-up period for new coronary events." | 3.68 | [Risk stratification after uncomplicated myocardial infarct: the usefulness of the echocardiographic-dipyridamole test]. ( De Benedictis, N; Margaria, F; Meinardi, F; Ugliengo, G; Vado, A, 1990) |
| "To evaluate safety and usefulness of dipyridamole-radionuclide ventriculography (D-RVG), soon after acute myocardial infarction (MI), in the prediction of future cardiac events." | 3.68 | [Cineventriculography with radionuclides and intravenous dipyridamole in the prognostic evaluation after acute myocardial infarction]. ( de Almeida, LA; Escosteguy, CC; Esteves, RN; Futuro, DO; Pantoja, MR; Pinto, JC; Saad, EA, 1990) |
| "We evaluated 50 consecutive patients who received thrombolytic therapy for acute myocardial infarction using thallium-201 single photon emission computed tomography in combination with oral dipyridamole (300 mg) to assess the frequency of residual myocardial ischemia." | 3.68 | Comparison of coronary angiography and early oral dipyridamole thallium-201 scintigraphy in patients receiving thrombolytic therapy for acute myocardial infarction. ( Adams, KF; Hicks, RR; Jain, A; McCarthy, JJ; Myers, GH; Perry, JR, 1990) |
| "The value of the oral dipyridamole-thallium stress test in identifying patients at high risk of myocardial infarction after vascular procedures has not been documented." | 3.68 | Cardiac risk in vascular surgery. The oral dipyridamole-thallium stress test. ( Arvan, S; Makaroun, MS; Rippey, A; Schreiner, D; Shuman-Jackson, N, 1990) |
| "The ability of dipyridamole-thallium-201 imaging to predict in-hospital and late cardiac events when performed very early (62 +/- 21 hours, range 23 to 102) after acute myocardial infarction (AMI) was tested in 50 patients." | 3.68 | Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. ( Brown, KA; Chambers, CE; O'Meara, J; Plante, DA, 1990) |
| "This report describes the occurrence of chest pain and electrocardiographic features of acute myocardial infarction following intravenous dipyridamole-handgrip stress." | 3.68 | Acute myocardial infarction associated with intravenous dipyridamole for rubidium-82 PET imaging. ( Hollman, J; Marwick, TH, 1990) |
| "To evaluate the safety and usefulness of serial thallium scanning immediately after intravenous dipyridamole, we studied 51 patients recovering from acute myocardial infarction." | 3.67 | Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. ( Getchell, JD; Lee, VW; Leppo, JA; O'Brien, J; Rothendler, JA, 1984) |
| "In the present study 27 post-myocardial infarction patients were treated with Persantin capsules (Depot-Kapseln, sustained release form), containing 200 mg dipyridamole, b." | 3.67 | Plasma concentrations of platelet-specific proteins and serum thromboxane B2 production in response to treatment with dipyridamole. A pilot study of 27 post-myocardial infarction patients. ( Kutti, J; Safai-Kutti, S; Vedin, A; Wilhelmsson, C, 1985) |
| "In order to examine the clinical usefulness of the vulnerability map, body surface mapping was performed in ten normal subjects and 32 patients with CAD using dipyridamole infusion to induce ventricular arrhythmias." | 3.67 | Using body surface mapping to detect vulnerability to ventricular arrhythmias in patients with coronary artery disease. ( Ikeda, K; Kubota, I; Tsuiki, K; Yasui, S; Yasumura, S, 1987) |
| "The prognostic value of predischarge dipyridamole-thallium scanning after uncomplicated myocardial infarction was determined by comparison with submaximal exercise electrocardiography and 6-week maximal exercise thallium imaging and by correlation with clinical events." | 3.67 | Prognostic utility of predischarge dipyridamole-thallium imaging compared to predischarge submaximal exercise electrocardiography and maximal exercise thallium imaging after uncomplicated acute myocardial infarction. ( Boucher, CA; Gimple, LW; Guiney, TE; Hutter, AM, 1989) |
| "Dipyridamole thallium scintigraphy (TI-DP) and dipyridamole two-dimensional echocardiography (Echo-DP) were performed on 38 patients (pts), 11 +/- 4 days after acute myocardial infarction." | 3.67 | [Myocardial scintigraphy using 201-thallium and 2-dimensional echocardiogram after dipyridamole infusion in the early evaluation of post-infarct residual ischemia]. ( Capacci, PF; Casanova, R; Jacopi, F; Maresta, A; Patroncini, A; Pirazzini, L; Zarabini, GE, 1989) |
| "The aim of this study was to evaluate the usefulness of the dipyridamole-echocardiography test soon after non Q wave myocardial infarction." | 3.67 | [Prognostic meaning of the echo-dipyridamole test in recent non-Q myocardial infarct]. ( De Ponti, C; Fiorini, G; Prina, L, 1989) |
| "In order to determine the safety and hemodynamic effects of intravenous dipyridamole infusion for thallium-201 scinitigraphy in patients with acute ischemic syndromes, 10 patients with recent uncomplicated myocardial infarction (7 +/- 2 days pre-test) had central pressures and cardiac output values measured serially in a coronary care unit during and after the administration of dipyridamole (0." | 3.67 | Acute hemodynamic changes during intravenous dipyridamole thallium imaging early after infarction. ( Blumhardt, R; Boucher, CA; Chaudhuri, TK; Miller, DD; O'Rourke, RA; Riesmeyer, JS; Scott, RA, 1989) |
| "Results of recent clinical trials on secondary prevention of ischemic heart disease indicate that judicious, long-term administration of adrenergic beta blockers and platelet-active drugs such as aspirin and Persantine (dipyridamole) would seem to yield protection against mortality associated with acute myocardial infarction, including sudden death." | 3.67 | Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases. ( Borhani, NO, 1985) |
| "To evaluate the safety and usefulness of myocardial thallium-201 scintigraphy after intravenous dipyridamole during the early post-infarction period, 35 patients under 60 years of age and with recent first transmural uncomplicated myocardial infarction (27 inferior, 8 anterior) were examined between the 5th and 13th day of hospitalization." | 3.67 | Dipyridamole-thallium 201 scintigraphy in the early post-infarction period. (Safety and accuracy in predicting the extent of coronary disease and future recurrence of angina in patients suffering from their first myocardial infarction). ( Campolo, L; Corrada, E; Inglese, E; Pirelli, S; Suppa, M, 1988) |
| "A case of cardiac arrest and subsequent acute myocardial infarction occurring during thallium-201 imaging with oral dipyridamole augmentation is presented." | 3.67 | Cardiac arrest during dipyridamole imaging. ( Blumenthal, MS; McCauley, CS, 1988) |
| "The investigations concerning the significance of the systolic time intervals in the dipyridamole test for the diagnosis of the coronary heart disease were carried out in 15 healthy test persons and 40 patients with coronary heart disease." | 3.67 | [The significance of systolic time intervals in the dipyridamole test for the diagnosis of coronary disease]. ( Cholewa, M; Gawor, Z; Markiewicz, K, 1988) |
| "In 41 patients with a history of an acute myocardial infarction, the location of myocardial ischemia was studied by 201Tl emission computed tomography immediately and 3 h after intravenous dipyridamole." | 3.67 | [Localization and quantification of ischemic myocardial areas in the postinfarct phase by dipyridamole 201thallium emission computerized tomography]. ( Bleifeld, W; Clausen, A; Montz, R; Nienaber, CA; Salge, D; Spielmann, RP, 1986) |
| " In this study, twenty hours after coronary ligature, cardiac arrhythmia was reduced by oral administration of quinidine and phenytoin." | 3.67 | Use of experimental myocardial infarct to demonstrate arrhythmogenic activity of drugs. ( Duchene-Marullaz, P; Lavarenne, J; Trolese, JF; Trolese-Mongheal, Y, 1985) |
| "Baseline white blood cell count (WCC) and haematocrit were examined in relation to recurrent coronary events and to all-cause mortality in 2026 persons enrolled in the first Persantin-Aspirin Reinfarction Study (PARIS-1) 2-60 months after myocardial infarction." | 3.67 | White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. ( Barton, BA; Forbes, CD; Krol, WF; Lowe, GD; Machado, SG, 1985) |
| "The effects on an acute myocardial infarction of equipotent hypotensive doses of nitroglycerin and dipyridamole were studied using the thermographic technique in open-chest dogs." | 3.66 | Effects of nitroglycerin and dipyridamole on acute myocardial infarction: a thermographic study in the dog. ( Arborelius, M; Bornmyr, S; Gil, RL; Lilja, B; Malm, A, 1979) |
| "On the basis of an examination of 412 patients with myocardial infarction the efficacy of a long-term employment (for 3--4 days) of a neuroleptic Droperidol and a vasodilator Curantyl was examined." | 3.65 | [Experience with combined use of neurolepsy and vasodilator substances in the treatment of patients with acute myocardial infarct]. ( Aleksandrova, LA; Avdiushko, BR; Gvatua, NA; Kravtsov, VL; Strokach, NT, 1976) |
| "The dipyridamole-atropine test was well tolerated and accomplished in all patients." | 2.68 | [Use of high doses of atropine during dipyridamole echocardiography: safety and efficacy of the combined test]. ( Ceci, V; Coletta, C; Galati, A; Greco, G; Ricci, R, 1995) |
| "Dipyridamole was applied in 550 interventions (455 interventions in men, 95 interventions in women, age = 59." | 2.68 | [Intracoronary dipyridamole reduces the incidence of acute coronary vessel occlusion in percutaneous transluminal coronary angioplasty--a prospective randomized study]. ( Heidland, UE; Heintzen, MP; Kelm, M; Klimek, WJ; Leschke, M; Michel, CJ; Schwartzkopff, B; Strauer, BE; Vester, EG, 1997) |
| " At 24 hours, 202 patients were randomized to continue intravenous heparin therapy (n = 99) in full dosage or to discontinue heparin therapy and begin an oral antiplatelet regimen of aspirin (300 mg/day) and dipyridamole (300 mg/day) (n = 103)." | 2.67 | A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group. ( Aylward, PE; Federman, J; Giles, RW; Harris, PJ; Hodge, RL; Nelson, GI; Thompson, PL; Thomson, A; Tonkin, AM; Walsh, WF, 1991) |
| "Following elective abdominal aortic aneurysm (AAA) repair the commonest cause for perioperative death is cardiac-related." | 2.42 | Abdominal aortic aneurysms and concomitant coronary artery disease. Is routine dipyridamole thallium scintigraphy still justified? ( Galland, RB, 2003) |
| "Dipyridamole was not more efficacious in the prevention of vascular death (relative risk [RR], 1." | 2.42 | Cochrane review: dipyridamole for preventing major vascular events in patients with vascular disease. ( Algra, A; De Schryver, EL; van Gijn, J, 2003) |
| "Early treatment of acute myocardial infarction (AMI) can improve the rate of coronary patency, salvage myocardium, and ultimately save lives; thus, rapid recognition of patients at a higher risk of developing AMI is very important." | 2.41 | Diagnostic and prognostic use of stress echo in acute coronary syndromes including emergency department imaging. ( Ismaeil, M; Zabalgoitia, M, 2000) |
| "Between 2008 and 2018, consecutive patients with HFrEF defined by left ventricular ejection fraction <40% prospectively referred for vasodilator stress perfusion CMR were followed for the occurrence of major adverse cardiovascular events (MACE), defined by cardiovascular death or nonfatal myocardial infarction." | 1.56 | Safety and Prognostic Value of Vasodilator Stress Cardiovascular Magnetic Resonance in Patients With Heart Failure and Reduced Ejection Fraction. ( Bonnet, G; Champagne, S; Claude Morice, M; Garot, J; Garot, P; Hovasse, T; Kinnel, M; Landon, V; Louvard, Y; Pezel, T; Sanguineti, F; Unterseeh, T, 2020) |
| "Death and myocardial infarction were the clinical end points." | 1.51 | Age- and Gender-Specific Prognostic Cutoff Values of Coronary Flow Velocity Reserve in Vasodilator Stress Echocardiography. ( Bovenzi, F; Ciampi, Q; Cortigiani, L; Lombardo, A; Picano, E; Rigo, F, 2019) |
| "The primary outcome was first recurrence of stroke of any type and the secondary outcome was a composite of stroke, myocardial infarction, or death from vascular causes." | 1.37 | Level of systolic blood pressure within the normal range and risk of recurrent stroke. ( Bath, PM; Cotton, D; Diener, HC; Donnan, GA; Martin, RH; Ovbiagele, B; Vinisko, R; Yusuf, S, 2011) |
| " This case shows that, in such particular conditions, a change in dipyridamole dosage can induce a myocardial infarction even if its blood level remains in the therapeutic range." | 1.36 | [Myocardial infarction after voluntary intoxication by drug interaction between dipyridamole and aspirin]. ( Amat, G; Brahic, H; Eschalier, A; Eschalier, R; Marcaggi, X; Ravan, R, 2010) |
| "Only in stunned myocardium (in the setting of single-vessel disease), dipyridamole tends to normalize deformation." | 1.35 | The quantification of dipyridamole induced changes in regional deformation in normal, stunned or infarcted myocardium as measured by strain and strain rate: an experimental study. ( Bijnens, B; Boettler, P; Claus, P; D'hooge, J; Marciniak, A; Marciniak, M; McLaughlin, M; Rademakers, F; Streb, W; Sutherland, GR, 2008) |
| "Dipyridamole (DIP) is a powerful antioxidant and increases adenosine concentration." | 1.33 | The beneficial effect of insulin, glucose, and dipyridamole on regional left ventricular function early after acute myocardial infarction. ( Bedetti, G; Bugiardini, R; Gabrieli, L; Pasanisi, E; Picano, E; Pizzi, C; Varga, A, 2005) |
| "The intramural coronary arteriosclerosis showed thickening of the wall due to medial hyperplasia by fibrosis, and arterial stenosis." | 1.33 | Chronic myocardial infarction due to arteriosclerosis of coronary arteries followed by acute thromboembolism of caudal abdominal aorta in a cat. ( Hikasa, Y; Minami, S; Morita, T; Okamoto, Y; Shimada, A; Tsujino, K, 2005) |
| "Myocardial infarction was defined as an area with hyperenhancement at delayed-enhancement imaging." | 1.33 | Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. ( Brady, TJ; Cattani, CA; Cury, RC; de Gois, JM; Gabure, LA; Lima, SS; Racy, DJ; Siebert, U, 2006) |
| "Adverse cardiac events were defined as congestive heart failure (CHF), myocardial infarction (MI), unstable angina (USA), and ventricular arrhythmias." | 1.31 | An abnormal dipyridamole thallium/sestamibi fails to predict long-term cardiac events in vascular surgery patients. ( de Virgilio, C; Donayre, C; Elbassir, M; Ephraim, L; Toosie, K; Wall, DB; White, R, 2001) |
| "Arbutamine is a new catecholamine that has been developed as a pharmacologic stress agent for the diagnosis of coronary artery disease." | 1.30 | [Whole body distribution of Tc-99m-sestamibi after pharmacological stress with arbutamine and dipyridamole compared with resting conditions]. ( Bergmann, K; Glatz, S; Höher, M; Kotzerke, J; Reske, SN, 1997) |
| "Thirty-eight patients with Kawasaki disease and 11 age-matched controls participated in the study." | 1.30 | Noninvasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing. ( Akagi, T; Fukuda, T; Inoue, O; Ishibashi, M; Kato, H; Sugimura, T, 1998) |
| "Furthermore." | 1.30 | Valsartan and coronary haemodynamics in early post-myocardial infarction in rats. ( De Gasparo, M; Fornes, P; Gervais, M; Giudicelli, JF; Richer, C, 1999) |
| "Dipyridamole 0." | 1.28 | Atrial fibrillation after intravenous dipyridamole for thallium imaging. ( Ell, PJ; Pennell, DJ, 1992) |
| "Large myocardial infarction is associated with reactive hypertrophy and dilation of the left ventricle, depressed coronary flow reserve, and the development of heart failure including systemic vasoconstriction." | 1.28 | Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction. ( Christes, A; Drexler, H; Hablawetz, E; Lu, W; Riede, U, 1992) |
| "A dipyridamole study was recommended instead of exercise because of arthritis, severe obesity, peripheral vascular disease, pulmonary disease, other chronic illnesses, or combinations of these problems." | 1.28 | Long-term prognostic value of a normal dipyridamole thallium-201 perfusion scan. ( Gal, RA; Gunasekera, J; Massardo, T; Port, SC; Shalev, Y, 1991) |
| " Use of parenteral aminophylline to treat adverse events associated with intravenous dipyridamole brought complete relief of symptoms in 439 of 454 patients (96." | 1.28 | The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. ( Kempthorne-Rawson, J; Ranhosky, A, 1990) |
| "Dipyridamole testing was positive (greater than or equal to 1 mm ST depression on electrocardiogram) in 7 of 22 patients with coronary arterial disease, of whom 6 had positive treadmill stress testing." | 1.28 | Evaluation of coronary arterial disease by oral dipyridamole stress testing using 12-lead electrocardiography. ( Akyol, T; Cağlar, N; Kaymakçalan, S; Oral, D; Pamir, G, 1990) |
| "Dipyridamole was infused intravenously at a rate of 0." | 1.27 | [Dipyridamole-loading scintigraphy in patients with subendocardial infarction using single photon emission computed tomography]. ( Bunkou, H; Masuda, M; Mori, K, 1988) |
| "Dipyridamole was infused intravenously at a rate of 0." | 1.27 | [Reverse redistribution in dipyridamole-loading thallium-201 images using single photon emission computed tomography]. ( Bunko, H; Masuda, M; Mori, K, 1986) |
| "Two cases with the heart murmurs considered to be caused by aortocoronary (A-C) bypass surgery were reported." | 1.26 | [Two cases with the heart murmur originated from aortocoronary bypass: the diagnostic use of dipyridamole (author's transl)]. ( Akiyama, M; Iuchi, K; Jinbo, M; Nozawa, T; Sugimoto, T; Terada, Y; Uraoka, T; Yokawa, S, 1981) |
| "The dipyridamole stress test was well tolerated by patients with unstable angina too and showed a diagnostic sensitivity equivalent to that with exercise stress, although the latter appears better as regards image quality and can give an increase of sensitivity provided electrocardiographic findings are evaluated." | 1.26 | [Clinical usefulness of thallium-201 myocardial scintigraphy with dipyridamole pharmacodynamic test in ischemic heart disease (author's transl)]. ( Ferrari, A; Picozzi, R; Roda, L; Tarolo, GL; Tramacere, PL; Vecchi, C, 1981) |
| "Sulfinpyrazone treatment of patients with myocardial infarction (Killip--classification I and II), starting 25--35 days after the acute myocardial infarction, reduces cardiac mortality and incidence of sudden death for a period of two years." | 1.26 | [Action mechanism and clinical indications for thrombocyte aggregation inhibitors]. ( Oelz, O, 1979) |
| "and sulfinpyrazone have been tested in several large scale clinical trials." | 1.26 | [Antiplatelet drugs (author's transl)]. ( Dechavanne, M; Follea, G; Trzeciak, MC, 1979) |
| "1 The effects of propranolol and practolol, at equivalent myocardial beta-adrenoceptor blocking doses, (as assessed by the degree of shift of isoprenaline dose-response curves) were investigated in anaesthetized greyhounds before and after acute coronary artery ligation." | 1.26 | Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction. ( Marshall, RJ; Parratt, JR, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 252 (45.00) | 18.7374 |
| 1990's | 204 (36.43) | 18.2507 |
| 2000's | 79 (14.11) | 29.6817 |
| 2010's | 24 (4.29) | 24.3611 |
| 2020's | 1 (0.18) | 2.80 |
| Authors | Studies |
|---|---|
| Pezel, T | 1 |
| Sanguineti, F | 1 |
| Kinnel, M | 1 |
| Landon, V | 1 |
| Bonnet, G | 1 |
| Garot, P | 1 |
| Hovasse, T | 1 |
| Unterseeh, T | 1 |
| Champagne, S | 1 |
| Louvard, Y | 1 |
| Claude Morice, M | 1 |
| Garot, J | 1 |
| Do, HP | 1 |
| Ramanan, V | 1 |
| Qi, X | 1 |
| Barry, J | 1 |
| Wright, GA | 1 |
| Ghugre, NR | 1 |
| Nayak, KS | 1 |
| Wang, MT | 1 |
| Liang, HL | 1 |
| Hung, CC | 1 |
| Tang, PL | 1 |
| Lin, KC | 1 |
| Chiang, CH | 1 |
| Kuo, FY | 1 |
| Yang, JS | 1 |
| Liu, CP | 1 |
| Mar, GY | 1 |
| Huang, WC | 1 |
| Cortigiani, L | 11 |
| Ciampi, Q | 1 |
| Lombardo, A | 1 |
| Rigo, F | 4 |
| Bovenzi, F | 2 |
| Picano, E | 19 |
| Romero-Farina, G | 1 |
| Candell-Riera, J | 3 |
| Aguadé-Bruix, S | 3 |
| Ferreira-González, I | 1 |
| Cuberas-Borrós, G | 1 |
| Pizzi, N | 1 |
| García-Dorado, D | 1 |
| Figueredo, VM | 1 |
| Okusa, C | 1 |
| Kaneda, K | 1 |
| Inamura, Y | 1 |
| Miyamae, M | 1 |
| Pontone, G | 1 |
| Andreini, D | 1 |
| Bertella, E | 1 |
| Loguercio, M | 1 |
| Guglielmo, M | 1 |
| Baggiano, A | 1 |
| Aquaro, GD | 1 |
| Mushtaq, S | 1 |
| Salerni, S | 1 |
| Gripari, P | 1 |
| Rossi, C | 1 |
| Segurini, C | 1 |
| Conte, E | 1 |
| Beltrama, V | 1 |
| Giovannardi, M | 1 |
| Veglia, F | 1 |
| Guaricci, AI | 1 |
| Bartorelli, AL | 1 |
| Agostoni, P | 1 |
| Pepi, M | 1 |
| Masci, PG | 1 |
| Sacco, RL | 1 |
| Diener, HC | 5 |
| Yusuf, S | 2 |
| Cotton, D | 2 |
| Ounpuu, S | 1 |
| Lawton, WA | 1 |
| Palesch, Y | 1 |
| Martin, RH | 2 |
| Albers, GW | 1 |
| Bath, P | 1 |
| Bornstein, N | 1 |
| Chan, BP | 1 |
| Chen, ST | 1 |
| Cunha, L | 1 |
| Dahlöf, B | 1 |
| De Keyser, J | 1 |
| Donnan, GA | 2 |
| Estol, C | 1 |
| Gorelick, P | 1 |
| Gu, V | 1 |
| Hermansson, K | 1 |
| Hilbrich, L | 1 |
| Kaste, M | 1 |
| Lu, C | 3 |
| Machnig, T | 2 |
| Pais, P | 1 |
| Roberts, R | 1 |
| Skvortsova, V | 1 |
| Teal, P | 1 |
| Toni, D | 1 |
| Vandermaelen, C | 1 |
| Voigt, T | 1 |
| Weber, M | 1 |
| Yoon, BW | 1 |
| Bhavsar, J | 1 |
| Rosenson, RS | 1 |
| Banko, LT | 1 |
| Haq, SA | 1 |
| Rainaldi, DA | 1 |
| Klem, I | 1 |
| Siegler, J | 1 |
| Fogel, J | 1 |
| Sacchi, TJ | 1 |
| Heitner, JF | 1 |
| Ye, Y | 2 |
| Long, B | 1 |
| Qian, J | 1 |
| Perez-Polo, JR | 2 |
| Birnbaum, Y | 2 |
| Ho, KT | 1 |
| Chua, KC | 1 |
| Klotz, E | 1 |
| Panknin, C | 1 |
| Tanzilli, G | 1 |
| Greco, C | 1 |
| Pasceri, V | 1 |
| Pelliccia, F | 1 |
| Arrivi, A | 1 |
| Placanica, A | 1 |
| Mangieri, E | 1 |
| Eschalier, R | 1 |
| Eschalier, A | 1 |
| Ravan, R | 1 |
| Brahic, H | 1 |
| Marcaggi, X | 1 |
| Amat, G | 1 |
| De Caterina, R | 1 |
| Massaro, M | 1 |
| Scoditti, E | 1 |
| Annunziata Carluccio, M | 1 |
| Gilchrist, IC | 1 |
| Muzzarelli, S | 1 |
| Ordovas, KG | 1 |
| Cannavale, G | 1 |
| Naeger, D | 1 |
| Michaels, AD | 1 |
| Higgins, CB | 1 |
| Ziadi, MC | 1 |
| Dekemp, RA | 1 |
| Williams, KA | 1 |
| Guo, A | 1 |
| Chow, BJ | 1 |
| Renaud, JM | 1 |
| Ruddy, TD | 2 |
| Sarveswaran, N | 1 |
| Tee, RE | 1 |
| Beanlands, RS | 1 |
| Greenhalgh, J | 1 |
| Bagust, A | 1 |
| Boland, A | 1 |
| Martin Saborido, C | 1 |
| Oyee, J | 1 |
| Blundell, M | 1 |
| Dundar, Y | 1 |
| Dickson, R | 1 |
| Proudlove, C | 1 |
| Fisher, M | 1 |
| Bodi, V | 1 |
| Husser, O | 1 |
| Sanchis, J | 1 |
| Núñez, J | 1 |
| Monmeneu, JV | 1 |
| López-Lereu, MP | 1 |
| Bosch, MJ | 1 |
| Rumiz, E | 1 |
| Miñana, G | 1 |
| García, C | 1 |
| Diago, JL | 1 |
| Chaustre, F | 1 |
| Moratal, D | 1 |
| Gómez, C | 1 |
| Aguilar, J | 1 |
| Chorro, FJ | 1 |
| Llacer, A | 1 |
| Ovbiagele, B | 1 |
| Vinisko, R | 1 |
| Bath, PM | 2 |
| Senior, R | 2 |
| Shah, BN | 1 |
| Gaibazzi, N | 2 |
| Reverberi, C | 2 |
| Lorenzoni, V | 2 |
| Molinaro, S | 2 |
| Porter, TR | 1 |
| Bartolomucci, F | 1 |
| Marwick, TH | 3 |
| Madsen, C | 1 |
| Andersen, KF | 1 |
| Zerahn, B | 1 |
| Etchells, E | 1 |
| Meade, M | 1 |
| Tomlinson, G | 1 |
| Cook, D | 1 |
| Mondillo, S | 1 |
| Ballo, P | 1 |
| Agricola, E | 1 |
| Guerrini, F | 1 |
| Barbati, R | 1 |
| Ammaturo, T | 1 |
| Bertelli, P | 1 |
| Neri, E | 1 |
| Sassi, C | 1 |
| Michalski, M | 1 |
| Wierzchowiecki, M | 1 |
| Poprawski, K | 1 |
| Jedliński, I | 1 |
| Pawlak, B | 1 |
| Adamczyk, W | 1 |
| De Lorenzo, A | 1 |
| Lima, RS | 1 |
| Siqueira-Filho, AG | 1 |
| Pantoja, MR | 2 |
| Ishikawa, K | 4 |
| Nakai, S | 2 |
| De Schryver, EL | 4 |
| Algra, A | 5 |
| van Gijn, J | 5 |
| Amici, E | 2 |
| Coletta, C | 6 |
| Franzin, S | 1 |
| Bigi, R | 10 |
| Desideri, A | 10 |
| Gambelli, G | 1 |
| Ceci, V | 3 |
| Rambaldi, R | 2 |
| Sabbadin, D | 1 |
| Curti, G | 1 |
| Celegon, L | 6 |
| Dörffler-Melly, J | 1 |
| Schmidli, J | 1 |
| Mahler, F | 1 |
| Odoguardi, L | 1 |
| Vaquette, B | 1 |
| Clergues, F | 1 |
| Kalangos, A | 1 |
| Dorsaz, PA | 1 |
| Righetti, A | 1 |
| Galland, RB | 1 |
| Oller-Martínez, G | 1 |
| Pereztol-Valdés, O | 1 |
| Castell-Conesa, J | 2 |
| Soler-Peter, M | 1 |
| Simó, M | 1 |
| Santana-Boado, C | 2 |
| Soler-Soler, J | 2 |
| CASELLAS BERNAT, A | 1 |
| TRILLA SANCHEZ, E | 1 |
| DE-VOS BERRUETA, M | 1 |
| GAUSI GENE, C | 1 |
| SHALABY, ES | 1 |
| ABDELSALAM, R | 1 |
| KOBAYASHI, T | 2 |
| TAKEUCHI, M | 1 |
| DUEX, A | 1 |
| HASPER, M | 1 |
| HILGER, HH | 1 |
| SCHAEDE, A | 2 |
| THURN, P | 1 |
| GRIEP, AH | 1 |
| LEIBERMAN, A | 1 |
| GUGLIELMELLI, S | 1 |
| GROSS, R | 1 |
| GIROLA, M | 1 |
| Fioretti, PM | 4 |
| Gregori, D | 2 |
| Vigna, C | 1 |
| Tota, F | 1 |
| Bax, J | 1 |
| Bui, H | 1 |
| Lee, JT | 1 |
| Greenway, S | 1 |
| Donayre, C | 3 |
| de Virgilio, C | 3 |
| Moreno, R | 3 |
| Villate, A | 1 |
| Zamorano, J | 1 |
| Almería, C | 1 |
| Pérez-González, JA | 1 |
| Rodrigo, JL | 1 |
| Perez de Isla, L | 1 |
| Mataix, L | 1 |
| Macaya, C | 1 |
| Janardhanan, R | 1 |
| Gawaz, M | 1 |
| Müller, I | 1 |
| Besta, F | 1 |
| Takase, B | 1 |
| Nagata, M | 1 |
| Kihara, T | 1 |
| Kameyawa, A | 1 |
| Noya, K | 1 |
| Matsui, T | 1 |
| Ohsuzu, F | 1 |
| Ishihara, M | 2 |
| Kurita, A | 1 |
| Nicholls, C | 1 |
| Sani, M | 1 |
| Leonardi-Bee, J | 1 |
| Bousser, MG | 1 |
| Davalos, A | 1 |
| Guiraud-Chaumeil, B | 1 |
| Sivenius, J | 2 |
| Yatsu, F | 1 |
| Dewey, ME | 1 |
| Fleming, JS | 1 |
| Buyniski, JP | 1 |
| Bhatheja, R | 1 |
| Francis, GS | 1 |
| Pothier, CE | 1 |
| Lauer, MS | 1 |
| Petix, NR | 1 |
| Sestini, S | 1 |
| Coppola, A | 1 |
| Marcucci, G | 1 |
| Nassi, F | 1 |
| Taiti, A | 1 |
| Guarnaccia, V | 1 |
| Mennuti, A | 1 |
| Mazzoni, V | 1 |
| Zipoli, A | 1 |
| Bedetti, G | 1 |
| Pizzi, C | 1 |
| Gabrieli, L | 1 |
| Varga, A | 2 |
| Pasanisi, E | 1 |
| Bugiardini, R | 1 |
| Tsujino, K | 1 |
| Hikasa, Y | 1 |
| Minami, S | 1 |
| Okamoto, Y | 1 |
| Morita, T | 1 |
| Shimada, A | 1 |
| Sicari, R | 9 |
| Palinkas, A | 1 |
| Pasanisi, EG | 1 |
| Venneri, L | 1 |
| Bernstein, RA | 1 |
| Ishikawa, Y | 1 |
| Fujiwara, M | 1 |
| Ono, Y | 1 |
| Tsuda, E | 1 |
| Matsubara, T | 1 |
| Furukawa, S | 1 |
| Echigo, S | 1 |
| Ascione, L | 1 |
| De Michele, M | 1 |
| Accadia, M | 1 |
| Granata, G | 1 |
| Sacra, C | 1 |
| D'Andrea, A | 1 |
| Guarini, P | 1 |
| Tuccillo, B | 1 |
| Radosavljevic-Radovanovic, M | 1 |
| Pokrajcic, ZV | 1 |
| Radovanovic, N | 1 |
| Beleslin, B | 2 |
| Marinkovic, J | 2 |
| Stankovic, G | 2 |
| Kostic, J | 1 |
| Mitrovic, P | 1 |
| Stefanovic, B | 1 |
| Karadzic, A | 1 |
| Ostojic, M | 2 |
| Landi, P | 8 |
| Sultan, A | 1 |
| Piot, C | 1 |
| Mariano-Goulart, D | 1 |
| Daures, JP | 1 |
| Comte, F | 1 |
| Renard, E | 1 |
| Avignon, A | 1 |
| Kim, YH | 1 |
| Lee, KH | 2 |
| Chang, HJ | 1 |
| Lee, EJ | 1 |
| Chung, HW | 1 |
| Choi, JY | 1 |
| Choi, Y | 1 |
| Choe, YS | 1 |
| Lee, SH | 1 |
| Kim, BT | 1 |
| Samady, H | 1 |
| Lepper, W | 1 |
| Powers, ER | 1 |
| Wei, K | 1 |
| Ragosta, M | 1 |
| Bishop, GG | 1 |
| Sarembock, IJ | 1 |
| Gimple, L | 1 |
| Watson, DD | 2 |
| Beller, GA | 6 |
| Barringhaus, KG | 1 |
| Cury, RC | 1 |
| Cattani, CA | 1 |
| Gabure, LA | 1 |
| Racy, DJ | 1 |
| de Gois, JM | 1 |
| Siebert, U | 1 |
| Lima, SS | 1 |
| Brady, TJ | 1 |
| Kishimoto, C | 1 |
| Yoshida, Y | 2 |
| Zen, E | 1 |
| Nakamura, R | 1 |
| Ito, K | 1 |
| Bochenek, A | 1 |
| Wilczyński, M | 1 |
| Dieker, HJ | 1 |
| French, JK | 2 |
| Joziasse, IC | 1 |
| Brouwer, MA | 1 |
| Elliott, J | 1 |
| West, TM | 1 |
| Webber, BJ | 1 |
| Verheugt, FW | 1 |
| White, HD | 2 |
| Bai, J | 1 |
| Hashimoto, J | 1 |
| Nakahara, T | 1 |
| Suzuki, T | 1 |
| Kubo, A | 1 |
| Einhäupl, K | 1 |
| Karamitsos, TD | 1 |
| Selvanayagam, JB | 1 |
| Marciniak, M | 1 |
| Claus, P | 1 |
| Streb, W | 1 |
| Marciniak, A | 1 |
| Boettler, P | 1 |
| McLaughlin, M | 1 |
| D'hooge, J | 1 |
| Rademakers, F | 1 |
| Bijnens, B | 1 |
| Sutherland, GR | 1 |
| Gherardi, S | 2 |
| Djordjevic-Dikic, A | 2 |
| Rossi, A | 1 |
| Moccetti, T | 1 |
| Faletra, F | 2 |
| Cattaneo, P | 1 |
| Rossi, M | 1 |
| Pasotti, E | 1 |
| Fantoni, C | 1 |
| Anzà, C | 1 |
| Baravelli, M | 1 |
| Johnson, SG | 1 |
| Rogers, K | 1 |
| Delate, T | 1 |
| Witt, DM | 1 |
| Nielsen, AA | 1 |
| Veien, KT | 1 |
| Jørgensen, LG | 1 |
| Buck, TC | 1 |
| Brandslund, I | 1 |
| Christensen, C | 1 |
| Schmidt, HD | 2 |
| Schmier, J | 3 |
| Rees, JR | 4 |
| Redding, VJ | 3 |
| McNicol, GP | 1 |
| Genton, E | 3 |
| Schröder, R | 1 |
| de Bono, DP | 1 |
| Gross, F | 1 |
| Fossati, C | 1 |
| Giustiniani, S | 1 |
| Toshima, H | 1 |
| Adachi, K | 1 |
| Spann, JF | 1 |
| Kelton, JG | 2 |
| Offerhaus, L | 1 |
| Dalen, JE | 2 |
| Goldberg, RJ | 1 |
| Gore, JM | 2 |
| Struckus, J | 1 |
| Hirsh, J | 8 |
| Bolte, HD | 1 |
| Buckler, P | 1 |
| Douglas, AS | 2 |
| Thiele, R | 1 |
| Sherry, S | 3 |
| Berger, HJ | 1 |
| Zaret, BL | 3 |
| Avellone, G | 1 |
| Mandalà, V | 1 |
| Novo, S | 1 |
| Pinto, A | 1 |
| Riolo, FP | 1 |
| Davì, G | 1 |
| Raneli, G | 1 |
| Khaja, F | 1 |
| Walton, JA | 1 |
| Brymer, JF | 1 |
| Lo, E | 1 |
| Osterberger, L | 1 |
| O'Neill, WW | 1 |
| Colfer, HT | 1 |
| Weiss, R | 1 |
| Lee, T | 1 |
| Kurian, T | 1 |
| Goldberg, AD | 1 |
| Pitt, B | 1 |
| Goldstein, S | 1 |
| Smalling, RW | 1 |
| Breddin, K | 1 |
| Markiewicz, M | 2 |
| Rymar, B | 1 |
| Florkiewicz, H | 2 |
| Wysokiński, A | 1 |
| Biller, J | 1 |
| Martin, GJ | 1 |
| Rivey, MP | 1 |
| Alexander, MR | 1 |
| Taylor, JW | 1 |
| Ordinas, A | 1 |
| Musiał, J | 1 |
| Dworski, R | 1 |
| Szczeklik, A | 1 |
| Mustard, JF | 2 |
| Kinlough-Rathbone, RL | 2 |
| Packham, MA | 2 |
| McCarty, MF | 1 |
| Hu, GJ | 1 |
| Zhang, JG | 1 |
| Jiang, WD | 1 |
| Wei, PJ | 1 |
| Krosse, B | 1 |
| Neumann, G | 1 |
| Graff, J | 1 |
| Trenckmann, H | 1 |
| Mannucci, PM | 1 |
| Heusch, G | 1 |
| Yoshimoto, N | 1 |
| Leppo, JA | 8 |
| O'Brien, J | 1 |
| Rothendler, JA | 1 |
| Getchell, JD | 1 |
| Lee, VW | 1 |
| Van Aken, WG | 1 |
| Uberfuhr, P | 1 |
| Reichart, B | 1 |
| Welz, A | 1 |
| Kreuzer, E | 1 |
| Kemkes, BM | 1 |
| Klinner, W | 1 |
| Hammer, C | 1 |
| Ertel, W | 1 |
| Reichenspurner, H | 1 |
| Gokel, M | 1 |
| Land, W | 1 |
| Franke, N | 1 |
| Mathes, P | 1 |
| Verstraete, M | 5 |
| Verdecchia, P | 1 |
| Machecourt, J | 2 |
| Denis, B | 2 |
| Bouvagnet, P | 1 |
| Wolf, JE | 1 |
| Page, E | 1 |
| Terraube, P | 1 |
| Comet, M | 1 |
| Poliwoda, H | 1 |
| Tornling, G | 2 |
| Nozawa, T | 1 |
| Sugimoto, T | 1 |
| Uraoka, T | 1 |
| Terada, Y | 1 |
| Yokawa, S | 1 |
| Iuchi, K | 1 |
| Akiyama, M | 1 |
| Jinbo, M | 1 |
| Bodenheimer, MM | 1 |
| Banka, VS | 1 |
| Helfant, RH | 1 |
| Jones, RJ | 1 |
| Mitchell, JR | 1 |
| Passamani, ER | 1 |
| Ashburn, WL | 1 |
| Tubau, J | 1 |
| Kanazawa, T | 1 |
| Matsuoka, H | 1 |
| Lubsen, J | 1 |
| Prentice, CR | 2 |
| Castaldi, PA | 1 |
| Boissel, JP | 1 |
| Leizorovicz, A | 1 |
| Schbath, J | 1 |
| Destors, JM | 1 |
| Gillet, J | 1 |
| Marshall, M | 1 |
| Adolfsson, J | 1 |
| Unge, G | 1 |
| Ljungqvist, A | 1 |
| Gendjev, Z | 1 |
| Onitsuka, T | 1 |
| Koga, Y | 1 |
| Shibata, K | 1 |
| Sakoda, K | 1 |
| Maeda, T | 1 |
| Tsuda, T | 1 |
| Aizawa, Y | 1 |
| Kamei, K | 1 |
| Shibata, A | 1 |
| Schmoliner, R | 1 |
| Dudczak, R | 1 |
| Kronik, G | 1 |
| Hutterer, B | 1 |
| Kletter, K | 1 |
| Mösslacher, H | 1 |
| Frischauf, H | 1 |
| Jacobi, E | 1 |
| Bremer, G | 1 |
| Richter, O | 1 |
| Tarolo, GL | 2 |
| Picozzi, R | 3 |
| Roda, L | 1 |
| Tramacere, PL | 1 |
| Vecchi, C | 1 |
| Ferrari, A | 2 |
| Blumenthal, DS | 1 |
| Hutchins, GM | 1 |
| Jugdutt, BI | 1 |
| Becker, LC | 1 |
| Sone, T | 1 |
| Mizutani, K | 1 |
| Yamamoto, M | 1 |
| Watanabe, T | 2 |
| Pavia, M | 1 |
| Idone, P | 1 |
| Ravera, A | 1 |
| Rey, L | 1 |
| Trucco, G | 1 |
| Aquaro, G | 1 |
| Roberts, AJ | 1 |
| Jacobstein, JG | 1 |
| Cipriano, PR | 1 |
| Alonso, DR | 1 |
| Combes, JR | 1 |
| Gay, WA | 1 |
| Griguer, P | 1 |
| Brochier, M | 1 |
| Leroy, J | 1 |
| Leclerc, MH | 1 |
| Antoine, G | 1 |
| Bertrand, H | 1 |
| Chalons, F | 1 |
| Culliton, BJ | 1 |
| Waterfall, WK | 1 |
| Weisse, AB | 1 |
| Regan, TJ | 1 |
| Kowalewski, J | 1 |
| Pluta, A | 1 |
| Koziara, Z | 1 |
| Szponar, M | 1 |
| Dmosyńska, A | 1 |
| Francini, D | 1 |
| Abbate, R | 1 |
| Croveri, G | 1 |
| Taccola, A | 1 |
| Cipolli, PL | 1 |
| Bossi, MC | 1 |
| Yang, CC | 2 |
| Chen, UW | 1 |
| Huang, YF | 1 |
| Lee, BF | 1 |
| Jong, SB | 2 |
| Pingitore, A | 3 |
| Minardi, G | 8 |
| Gandolfo, N | 7 |
| Seveso, G | 7 |
| Chiarella, F | 5 |
| Bolognese, L | 11 |
| Chiaranda, G | 5 |
| Sclavo, MG | 4 |
| Naito, H | 1 |
| Hamada, S | 1 |
| Takamiya, M | 1 |
| Yoshibayashi, M | 1 |
| Kamiya, T | 1 |
| Tamura, S | 1 |
| Palagi, B | 3 |
| Heyman, J | 2 |
| Belloni, A | 1 |
| Ferrari, F | 1 |
| Polese, A | 1 |
| Rovelli, G | 1 |
| Cox, JL | 1 |
| Wright, LM | 1 |
| Burns, RJ | 1 |
| Nohara, R | 1 |
| Hata, T | 1 |
| Hosokawa, R | 1 |
| Lee, L | 1 |
| Fujita, M | 1 |
| Kambara, H | 2 |
| Sasayama, S | 1 |
| Antalffy, J | 1 |
| Bajnok, L | 2 |
| Kozlovszky, B | 1 |
| Varga, J | 2 |
| Olvasztó, S | 1 |
| Fülöp, T | 1 |
| Lette, J | 5 |
| Bertrand, C | 1 |
| Gossard, D | 1 |
| Ruscito, O | 1 |
| Cerino, M | 4 |
| McNamara, D | 1 |
| Picard, M | 4 |
| Eybalin, MC | 1 |
| Levasseur, A | 1 |
| Nattel, S | 2 |
| L'Italien, GJ | 2 |
| Cambria, RP | 1 |
| Cutler, BS | 6 |
| Paul, SD | 2 |
| Brewster, DC | 1 |
| Hendel, RC | 4 |
| Abbott, WM | 1 |
| Eagle, KA | 2 |
| Pan, JP | 1 |
| Chou, CY | 1 |
| Chu, LS | 1 |
| Chu, YK | 1 |
| Liu, RS | 1 |
| Wang, SP | 1 |
| Chang, MS | 1 |
| Hamer, AW | 1 |
| Brown, MA | 1 |
| Williams, BF | 1 |
| Ormiston, JA | 1 |
| Cross, DB | 1 |
| Blanksma, PK | 1 |
| Willemsen, AT | 1 |
| Meeder, JG | 1 |
| de Jong, RM | 1 |
| Anthonio, RL | 1 |
| Pruim, J | 1 |
| Vaalburg, W | 1 |
| Lie, KI | 1 |
| Nesković, AN | 2 |
| Popović, AD | 2 |
| Babić, R | 2 |
| Obradović, V | 1 |
| Koroneos, A | 1 |
| Engels, G | 1 |
| Bachmann, K | 1 |
| Simm, C | 1 |
| Wilke, N | 1 |
| Ellermann, J | 1 |
| Zhang, J | 1 |
| Ya, X | 1 |
| Merkel, H | 1 |
| Connolly, LP | 1 |
| Hill, TC | 1 |
| Cohen, MC | 1 |
| Burger, AJ | 1 |
| Chen, MH | 1 |
| Newell, JB | 1 |
| Vilacosta, I | 1 |
| San Román, JA | 1 |
| Castillo, JA | 1 |
| Rollán, MJ | 1 |
| Arganda, L | 1 |
| Alonso, L | 1 |
| Peral, V | 1 |
| Sánchez-Harguindey, L | 1 |
| Talalak, P | 1 |
| Chaithiraphan, S | 1 |
| Opartkiattikul, N | 1 |
| Leowattana, W | 1 |
| Sangtawesin, W | 1 |
| Tresukosol, D | 1 |
| Fukuda, H | 2 |
| Yoshikawa, J | 1 |
| Yoshida, K | 2 |
| Akasaka, T | 1 |
| Shakudo, M | 1 |
| Takagi, T | 1 |
| Hozumi, T | 1 |
| Maeda, K | 2 |
| Miyake, S | 1 |
| Honda, Y | 1 |
| Nakayama, M | 2 |
| Tanno, M | 2 |
| Yamada, H | 2 |
| Ohkawa, S | 2 |
| Mashima, S | 2 |
| Bauer, JA | 1 |
| Bassevich, R | 1 |
| Zafrir, N | 1 |
| Sulkes, J | 1 |
| Lubin, E | 1 |
| Matzer, L | 1 |
| Kiat, H | 1 |
| Wang, FP | 1 |
| Van Train, K | 1 |
| Germano, G | 1 |
| Friedman, J | 1 |
| Berman, DS | 1 |
| Poli, A | 3 |
| Previtali, M | 8 |
| Lanzarini, L | 3 |
| Fetiveau, R | 3 |
| Ferrario, M | 2 |
| Diotallevi, P | 3 |
| Mussini, A | 2 |
| Montemartini, C | 2 |
| Rosselli, P | 1 |
| Garfagnini, A | 1 |
| Bianchi, F | 2 |
| Bollini, R | 1 |
| Zigliara, A | 1 |
| De Marchi, E | 1 |
| Boggiano, P | 1 |
| Deutsch, HJ | 1 |
| Schenkel, C | 1 |
| Klaer, R | 1 |
| Curtius, JM | 1 |
| Steinberg, JB | 1 |
| Kresowik, TF | 2 |
| Behrendt, DM | 1 |
| Domenicucci, S | 1 |
| Bellotti, P | 2 |
| Bellone, P | 1 |
| Scarsi, G | 1 |
| Vecchio, C | 1 |
| Ferreira, J | 1 |
| Gil, VM | 1 |
| Ventosa, A | 1 |
| Calqueiro, J | 1 |
| Seabra-Gomes, R | 1 |
| Danchin, N | 1 |
| Juillière, Y | 1 |
| Kettani, C | 1 |
| Buffet, P | 1 |
| Anconina, J | 1 |
| Cuillière, M | 1 |
| Cherrier, F | 1 |
| Bestetti, A | 1 |
| Lomuscio, A | 1 |
| Castellani, M | 1 |
| Giovanella, L | 1 |
| Pedrazzini, L | 1 |
| Chiti, A | 1 |
| Boccardi, L | 2 |
| Di Segni, M | 3 |
| Pucci, E | 2 |
| Tubaro, M | 2 |
| Natale, E | 2 |
| Milazzotto, F | 1 |
| Loschiavo, P | 1 |
| Lioy, E | 2 |
| Biffani, G | 1 |
| D'Urbano, M | 2 |
| Cafiero, F | 2 |
| Cammelli, F | 2 |
| Spreafico, GL | 1 |
| Romano, S | 2 |
| Kern, MJ | 1 |
| Wolford, T | 1 |
| Donohue, TJ | 1 |
| Bach, RG | 1 |
| Aguirre, FV | 1 |
| Caracciolo, EA | 1 |
| Flynn, MS | 1 |
| Verani, MS | 1 |
| Camerieri, A | 1 |
| Michelassi, C | 5 |
| Bjoernstad, K | 1 |
| Aakhus, S | 1 |
| Lundbom, J | 1 |
| Bolz, KD | 1 |
| Rokseth, R | 1 |
| Skjaerpe, T | 1 |
| Hatle, L | 1 |
| Villanueva, FS | 3 |
| Glasheen, WP | 2 |
| Sklenar, J | 3 |
| Kaul, S | 3 |
| Baroffio, R | 2 |
| Orlandini, A | 1 |
| Putini, RL | 1 |
| Ricci, R | 3 |
| Giovannini, E | 2 |
| Dellavesa, P | 2 |
| Rossi, L | 6 |
| Sarasso, G | 6 |
| Bongo, AS | 6 |
| Scianaro, MC | 1 |
| Metz, D | 1 |
| Pommier, JL | 1 |
| Nazeyrollas, P | 1 |
| Chapoutot, L | 1 |
| Graciet, J | 1 |
| Chabert, JP | 1 |
| Elaerts, J | 1 |
| Bajolet, A | 1 |
| Bry, JD | 1 |
| Belkin, M | 1 |
| O'Donnell, TF | 1 |
| Mackey, WC | 1 |
| Udelson, JE | 1 |
| Schmid, CH | 1 |
| Safran, DG | 1 |
| Riekkinen, PJ | 1 |
| Lowenthal, A | 2 |
| Smets, P | 1 |
| Laakso, M | 1 |
| D'Angelo, M | 1 |
| Simonelli, P | 1 |
| Del Mastro, L | 1 |
| Auriemma, F | 1 |
| Abate, R | 1 |
| Vetrano, A | 1 |
| Chikamori, T | 5 |
| Doi, YL | 1 |
| Yamada, M | 3 |
| Takata, J | 3 |
| Yonezawa, Y | 3 |
| Ozawa, T | 4 |
| Grip, L | 1 |
| Bone, D | 1 |
| Holmgren, A | 1 |
| Rydén, L | 1 |
| Brown, KA | 5 |
| Rowen, M | 1 |
| Lekakis, J | 1 |
| Vassilopoulos, N | 1 |
| Germanidis, J | 1 |
| Theodorakos, A | 1 |
| Nanas, J | 1 |
| Kostamis, P | 1 |
| Moulopoulos, S | 1 |
| Bower, TR | 1 |
| Garner, SA | 1 |
| Grover-McKay, M | 1 |
| Slaymaker, EE | 1 |
| Sharp, WJ | 1 |
| Hoballah, JJ | 1 |
| Corson, JD | 1 |
| McPhail, NV | 1 |
| Barber, GG | 1 |
| Cole, CW | 1 |
| Marois, LJ | 1 |
| Gulenchyn, KY | 1 |
| Fukazawa, M | 1 |
| Fukushige, J | 1 |
| Takeuchi, T | 1 |
| Narabayashi, H | 1 |
| Igarashi, H | 1 |
| Hijii, T | 1 |
| Ueda, K | 1 |
| Kuwabara, Y | 1 |
| Otsuka, M | 1 |
| Ichiya, Y | 1 |
| Doi, Y | 6 |
| Dubrey, S | 1 |
| Huehns, TY | 1 |
| Parker, S | 1 |
| Jewkes, RF | 1 |
| Noble, MI | 1 |
| Carrel, T | 1 |
| Zünd, G | 1 |
| Jenni, R | 1 |
| Turina, M | 1 |
| Altman, R | 1 |
| Rouvier, J | 1 |
| Gurfinkel, E | 1 |
| Barberis, P | 1 |
| Emlein, G | 1 |
| Villegas, B | 1 |
| Dahlberg, S | 1 |
| Leppo, J | 2 |
| Stratmann, HG | 3 |
| Younis, LT | 6 |
| Wittry, MD | 2 |
| Amato, M | 2 |
| Miller, DD | 4 |
| Schröder, K | 1 |
| Völler, H | 1 |
| Dingerkus, H | 1 |
| Münzberg, H | 1 |
| Dissmann, R | 1 |
| Linderer, T | 1 |
| Schultheiss, HP | 1 |
| Bosch, X | 1 |
| Magriñá, J | 1 |
| March, R | 1 |
| Sanz, G | 1 |
| García, A | 1 |
| Betriu, A | 1 |
| Navarro-López, F | 1 |
| Greco, G | 2 |
| Galati, A | 4 |
| Urbinati, S | 1 |
| Rosas-Munive, E | 1 |
| Abundes-Velasco, A | 1 |
| Villa-Godínez, G | 1 |
| López-Winter, JF | 1 |
| Miller, GL | 1 |
| Herman, SD | 3 |
| Heller, GV | 6 |
| Kalla, S | 1 |
| Levin, WA | 1 |
| Stillwell, KM | 1 |
| Travin, MI | 3 |
| Kontos, MC | 2 |
| Akosah, KO | 2 |
| Brath, LK | 2 |
| Funai, JT | 1 |
| Mohanty, PK | 2 |
| Rovai, D | 1 |
| Zanchi, M | 1 |
| Lombardi, M | 1 |
| Magagnini, E | 1 |
| Chella, P | 1 |
| Pieroni, A | 1 |
| Ferdeghini, M | 1 |
| Morris, H | 1 |
| Distante, A | 6 |
| L'Abbate, A | 6 |
| Salas, J | 1 |
| Nuno de la Rosa, JA | 1 |
| Valentí, JA | 1 |
| Contreras, J | 1 |
| Martínez, J | 1 |
| Martínez, A | 1 |
| Ruiz, JA | 1 |
| Campos, JV | 1 |
| Picó, F | 1 |
| Ruipérez, JA | 1 |
| Petix, N | 1 |
| Margaria, F | 4 |
| Magaia, O | 4 |
| Mathias, W | 2 |
| Gigli, G | 2 |
| Raciti, M | 2 |
| Camarano, G | 1 |
| Ismail, S | 1 |
| Goodman, NC | 1 |
| Mark, AL | 2 |
| Specchia, G | 1 |
| Hurwitz, GA | 1 |
| Weingert, ME | 1 |
| Silver, DL | 1 |
| MacDonald, AC | 1 |
| Finnie, KJ | 1 |
| Powe, JE | 1 |
| Dawdy, JA | 1 |
| Darbar, D | 1 |
| Gillespie, N | 1 |
| Main, G | 1 |
| Bridges, AB | 1 |
| Kennedy, NS | 1 |
| Pringle, TH | 1 |
| McNeill, GP | 1 |
| Pak, S | 1 |
| Arnell, T | 1 |
| Lewis, RJ | 1 |
| Stabile, BE | 1 |
| White, R | 2 |
| Sato, H | 1 |
| Tateishi, H | 1 |
| Kawagoe, T | 1 |
| Shimatani, Y | 1 |
| Kurisu, S | 1 |
| Sakai, K | 1 |
| Goletta, C | 1 |
| Serdoz, R | 1 |
| Richichi, G | 1 |
| Nagueh, SF | 1 |
| Zoghbi, WA | 1 |
| Geleijnse, ML | 1 |
| Candelpergher, G | 2 |
| Suzzi, G | 1 |
| Terlizzi, R | 4 |
| Canel, F | 2 |
| Colangeli, G | 2 |
| Cisotto, P | 1 |
| Maggiolo, G | 1 |
| Kim, S | 1 |
| Yamabe, H | 2 |
| Yokoyama, M | 1 |
| McClellan, JR | 1 |
| Baron, JI | 1 |
| Golub, RJ | 1 |
| Gallagher, JJ | 1 |
| Waters, D | 5 |
| Kanamasa, K | 1 |
| Hama, J | 1 |
| Ogawa, I | 1 |
| Takenaka, T | 1 |
| Naito, T | 1 |
| Yamamoto, T | 2 |
| Oyaizu, M | 1 |
| Kimura, A | 1 |
| Yamamoto, K | 1 |
| Katori, R | 1 |
| Kotzerke, J | 1 |
| Bergmann, K | 1 |
| Glatz, S | 1 |
| Höher, M | 1 |
| Reske, SN | 1 |
| Mohr-Kahaly, S | 1 |
| Wagner, S | 1 |
| Meyer, J | 2 |
| Marzilli, M | 2 |
| DeNes, M | 1 |
| Wang, Y | 2 |
| Biagini, A | 1 |
| Kitakaze, M | 1 |
| Minamino, T | 1 |
| Funaya, H | 1 |
| Node, K | 1 |
| Shinozaki, Y | 1 |
| Mori, H | 1 |
| Hori, M | 1 |
| Bojić, M | 1 |
| Pirelli, S | 6 |
| Moreo, A | 1 |
| Piccalo, G | 2 |
| Corato, A | 1 |
| Sara, R | 1 |
| Danzi, GB | 1 |
| Corrada, E | 3 |
| Massa, D | 2 |
| De Vita, C | 1 |
| Hillis, GS | 1 |
| al-Mohammad, A | 1 |
| Jennings, KP | 1 |
| Baroni, M | 1 |
| Del Negro, B | 1 |
| Vassalle, C | 1 |
| Severi, S | 3 |
| Massie, MT | 1 |
| Rohrer, MJ | 1 |
| White, MP | 1 |
| Russell, A | 1 |
| Mascitelli, VA | 1 |
| Morris, RS | 1 |
| Shehata, AR | 1 |
| Jain, D | 1 |
| Thompson, B | 1 |
| Wackers, FJ | 3 |
| Duca, MD | 1 |
| Kline, GM | 1 |
| Demus, DD | 1 |
| Landin, RJ | 1 |
| Haber, SB | 2 |
| Murai, T | 2 |
| Yamasaki, F | 2 |
| Yabe, T | 2 |
| Kitaoka, H | 3 |
| Matsumura, Y | 2 |
| Furuno, T | 3 |
| Lualdi, JC | 1 |
| Douglas, PS | 1 |
| Sclavo, M | 2 |
| Aruta, E | 1 |
| Presbitero, P | 3 |
| Zanco, P | 1 |
| Suzzi, GL | 4 |
| Favero, A | 1 |
| Ferlin, G | 1 |
| Manzara, CC | 1 |
| Pulignano, G | 1 |
| Chiantera, A | 1 |
| De Santis, F | 1 |
| Armiento, G | 1 |
| Vajola, FS | 1 |
| Hirakawa, K | 1 |
| Seo, H | 1 |
| Hung, J | 1 |
| Moshiri, M | 1 |
| Groom, GN | 1 |
| Van der Schaaf, AA | 1 |
| Parsons, RW | 1 |
| Hands, ME | 1 |
| Nallamothu, N | 1 |
| Johnson, JH | 1 |
| Bagheri, B | 1 |
| Heo, J | 1 |
| Iskandrian, AE | 1 |
| Hamasaki, S | 1 |
| Arima, S | 1 |
| Fukumoto, N | 1 |
| Yamaguchi, T | 1 |
| Nakano, F | 1 |
| Kamekou, M | 1 |
| Kihara, K | 1 |
| Shono, H | 1 |
| Nakao, S | 1 |
| Tanaka, H | 1 |
| Suzuki, K | 1 |
| Miura, T | 2 |
| Miki, T | 1 |
| Tsuchida, A | 1 |
| Shimamoto, K | 2 |
| De Nes, M | 1 |
| Marraccini, P | 1 |
| Heintzen, MP | 2 |
| Heidland, UE | 2 |
| Klimek, WJ | 1 |
| Michel, CJ | 2 |
| Kelm, M | 1 |
| Leschke, M | 1 |
| Schwartzkopff, B | 1 |
| Vester, EG | 1 |
| Strauer, BE | 2 |
| Fukuda, T | 1 |
| Akagi, T | 1 |
| Ishibashi, M | 1 |
| Inoue, O | 1 |
| Sugimura, T | 1 |
| Kato, H | 1 |
| Sánchez, P | 1 |
| Paré, JC | 1 |
| Azqueta, M | 1 |
| Sanz, GA | 1 |
| Jin-nouchi, Y | 1 |
| Kawai, K | 1 |
| Nannini, E | 1 |
| Miyagawa, M | 1 |
| Mochizuki, T | 1 |
| Murase, K | 1 |
| Tanada, S | 1 |
| Ikezoe, J | 1 |
| Sekiya, M | 1 |
| Hamamoto, K | 1 |
| Matsumoto, S | 1 |
| Niino, M | 1 |
| Cernetti, C | 1 |
| Mota, P | 1 |
| Jain, S | 1 |
| Baird, JB | 1 |
| Fischer, KC | 1 |
| Rich, MW | 1 |
| Vanzetto, G | 1 |
| Halimi, S | 1 |
| Hammoud, T | 1 |
| Fagret, D | 1 |
| Benhamou, PY | 1 |
| Cordonnier, D | 1 |
| Matsumoto, K | 1 |
| Nakamaru, M | 1 |
| Obara, H | 1 |
| Hayashi, S | 1 |
| Harada, H | 1 |
| Kitajima, M | 1 |
| Franklin, KB | 1 |
| Valente, G | 1 |
| Fioretti, P | 2 |
| Heiba, SI | 1 |
| Jacobson, AF | 1 |
| Shattuc, S | 1 |
| Ferreira, MJ | 1 |
| Sharma, PN | 1 |
| Cerqueira, MD | 1 |
| Landin, RS | 1 |
| Shaw, LJ | 1 |
| Pasquale, MJ | 1 |
| Guerra, UP | 1 |
| Giacomuzzi, F | 1 |
| Di Gregorio, F | 1 |
| Bax, JJ | 2 |
| Slavich, GA | 1 |
| Gervais, M | 1 |
| Richer, C | 1 |
| Fornes, P | 1 |
| De Gasparo, M | 1 |
| Giudicelli, JF | 1 |
| Hirai, M | 1 |
| Yamada, T | 1 |
| Tsuji, Y | 1 |
| Kondo, T | 1 |
| Inden, Y | 1 |
| Akahoshi, M | 1 |
| Murakami, Y | 1 |
| Tsuda, M | 1 |
| Tsuboi, N | 1 |
| Hirayama, H | 1 |
| Okamoto, M | 1 |
| Ito, T | 1 |
| Saito, H | 1 |
| Toyama, J | 1 |
| Astarita, C | 1 |
| Liguori, E | 1 |
| Stella, P | 1 |
| Rumolo, S | 1 |
| Gambardella, S | 1 |
| Severino, S | 1 |
| Caso, P | 1 |
| Maresca, FS | 1 |
| Joubert, J | 1 |
| McLean, CA | 1 |
| Reid, CM | 1 |
| Davel, D | 1 |
| Pilloy, W | 1 |
| Delport, R | 1 |
| Steyn, L | 1 |
| Walker, AR | 1 |
| Klijn, CJ | 1 |
| van Buren, PA | 1 |
| Kappelle, LJ | 1 |
| Tulleken, CA | 1 |
| Eikelboom, BC | 1 |
| Ginocchio, G | 1 |
| Smart, SC | 1 |
| Sagar, KB | 1 |
| Zabalgoitia, M | 1 |
| Ismaeil, M | 1 |
| Breuer, HW | 1 |
| Bermejo-Fraile, B | 1 |
| Ortega, A | 2 |
| Alonso-Farto, JC | 1 |
| Almoguera, I | 2 |
| Domínguez, P | 2 |
| Bittini, A | 2 |
| Martínez, L | 2 |
| Moreno, M | 2 |
| Sosa, V | 2 |
| García-Fernández, MA | 1 |
| Pérez Vázquez, JM | 2 |
| Germain, P | 1 |
| Roul, G | 1 |
| Baruthio, J | 1 |
| Jahn, C | 1 |
| Coulbois, PM | 1 |
| Dumitresco, B | 1 |
| Dietemann, JL | 1 |
| Bareiss, P | 1 |
| Constantinesco, A | 1 |
| Koskenvuo, JW | 1 |
| Sakuma, H | 1 |
| Niemi, P | 1 |
| Toikka, JO | 1 |
| Knuuti, J | 1 |
| Laine, H | 1 |
| Komu, M | 1 |
| Kormano, M | 1 |
| Saraste, M | 1 |
| Hartiala, JJ | 1 |
| Fiorentini, C | 1 |
| Wall, DB | 1 |
| Ephraim, L | 1 |
| Toosie, K | 1 |
| Elbassir, M | 1 |
| Alonso, JC | 1 |
| García Fernández, MA | 1 |
| Heidebrink, JL | 1 |
| Darius, H | 2 |
| Bertrand-Hardy, JM | 2 |
| Humphreys, M | 2 |
| Ueda, T | 1 |
| Shimizu, H | 1 |
| Shin, H | 1 |
| Kashima, I | 1 |
| Tsutsumi, K | 1 |
| Iino, Y | 1 |
| Yozu, R | 1 |
| Kawada, S | 1 |
| Harel, F | 1 |
| Génin, R | 1 |
| Daou, D | 1 |
| Lebtahi, R | 1 |
| Delahaye, N | 1 |
| Helal, BO | 1 |
| Le Guludec, D | 1 |
| Faraggi, M | 1 |
| Mamode, N | 1 |
| Docherty, G | 1 |
| Lowe, GD | 2 |
| Macfarlane, PW | 1 |
| Martin, W | 1 |
| Pollock, JG | 1 |
| Cobbe, SM | 1 |
| Nedeljkovic, MA | 1 |
| Nedeljkovic, IP | 1 |
| Stojkovic, S | 1 |
| Saponjski, J | 1 |
| Vukcevic, V | 1 |
| Ristic, AD | 1 |
| Orlic, D | 1 |
| Miyazaki, T | 1 |
| Hirano, Y | 1 |
| Seo, JK | 1 |
| Kwan, J | 1 |
| Suh, JH | 1 |
| Kim, DH | 1 |
| Hyun, IY | 1 |
| Choe, WS | 1 |
| Park, KS | 1 |
| Lee, WH | 1 |
| Cecchi, E | 1 |
| Brusasco, G | 1 |
| Tidu, M | 1 |
| Imazio, M | 1 |
| Chinaglia, A | 1 |
| Pomari, F | 1 |
| Moratti, M | 1 |
| Ghisio, A | 1 |
| Trinchero, R | 1 |
| Haft, JI | 2 |
| Loo, J | 1 |
| Melloni, GF | 1 |
| Lureti, GF | 1 |
| Minoja, GM | 1 |
| Melloni, CF | 1 |
| Scarlatti, GF | 1 |
| Facchetti, M | 1 |
| Fassini, G | 1 |
| Malm, A | 1 |
| Arborelius, M | 1 |
| Lilja, B | 1 |
| Gil, RL | 1 |
| Bornmyr, S | 1 |
| Frol'kis, RA | 1 |
| Likhtenshteĭn, IE | 1 |
| Smirnova, IP | 1 |
| Tsiomik, VA | 1 |
| Aldor, E | 1 |
| Krol, WF | 2 |
| Jhawar, BK | 1 |
| Trivedi, HH | 1 |
| Bhargava, RK | 1 |
| Misra, NP | 1 |
| Yasunaga, K | 1 |
| Gantmacher, ML | 1 |
| Oelz, O | 1 |
| Olszańska-Skorek, T | 1 |
| Mazurowa, A | 1 |
| Połczyńska, I | 1 |
| Chojnowski, K | 1 |
| Eichelkraut, A | 1 |
| Kuźmicka, J | 1 |
| Dechavanne, M | 1 |
| Follea, G | 1 |
| Trzeciak, MC | 1 |
| Bruhn, HD | 1 |
| Wichmann, J | 1 |
| Löser, R | 1 |
| Diemer, HP | 1 |
| Lochner, W | 1 |
| Caruzzo, C | 1 |
| Belli, R | 2 |
| Beasci, R | 1 |
| Lanovaia, NI | 1 |
| Pasternak, RC | 1 |
| DeSanctis, RW | 1 |
| Gertz, SD | 1 |
| Bucher, HJ | 1 |
| Valiensi, M | 1 |
| Del Giallo, P | 1 |
| Klimt, CR | 2 |
| Doub, PH | 1 |
| Doub, NH | 1 |
| Weiss, HJ | 2 |
| Gallus, AS | 1 |
| Aledort, LM | 1 |
| Bleifeld, W | 8 |
| Avdiushko, BR | 3 |
| Marshall, RJ | 2 |
| Parratt, JR | 2 |
| Kraikitpanitch, S | 1 |
| Haygood, CC | 1 |
| Baxter, DJ | 1 |
| Yunice, AA | 1 |
| Lindeman, RD | 1 |
| Wu, KK | 1 |
| Hoak, JC | 1 |
| Gvatua, NA | 1 |
| Aleksandrova, LA | 1 |
| Strokach, NT | 1 |
| Kravtsov, VL | 1 |
| Wirth, RH | 1 |
| Finke, R | 1 |
| Mittmann, U | 1 |
| Müller, JH | 1 |
| Opherk, D | 1 |
| Gent, M | 2 |
| Harker, LA | 2 |
| Tamura, K | 1 |
| Honda, T | 1 |
| Muto, N | 1 |
| Bannai, S | 1 |
| Cifaldi, S | 1 |
| Viglietto, A | 1 |
| Marone, G | 1 |
| Azzinnari, G | 1 |
| Colantuoni, A | 1 |
| Davydova, NT | 1 |
| Ianovskiĭ, AD | 1 |
| Wu, CC | 1 |
| Douard, H | 1 |
| Odawara, H | 2 |
| Hamashige, N | 2 |
| Kuzume, O | 1 |
| Fuster, V | 3 |
| Harker, LB | 1 |
| Salzman, EW | 1 |
| Noussan, P | 2 |
| Pallisco, O | 1 |
| Zoccarato, O | 1 |
| Whitfield, SS | 1 |
| Villegas, BJ | 1 |
| Casanova, R | 3 |
| Patroncini, A | 3 |
| Guidalotti, PL | 1 |
| Capacci, PF | 2 |
| Jacopi, F | 3 |
| Fabbri, M | 2 |
| Maresta, A | 3 |
| Iskandrian, AS | 1 |
| Pennell, DJ | 1 |
| Ell, PJ | 1 |
| Woo, KS | 2 |
| Tse, KK | 2 |
| Mak, YK | 2 |
| Chung, HK | 2 |
| Tse, CY | 2 |
| Ogawa, T | 1 |
| Iwamoto, T | 1 |
| Iimura, O | 1 |
| Marzullo, P | 1 |
| Reisenhofer, B | 1 |
| Parodi, O | 1 |
| Fleisher, LA | 1 |
| Nelson, AH | 1 |
| Rosenbaum, SH | 1 |
| Prando, MD | 1 |
| Rossi, P | 5 |
| Jahangiri, M | 1 |
| Holdright, DR | 1 |
| Shaw, L | 3 |
| Chaitman, BR | 4 |
| Hilton, TC | 1 |
| Stocke, K | 1 |
| Caralis, DG | 1 |
| Kong, BA | 1 |
| Champagne, P | 1 |
| Lapointe, J | 1 |
| Sztankay, A | 1 |
| Hattori, A | 1 |
| Drexler, H | 1 |
| Hablawetz, E | 1 |
| Lu, W | 1 |
| Riede, U | 1 |
| Christes, A | 1 |
| Fudo, T | 1 |
| Ono, S | 1 |
| Go, RT | 1 |
| MacIntyre, WJ | 1 |
| Cook, SA | 1 |
| Neumann, DR | 1 |
| Huber, KC | 1 |
| Evans, MA | 1 |
| Bresnahan, JF | 1 |
| Gibbons, RJ | 1 |
| Holmes, DR | 1 |
| Morselli, L | 1 |
| Alpert, JS | 1 |
| Ferlito, S | 1 |
| Jafri, SM | 1 |
| Shibata, T | 1 |
| Kubota, I | 3 |
| Ikeda, K | 4 |
| Yamaki, M | 2 |
| Hanashima, K | 1 |
| Tsuiki, K | 4 |
| Yasui, S | 4 |
| Gal, RA | 1 |
| Gunasekera, J | 1 |
| Massardo, T | 1 |
| Shalev, Y | 1 |
| Port, SC | 1 |
| Kunstmann, S | 1 |
| Corbalán, R | 1 |
| Olea, E | 1 |
| Orellana, P | 1 |
| Marchant, E | 1 |
| Puschel, K | 1 |
| Galleguillos, CG | 1 |
| Lassonde, J | 2 |
| René, P | 1 |
| Laurendeau, F | 1 |
| Levy, R | 1 |
| Aralda, D | 4 |
| Piccinino, C | 3 |
| Okada, RD | 1 |
| Glover, DK | 1 |
| Francalacci, G | 1 |
| Prando, ME | 1 |
| Thompson, PL | 1 |
| Aylward, PE | 1 |
| Federman, J | 1 |
| Giles, RW | 1 |
| Harris, PJ | 1 |
| Hodge, RL | 1 |
| Nelson, GI | 1 |
| Thomson, A | 1 |
| Tonkin, AM | 1 |
| Walsh, WF | 1 |
| Pirazzini, L | 2 |
| Varani, E | 1 |
| Passoni, F | 1 |
| Castelli, C | 1 |
| Spaziani, D | 1 |
| Jain, A | 3 |
| Myers, GH | 3 |
| Rowe, MW | 2 |
| Dehmer, GJ | 1 |
| Robinson, DS | 1 |
| Bosco, M | 1 |
| Parigi, A | 1 |
| Schon, W | 1 |
| Takeishi, Y | 1 |
| Tono-oka, I | 1 |
| Meguro, M | 1 |
| Hoshi, H | 1 |
| Masakane, I | 1 |
| Ugliengo, G | 1 |
| Meinardi, F | 1 |
| Vado, A | 1 |
| De Benedictis, N | 1 |
| Wang, S | 1 |
| Futuro, DO | 1 |
| Escosteguy, CC | 1 |
| de Almeida, LA | 1 |
| Esteves, RN | 1 |
| Pinto, JC | 1 |
| Saad, EA | 1 |
| Duval, AM | 1 |
| Dubois-Randé, JL | 1 |
| Castillon, G | 1 |
| Brun, P | 1 |
| Vernant, P | 1 |
| Lellouche, D | 1 |
| Castaigne, A | 1 |
| Ranhosky, A | 2 |
| Kempthorne-Rawson, J | 1 |
| Hicks, RR | 2 |
| Frantz, DM | 1 |
| Williams, GA | 1 |
| Buchalter, MB | 1 |
| Bourke, JP | 1 |
| Heads, A | 1 |
| Hawkins, T | 1 |
| Charvát, J | 1 |
| Fiserová, J | 1 |
| McCarthy, JJ | 1 |
| Perry, JR | 1 |
| Adams, KF | 1 |
| Nienaber, CA | 5 |
| Salge, D | 5 |
| Spielmann, RP | 5 |
| Todd, C | 1 |
| Nesto, RW | 1 |
| Watson, FS | 1 |
| Kowalchuk, GJ | 1 |
| Zarich, SW | 1 |
| Hill, T | 1 |
| Lewis, SM | 1 |
| Lane, SE | 1 |
| Makaroun, MS | 1 |
| Shuman-Jackson, N | 1 |
| Rippey, A | 1 |
| Schreiner, D | 1 |
| Arvan, S | 1 |
| Grégoire, J | 1 |
| Taillefer, R | 1 |
| Pamir, G | 1 |
| Cağlar, N | 1 |
| Oral, D | 1 |
| Akyol, T | 1 |
| Kaymakçalan, S | 1 |
| Clausen, A | 3 |
| Montz, R | 3 |
| Sternon, J | 1 |
| Dubé, S | 1 |
| Heyen, F | 1 |
| Morin, M | 1 |
| O'Meara, J | 1 |
| Chambers, CE | 1 |
| Plante, DA | 1 |
| Laverdière, M | 1 |
| Hollman, J | 1 |
| Aguirre, F | 1 |
| Byers, S | 3 |
| Dowell, S | 1 |
| Barth, G | 3 |
| Walker, H | 1 |
| Carrachi, B | 1 |
| Peterson, G | 1 |
| Lembo, NJ | 1 |
| Black, AJ | 1 |
| Roubin, GS | 1 |
| Wilentz, JR | 1 |
| Mufson, LH | 1 |
| Douglas, JS | 1 |
| King, SB | 1 |
| Safai-Kutti, S | 1 |
| Kutti, J | 1 |
| Vedin, A | 1 |
| Wilhelmsson, C | 1 |
| Yasumura, S | 2 |
| Stein, B | 1 |
| Al-Mondhiry, H | 1 |
| Pierce, WS | 1 |
| Pennock, JL | 1 |
| Goodgold, H | 2 |
| Gimple, LW | 1 |
| Hutter, AM | 1 |
| Guiney, TE | 1 |
| Boucher, CA | 3 |
| Gara, E | 1 |
| Alberti, A | 1 |
| Mafrici, A | 1 |
| Formentini, A | 1 |
| Campolo, L | 2 |
| Chikamori, D | 1 |
| Kusume, O | 1 |
| Johannessen, KA | 1 |
| Stratton, JR | 1 |
| Taulow, E | 1 |
| Osterud, B | 1 |
| von der Lippe, G | 1 |
| Shalaev, SV | 1 |
| Kinoshenko, EI | 1 |
| Aliavi, AL | 1 |
| Vlasenko, MA | 1 |
| Zarabini, GE | 1 |
| Lattanzi, F | 2 |
| Masini, M | 2 |
| Orsini, E | 1 |
| Fiorini, G | 1 |
| Prina, L | 1 |
| De Ponti, C | 1 |
| Biddle, P | 1 |
| Lanspa, TJ | 1 |
| Mohiuddin, SM | 1 |
| Malesker, MA | 1 |
| Hilleman, DE | 1 |
| Scott, RA | 1 |
| Riesmeyer, JS | 1 |
| Chaudhuri, TK | 1 |
| Blumhardt, R | 1 |
| O'Rourke, RA | 1 |
| Borhani, NO | 2 |
| Bélanger, GL | 1 |
| Lavallée, JP | 1 |
| Lenis, J | 1 |
| Ouellet, CA | 1 |
| Knatterud, GL | 1 |
| Stamler, J | 1 |
| Meier, P | 1 |
| Gelman, JS | 1 |
| Mehta, J | 1 |
| Frishman, WH | 1 |
| Miller, KP | 1 |
| Hayashida, N | 1 |
| DePuey, EG | 1 |
| Guertler-Krawczynska, E | 1 |
| Perkins, JV | 1 |
| Robbins, WL | 1 |
| Whelchel, JD | 1 |
| Clements, SD | 1 |
| Wood, M | 1 |
| Vassanelli, C | 1 |
| Menegatti, G | 1 |
| Nidasio, GP | 1 |
| Franceschini, L | 1 |
| Cocco, C | 1 |
| Rizzotti, P | 1 |
| Shimizu, Y | 1 |
| Tanaka, T | 1 |
| Takayama, Y | 1 |
| Hayashi, T | 1 |
| Ito, Y | 1 |
| Abe, M | 1 |
| Matsuda, M | 1 |
| Ida, T | 1 |
| Sakakibara, T | 1 |
| Obunai, Y | 1 |
| Inglese, E | 1 |
| Suppa, M | 1 |
| Himi, T | 1 |
| Endo, M | 1 |
| Kagaya, A | 1 |
| Masuda, Y | 1 |
| Inagaki, Y | 1 |
| Fukuda, N | 1 |
| Iinuma, T | 1 |
| Yamazaki, T | 1 |
| Mori, K | 2 |
| Masuda, M | 2 |
| Bunkou, H | 1 |
| Markiewicz, K | 2 |
| Cholewa, M | 2 |
| Jazdzewski, B | 1 |
| Budzyła, J | 1 |
| Górski, L | 1 |
| Gawor, Z | 2 |
| Cairns, JA | 1 |
| Hays, LJ | 1 |
| Moore, CA | 1 |
| Burwell, LR | 1 |
| Craddock, GB | 1 |
| Gascho, JA | 1 |
| Smucker, ML | 1 |
| Tedesco, C | 1 |
| Nygaard, TW | 1 |
| Blumenthal, MS | 1 |
| McCauley, CS | 1 |
| Sachs, RN | 1 |
| Tellier, P | 1 |
| Larmignat, P | 1 |
| Azorin, J | 1 |
| Fischbein, L | 1 |
| Beaudet, B | 1 |
| Cadilhac, P | 1 |
| Cupa, M | 1 |
| De Saint Florent, G | 1 |
| Vulpillat, M | 1 |
| Mori, T | 1 |
| Suda, K | 1 |
| Ohnishi, M | 1 |
| Shiotani, H | 1 |
| Kurimoto, Y | 1 |
| Kobayashi, K | 1 |
| Fukuzaki, H | 1 |
| Gastaldi, L | 1 |
| Morello, M | 1 |
| Casalucci, D | 1 |
| Ribetto-Bruno, M | 1 |
| O'Konski, MS | 1 |
| White, FC | 1 |
| Longhurst, J | 1 |
| Roth, D | 1 |
| Bloor, CM | 1 |
| Miturzyńska-Stryjecka, H | 1 |
| Bunko, H | 1 |
| Resnekov, L | 1 |
| Chediak, J | 1 |
| Lewis, D | 1 |
| Patrono, C | 1 |
| Strauss, HW | 1 |
| Colwell, JA | 2 |
| Bingham, SF | 2 |
| Michalík, D | 1 |
| Simícek, J | 1 |
| David, JL | 1 |
| Valladares, BK | 1 |
| Lemberg, L | 1 |
| Kawashima, S | 1 |
| Igarashi, A | 1 |
| Gibson, RS | 1 |
| Tondiĭ, LD | 1 |
| Bondarenko, SV | 1 |
| Shtern, MR | 1 |
| Karuna, IT | 1 |
| Plaja, J | 1 |
| Gionet, M | 1 |
| Tumolo, J | 1 |
| Paraskos, JA | 1 |
| Artese, D | 1 |
| Albani, A | 1 |
| Di Nicola, A | 1 |
| Rühle, H | 1 |
| Davies, JA | 1 |
| Abraira, C | 1 |
| Anderson, JW | 1 |
| Kwaan, HC | 1 |
| Jouve, R | 1 |
| Larrue, J | 1 |
| Trolese-Mongheal, Y | 1 |
| Trolese, JF | 1 |
| Lavarenne, J | 1 |
| Duchene-Marullaz, P | 1 |
| Hillis, LD | 1 |
| Borer, J | 1 |
| Braunwald, E | 1 |
| Chesebro, JH | 1 |
| Cohen, LS | 1 |
| Dalen, J | 1 |
| Dodge, HT | 1 |
| Francis, CK | 1 |
| Knatterud, G | 1 |
| Ludbrook, P | 1 |
| Loeliger, EA | 1 |
| Machado, SG | 1 |
| Barton, BA | 1 |
| Forbes, CD | 1 |
| Kinsbergen, M | 1 |
| Friedemann, M | 2 |
| Schaper, W | 1 |
| Vormittag, E | 1 |
| Zekert, F | 1 |
| Kohn, P | 1 |
| Grabner, H | 1 |
| Vormittag, D | 1 |
| Weser, C | 1 |
| Scheidler, K | 1 |
| Teik, KO | 1 |
| Poh, FW | 1 |
| Fun, CS | 1 |
| Mong, BC | 1 |
| Akiyama, K | 1 |
| Popescu, P | 1 |
| Gherasim, L | 1 |
| Wende, W | 1 |
| Bussmann, WD | 1 |
| Doĭchinov, A | 1 |
| Buchvarova, B | 1 |
| Shintani, F | 1 |
| Fu, L | 1 |
| Kato, K | 1 |
| Koyama, S | 1 |
| Wessler, S | 1 |
| Sherman, LA | 1 |
| Didisheim, P | 1 |
| Kazmier, FJ | 1 |
| Gershengorn, K | 1 |
| Kranz, PD | 1 |
| Oestreicher, R | 1 |
| Irnich, W | 1 |
| Ledingham, IM | 1 |
| Gent, AE | 1 |
| Brook, CG | 1 |
| Foley, TH | 1 |
| Miller, TN | 1 |
| Ogston, D | 1 |
| Aoyama, S | 1 |
| Mantero, O | 1 |
| Conti, F | 1 |
| Kobayakawa, T | 1 |
| Yokoyama, H | 1 |
| Osugi, S | 1 |
| Wernitsch, W | 1 |
| Richter, G | 1 |
| Halmagyi, M | 1 |
| Zeitler, E | 1 |
| Itatsu, H | 2 |
| Cerbella, E | 1 |
| Pauchant, M | 1 |
| Bernard, JM | 1 |
| Nolla Panadés, J | 1 |
| Krug, A | 1 |
| Krug, C | 1 |
| Dharamadhach, A | 1 |
| Geraga, W | 1 |
| Gwoźdź, E | 1 |
| Mroszczyk, M | 1 |
| Bouvier, CA | 1 |
| Rosner, P | 1 |
| Berthoud, S | 1 |
| Ritschard, J | 1 |
| Scherrer, JR | 1 |
| Hausser, E | 1 |
| Martinetti, L | 2 |
| Furlotti-Marino, G | 1 |
| Ando, M | 1 |
| Düx, A | 1 |
| Morris, CD | 1 |
| Menna, J | 1 |
| Sawayama, T | 1 |
| Shiozu, N | 1 |
| Niki, I | 1 |
| Matsuura, T | 1 |
| Ichinose, S | 1 |
| Balzano, I | 1 |
| Capelli, F | 1 |
| Lotto, A | 1 |
| Lomanto, B | 1 |
| Marangoni, R | 1 |
| Brera, V | 1 |
| Meesmann, W | 1 |
| Bachmann, GW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial[NCT00991029] | Phase 3 | 4,881 participants (Actual) | Interventional | 2010-05-28 | Terminated (stopped due to The trial was halted by the DSMB.) | ||
| PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes: A Double-blind, Active and Placebo Controlled Study of Aggrenox vs. Clopidogrel, With and Without Micardis[NCT00153062] | Phase 4 | 20,332 participants (Actual) | Interventional | 2003-08-31 | Completed | ||
| Ammonia N-13 Myocardial Blood Flow Absolute Quantification by Positron Emission Tomography in Patients With Known or Suspected Coronary Artery Disease (Ammonia MAP)[NCT04343209] | 2,500 participants (Anticipated) | Observational | 2020-09-14 | Recruiting | |||
| Prospective Evaluation of Chemotherapy-Induced Cardiotoxicity by Serial PET Myocardial Perfusion and Blood Flow Assessment - the PRECISION Trial[NCT05913999] | 60 participants (Anticipated) | Observational | 2023-06-01 | Enrolling by invitation | |||
| "PGDT With the Hypotension Prediction Index to Reduce the Number and Duration of Intraoperative Hypotension and the Incidence of Renal Failure in Patients Undergoing Lung Surgery"[NCT04149314] | 142 participants (Actual) | Interventional | 2019-11-20 | Completed | |||
| To Establish a Multimodal Dynamic Risk Assessment System of Heart Failure in Patients With Myocardial Infarction Based on Coronary Microcirculation.[NCT05760157] | 567 participants (Anticipated) | Observational | 2023-01-01 | Recruiting | |||
| Comparison of Dobutamine Stress Echocardiography and Fractional Flow Reserve in Patients With Moderate Coronary Artery Disease: Stable and Non-culprit Lesions Investigation[NCT03383718] | 200 participants (Actual) | Observational | 2014-12-01 | Completed | |||
| A Pilot Study Examining the Value of Combined Exercise and Adenosine Stress Myocardial Perfusion Imaging as Compared With Adenosine Testing Alone for the Evaluation of Women at Intermediate or High Likelihood for Coronary Artery Disease[NCT00200629] | Phase 4 | 200 participants (Anticipated) | Interventional | 2005-06-30 | Terminated (stopped due to Poor enrollment) | ||
| [NCT00000472] | Phase 3 | 0 participants | Interventional | 1989-04-30 | Completed | ||
| Metabolomic Profile of Patients Undergoing Myocardial Perfusion SPECT[NCT02968771] | 500 participants (Anticipated) | Observational | 2016-11-30 | Active, not recruiting | |||
| [NCT00000505] | Phase 3 | 0 participants | Interventional | 1983-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Secondary efficacy outcome: Number of participants with ischemic stroke, myocardial infarction, death from ischemic vascular causes, or major hemorrhage (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 141 |
| Placebo | 167 |
Primary efficacy outcome: Number of Participants with Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 121 |
| Placebo | 160 |
Other safety outcome: Number of Participants with Death from any cause (NCT00991029)
Timeframe: up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 18 |
| Placebo | 12 |
Secondary efficacy outcome: Number of participants with Death from ischemic vascular causes (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 6 |
| Placebo | 4 |
Other safety outcome: Number of participants with Hemorrhagic stroke (NCT00991029)
Timeframe: up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 5 |
| Placebo | 3 |
Secondary efficacy outcome: Number of participants with Ischemic or hemorrhagic stroke (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 116 |
| Placebo | 156 |
Secondary efficacy outcome:Number of participants with Ischemic stroke (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 112 |
| Placebo | 155 |
Primary safety outcome: Number of Participants with major hemorrhage (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 23 |
| Placebo | 10 |
Other safety outcome: Number of Participants with Major hemorrhage other than intracranial hemorrhage (NCT00991029)
Timeframe: up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 17 |
| Placebo | 7 |
Other safety outcome:Number of Participants with Minor hemorrhage (NCT00991029)
Timeframe: up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 40 |
| Placebo | 13 |
Secondary efficacy outcome: Number of participants with Myocardial infarction (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 10 |
| Placebo | 7 |
Other safety outcome: Number of participants with other symptomatic intracranial hemorrhage (NCT00991029)
Timeframe: up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 2 |
| Placebo | 0 |
Other safety outcome: Number of participants with Symptomatic intracerebral hemorrhage (NCT00991029)
Timeframe: up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 2 |
| Placebo | 2 |
Number of patients with any of stroke, myocardial infarction, vascular death (NCT00153062)
Timeframe: time since randomization; follow-up period is 1.5 to 4.4 years
| Intervention | Participants (Number) |
|---|---|
| Aspirin + Extended Release Dipyridamole | 1333 |
| Clopidogrel | 1333 |
Number of patients with any of stroke, myocardial infarction, vascular death, or new or worsening congestive heart failure (NCT00153062)
Timeframe: time since randomization; follow-up period is 1.5 to 4.4 years
| Intervention | Participants (Number) |
|---|---|
| Telmisartan | 1367 |
| Placebo | 1463 |
(NCT00153062)
Timeframe: time since randomization; follow-up period is 1.5 to 4.4 years
| Intervention | Participants (Number) |
|---|---|
| Aspirin + Extended Release Dipyridamole | 916 |
| Clopidogrel | 898 |
(NCT00153062)
Timeframe: time since randomization; follow-up period is 1.5 to 4.4 years
| Intervention | Participants (Number) |
|---|---|
| Telmisartan | 880 |
| Placebo | 934 |
(NCT00153062)
Timeframe: Randomization to final patient contact
| Intervention | Participants (Number) |
|---|---|
| Telmisartan | 125 |
| Placebo | 151 |
92 reviews available for dipyridamole and Cardiovascular Stroke
| Article | Year |
|---|---|
Adenosine transport, erythrocyte deformability and microvascular dysfunction: an unrecognized potential role for dipyridamole therapy.
Topics: Adenosine; Blood Viscosity; Dipyridamole; Erythrocyte Deformability; Erythrocytes; Humans; Myocardia | 2010 |
Pharmacological modulation of vascular inflammation in atherothrombosis.
Topics: Atherosclerosis; Biomarkers; Dipyridamole; Endothelium; Humans; Inflammation Mediators; Models, Card | 2010 |
Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions.
Topics: Aspirin; Cilostazol; Dipyridamole; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase In | 2010 |
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
Topics: Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Clopidogrel; Cost-Benefit Analysis; Delayed-Ac | 2011 |
Semiquantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a meta-analysis.
Topics: Dipyridamole; Exercise Test; Heart; Humans; Intraoperative Complications; Myocardial Infarction; Pos | 2002 |
[Anticoagulants and antiplatelets].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heparin; Humans; | 1994 |
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Humans; Ische | 2003 |
[Anticoagulant, antiplatelet agents].
Topics: Anticoagulants; Aspirin; Death, Sudden, Cardiac; Dipyridamole; Drug Therapy, Combination; Heparin; H | 2003 |
Abdominal aortic aneurysms and concomitant coronary artery disease. Is routine dipyridamole thallium scintigraphy still justified?
Topics: Aortic Aneurysm, Abdominal; Coronary Artery Disease; Dipyridamole; Humans; Myocardial Infarction; Po | 2003 |
Cochrane review: dipyridamole for preventing major vascular events in patients with vascular disease.
Topics: Death, Sudden, Cardiac; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Infarction; Plat | 2003 |
Combined antithrombotic therapy for acute coronary syndrome.
Topics: Administration, Oral; Angina, Unstable; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; D | 2003 |
Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
Topics: Aspirin; Blood Pressure; Brain Ischemia; Dipyridamole; Drug Therapy, Combination; Female; Humans; Is | 2005 |
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Humans; Ische | 2006 |
[Antiplatelet agents--problem for cardiac surgeon].
Topics: Anticoagulants; Aspirin; Coronary Thrombosis; Dipyridamole; Fibrinolytic Agents; Humans; Myocardial | 2006 |
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Humans; Ische | 2007 |
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibr | 1981 |
[Therapy of non-complicated acute myocardial infarct].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Analgesics; Animals; Anticoagulants; Calcium C | 1982 |
[Prevention of myocardial infarction by chemotherapy].
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Blood Platelets | 1982 |
Changing concepts of pathophysiology, prognosis, and therapy in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspirin; Coronary Disease; Coronary Vasospasm; Death, Sudden; Dipyridam | 1983 |
Antiplatelet agents: rationale and results.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Animals; Arachidonic Acids; Aspirin; Blood Plate | 1983 |
Bleeding associated with antithrombotic therapy.
Topics: 4-Hydroxycoumarins; Aspirin; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic | 1980 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas | 1982 |
Nuclear cardiology (first of two parts).
Topics: Antibodies; Coronary Disease; Diphosphates; Dipyridamole; Gallium Radioisotopes; Heart; Humans; Indi | 1981 |
[Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].
Topics: Adult; Anticoagulants; Antithrombin III; Arrhythmias, Cardiac; Clofibrate; Dipyridamole; Female; Hum | 1981 |
The SPECTrum of thallium-201 imaging in coronary artery disease.
Topics: Coronary Disease; Dipyridamole; Exercise Test; Humans; Myocardial Infarction; Radioisotopes; Thalliu | 1983 |
Role of platelet-active drugs in coronary artery disease.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Drug Therapy, Co | 1983 |
[Primary thrombocyte reactions in hemostasis and thrombogenesis and the possibilities of influencing them by drugs].
Topics: Animals; Aspirin; Blood Platelets; Dipyridamole; Dose-Response Relationship, Drug; Drug Evaluation; | 1984 |
Cardiogenic cerebral embolism.
Topics: Anticoagulants; Aspirin; Cardiac Surgical Procedures; Cerebral Hemorrhage; Cerebral Infarction; Dipy | 1984 |
Dipyridamole: a critical evaluation.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1984 |
[Current clinical results of antiplatelet medication].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Brain Ischemia; Coronary Disease; Dipyridamole; D | 1984 |
[Blood platelets and myocardial infarction].
Topics: Aspirin; Blood Platelets; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Aggreg | 1984 |
Aspirin in the treatment of cardiovascular disease: a review.
Topics: Aspirin; Blood Platelets; Blood Vessels; Cell Adhesion; Clinical Trials as Topic; Cyclooxygenase Inh | 1983 |
Nuclear cardiology. II. The role of myocardial perfusion imaging using thallium-201 in diagnosis of coronary heart disease.
Topics: Acute Disease; Computers; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Coronary V | 1980 |
Myocardial perfusion imaging in ischemic heart disease.
Topics: Animals; Coronary Disease; Dipyridamole; Heart Function Tests; Humans; Kinetics; Medical Laboratory | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Di | 1981 |
[Myocardial infarct: secondary prevention with drugs and their effects].
Topics: Alprenolol; Aspirin; Dipyridamole; Humans; Myocardial Infarction; Prognosis; Sulfinpyrazone | 1980 |
Myocardial infarction.
Topics: Anticoagulants; Aspirin; Blood Platelets; Death, Sudden; Dipyridamole; Fibrinolytic Agents; Humans; | 1981 |
Antiplatelet agents: their role in the prevention of sudden death.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Clinical Trials as Topic; Coronary Circulation; Co | 1982 |
[Estimation of perioperative cardiac risk by means of dipyridamole myocardial scintigraphy in patients undergoing vascular surgery on the lower limbs].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Dipyridamole; Female; Humans; Leg; Male; Middle Aged; Myoc | 1995 |
Pharmacologic stress myocardial perfusion imaging.
Topics: Adenosine; Contraindications; Coronary Circulation; Coronary Disease; Dipyridamole; Dobutamine; Exer | 1993 |
Oral anticoagulant treatment with and without aspirin.
Topics: Administration, Oral; Angina, Unstable; Anticoagulants; Aspirin; Clinical Trials as Topic; Dipyridam | 1995 |
Prognostic value of stress echocardiography in stable angina or after myocardial infarction.
Topics: Angina Pectoris; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Humans; Myocardial Infar | 1996 |
Echocardiography for the assessment of myocardial viability.
Topics: Adrenergic beta-Agonists; Chronic Disease; Coronary Disease; Dipyridamole; Dobutamine; Echocardiogra | 1997 |
[Stress echocardiography in myocardial infarct].
Topics: Cardiotonic Agents; Dipyridamole; Dobutamine; Echocardiography; Humans; Myocardial Contraction; Myoc | 1998 |
Risk stratification after myocardial infarction: targets and tools.
Topics: Cardiac Catheterization; Coronary Angiography; Dipyridamole; Echocardiography; Exercise Test; Heart; | 1995 |
Use of stress echocardiography for risk assessment of patients after myocardial infarction.
Topics: Adrenergic beta-Agonists; Cardiac Pacing, Artificial; Cardiotonic Agents; Dipyridamole; Dobutamine; | 1999 |
Diagnostic and prognostic use of stress echocardiography in stable patients.
Topics: Coronary Disease; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Humans; Myocardial Infa | 2000 |
Diagnostic and prognostic use of stress echo in acute coronary syndromes including emergency department imaging.
Topics: Diagnosis, Differential; Dipyridamole; Dobutamine; Echocardiography; Emergencies; Exercise Test; Hum | 2000 |
[Ergometry after acute myocardial infarct].
Topics: Adult; Aged; Aged, 80 and over; Atropine; Cardiac Catheterization; Cardiotonic Agents; Dipyridamole; | 2000 |
Risk stratification with pharmacological stress echocardiography in post-acute myocardial infarction patients.
Topics: Cardiotonic Agents; Dipyridamole; Dobutamine; Echocardiography, Stress; Humans; Myocardial Infarctio | 2001 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Co | 1979 |
[Diagnostic and prognostic value of scintigraphic methods in cardiology (static methods)].
Topics: Angina Pectoris; Cardiac Catheterization; Chemotherapy, Cancer, Regional Perfusion; Coronary Vessels | 1979 |
[Indications and uncertainties of antiaggregating agents].
Topics: Anticoagulants; Aspirin; Clofibrate; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregati | 1977 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; | 1978 |
[Prophylactic value of platelet anti-aggregants in coronary disease].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Embolism; Hea | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofi | 1979 |
[Anticoagulation therapy in myocardial infarction (author's transl)].
Topics: Anticoagulants; Aspirin; Coumarins; Dipyridamole; Fibrinolysis; Heparin; Humans; Leg; Myocardial Inf | 1975 |
Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prospe | 1976 |
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Brain; Clofibrate; Dextrans; Dipyridamole; Humans; Ischemi | 1976 |
Antithrombotic drugs: part II.
Topics: Anabolic Agents; Ancrod; Animals; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Fibr | 1976 |
Platelets and thromboembolism.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Dext | 1976 |
[Possibilities of preserving ischemic myocardium].
Topics: Acute Disease; Animals; Coronary Circulation; Coronary Disease; Dipyridamole; Fibrinolysis; Humans; | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Dose-Response Relationship, Drug; | 1992 |
Prognostic value of thallium-201 myocardial perfusion imaging in three primary patient populations.
Topics: Coronary Disease; Dipyridamole; Exercise Test; Humans; Myocardial Infarction; Myocardium; Perfusion; | 1992 |
[Accurate assessment of myocardial viability: complementation of Thallium-201 scintigraphy with a subsequent reinjection study].
Topics: Adult; Aged; Cardiomyopathies; Dipyridamole; Female; Heart Function Tests; Humans; Male; Middle Aged | 1992 |
[Coronary thrombolysis in patients with acute myocardial infarction].
Topics: Animals; Aspirin; Dipyridamole; Heparin; Humans; Myocardial Infarction; Plasminogen Activators; Reco | 1992 |
Myocardial perfusion imaging in the diagnosis of coronary artery disease.
Topics: Adenosine; Coronary Circulation; Coronary Disease; Dipyridamole; Heart; Humans; Myocardial Infarctio | 1992 |
[Platelet antiaggregants in the treatment of arterial thrombosis].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cerebrovascular Disorders; Coronary Artery | 1991 |
Antiplatelet and anticoagulant therapy in acute myocardial infarction.
Topics: Aspirin; Dipyridamole; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Sulf | 1991 |
Current status of nuclear cardiology techniques.
Topics: Antibodies; Coronary Disease; Dipyridamole; False Negative Reactions; Heart; Humans; Myocardial Infa | 1991 |
Stress testing in the period after infarction.
Topics: Coronary Disease; Dipyridamole; Echocardiography; Electrocardiography; Exercise Test; Humans; Myocar | 1991 |
Prognostic impact of stress testing in coronary artery disease.
Topics: Cardiology; Coronary Disease; Dipyridamole; Electrocardiography; Exercise Test; Female; Humans; Male | 1991 |
A review of secondary coronary prevention with dipyridamole and aspirin.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Infar | 1990 |
Myocardial perfusion imaging.
Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Dipyridamole; Exercise Test; Heart; Humans; Myocar | 1990 |
[Current aspects of arterial anti-thrombosis prophylaxis].
Topics: Adult; Aged; Aspirin; Contraindications; Dipyridamole; Humans; Middle Aged; Myocardial Infarction; P | 1990 |
Role of platelet inhibitor therapy in myocardial infarction.
Topics: Aspirin; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Sulfinpyrazon | 1989 |
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug | 1989 |
Secondary prevention of coronary events after myocardial infarction. Beta-blockers and/or anti-platelets: to whom, when and for how long. A review.
Topics: Adrenergic beta-Antagonists; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Myoca | 1985 |
Platelets and prostaglandins in sudden death: therapeutic implications.
Topics: Adrenergic beta-Antagonists; Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Aspirin | 1985 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials a | 1986 |
[Thrombosis in various diseases: myocardial infarct].
Topics: Angioplasty, Balloon; Aspirin; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Th | 1986 |
Plasma drug binding: implications for anesthesiologists.
Topics: Age Factors; Alfentanil; Alprenolol; Anesthesia; Anesthetics; Blood Proteins; Bupivacaine; Burns; Ca | 1986 |
Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Arte | 1987 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical | 1986 |
Antithrombotic agents in coronary artery disease.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disea | 1986 |
Aspirin for the prevention of coronary thrombosis: current facts and perspectives.
Topics: Angina, Unstable; Animals; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disea | 1986 |
VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis.
Topics: Amputation, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; | 1986 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Femal | 1985 |
Antiplatelet aggregant agents and thrombolytic compounds in myocardial infarction: current status.
Topics: Anticoagulants; Aspirin; Blood Coagulation Factors; Coumarins; Dextrans; Dipyridamole; Fibrinolytic | 1972 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamol | 1974 |
Anticoagulant and thrombolytic drugs. II. Clinical aspects.
Topics: Administration, Oral; Adult; Anticoagulants; Blood Coagulation Factors; Coronary Disease; Coumarins; | 1971 |
97 trials available for dipyridamole and Cardiovascular Stroke
| Article | Year |
|---|---|
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; | 2008 |
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; | 2008 |
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; | 2008 |
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; | 2008 |
Incidence of caffeine in serum of patients undergoing dipyridamole myocardial perfusion stress test by an intensive versus routine caffeine history screening.
Topics: Aged; Caffeine; Coronary Disease; Dipyridamole; Drug Interactions; Exercise Test; Female; Hemodynami | 2010 |
Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Chi-Square Distribution; Coronary Angiography; Coronary Circul | 2010 |
Prognostic value of high-dose dipyridamole stress myocardial contrast perfusion echocardiography.
Topics: Aged; Contrast Media; Coronary Artery Disease; Dipyridamole; Echocardiography; Exercise Test; Female | 2012 |
Noninvasive tests for risk stratification in major vascular surgery.
Topics: Aged; Aortic Aneurysm; Arterial Occlusive Diseases; Coronary Disease; Dipyridamole; Echocardiography | 2002 |
Cost of strategies after myocardial infarction (COSTAMI): a multicentre, international, randomized trial for cost-effective discharge after uncomplicated myocardial infarction.
Topics: Cardiotonic Agents; Cost-Benefit Analysis; Dipyridamole; Dobutamine; Echocardiography, Stress; Femal | 2003 |
Predictive value of biphasic response during dipyridamole echocardiography test in the low-risk group of patients after acute myocardial infarction.
Topics: Dipyridamole; Disease-Free Survival; Echocardiography; Female; Humans; Incidence; Male; Myocardial I | 2005 |
Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
Topics: Aspirin; Coronary Angiography; Coronary Disease; Dipyridamole; Disease Progression; Drug Therapy, Co | 2007 |
ESPRIT study design and outcomes--a critical appraisal.
Topics: Aspirin; Biomarkers; Brain Ischemia; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; H | 2007 |
A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Topics: Adrenergic beta-Antagonists; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascula | 1980 |
Prophylaxis of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial Inf | 1981 |
[Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Clinical Trials as Top | 1983 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas | 1982 |
Intracoronary fibrinolytic therapy in acute myocardial infarction. Report of a prospective randomized trial.
Topics: Adult; Aged; Angiography; Aspirin; Clinical Enzyme Tests; Clinical Trials as Topic; Coronary Circula | 1983 |
Role of platelet-active drugs in coronary artery disease.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Drug Therapy, Co | 1983 |
Doubts about dipyridamole as an antithrombotic drug.
Topics: Antithrombins; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial | 1984 |
[Results of ambulatory follow-up of patients after myocardial infarction treated with platelet aggregation inhibitors and antithrombotic drugs].
Topics: Acenocoumarol; Adult; Ambulatory Care; Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyrida | 1983 |
Dipyridamole: a critical evaluation.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1984 |
Aspirin in the treatment of cardiovascular disease: a review.
Topics: Aspirin; Blood Platelets; Blood Vessels; Cell Adhesion; Clinical Trials as Topic; Cyclooxygenase Inh | 1983 |
Registry of prospective clinical trials--fifth report.
Topics: Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Bl | 1982 |
[Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation | 1982 |
Aspirin and recurrent myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infar | 1980 |
Secondary prevention of myocardial infarction--the present state of the ART.
Topics: Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial | 1980 |
Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
Topics: Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials a | 1980 |
The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Topics: Aspirin; Blood Pressure; Blood Urea Nitrogen; Cerebrovascular Disorders; Clinical Trials as Topic; C | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Di | 1981 |
[Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Humans; M | 1981 |
Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Collagen; Coronary Disease; Dipyridamo | 1981 |
E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Data Collectio | 1981 |
Antiplatelet agents: their role in the prevention of sudden death.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Clinical Trials as Topic; Coronary Circulation; Co | 1982 |
Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group.
Topics: Adult; Aged; Animals; Aspirin; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Electrocar | 1980 |
[Long term prophylaxis of re-infarct. Results of the persantin-acetylsalicylic acid re-infarct study].
Topics: Adult; Aged; Aspirin; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; | 1980 |
Stress echocardiographic results predict risk of reinfarction early after uncomplicated acute myocardial infarction: large-scale multicenter study. Echo Persantine International Cooperative (EPIC) Study Group.
Topics: Dipyridamole; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; L | 1995 |
Prognostic significance of increased thallium-201 lung uptake during dipyridamole myocardial scintigraphy: comparison with exercise scintigraphy.
Topics: Aged; Coronary Disease; Dipyridamole; Dose-Response Relationship, Radiation; Exercise Test; Female; | 1995 |
Effects of nisoldipine in silent myocardial ischemia after healing of acute myocardial infarction.
Topics: Adult; Aged; Dipyridamole; Exercise Tolerance; Female; Hemodynamics; Humans; Male; Middle Aged; Myoc | 1995 |
Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy.
Topics: Aspirin; Coronary Angiography; Coronary Disease; Coronary Vessels; Dipyridamole; Double-Blind Method | 1995 |
Laboratory assessment of thrombolytic therapy in acute myocardial infarction.
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Dipyridamole; Drug Monitoring; Drug Therapy, C | 1993 |
Pharmacologic stress dual-isotope myocardial perfusion single-photon emission computed tomography.
Topics: Adenosine; Aged; Coronary Angiography; Coronary Disease; Dipyridamole; Feasibility Studies; Female; | 1994 |
[The echo-dobutamine and echo-dipyridamole tests in assessing vital myocardium and residual ischemia in myocardial infarct after thrombolysis].
Topics: Adult; Aged; Analysis of Variance; Coronary Angiography; Dipyridamole; Dobutamine; Echocardiography; | 1994 |
Effect on early acute occlusion rate of adjunctive antithrombotic treatment with intravenously administered dipyridamole during percutaneous transluminal coronary angioplasty.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Aspirin; Chemotherapy, Adjuvant; Coronary Thrombosis; | 1994 |
Prognostic value of dipyridamole echocardiography early after myocardial infarction in elderly patients. Echo Persantine Italian Cooperative (EPIC) Study Group.
Topics: Aged; Dipyridamole; Echocardiography; Electrocardiography; Exercise Test; Feasibility Studies; Femal | 1993 |
Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large-scale, multicenter trial. The EPIC Study Group.
Topics: Adult; Aged; Confounding Factors, Epidemiologic; Dipyridamole; Echocardiography; Feasibility Studies | 1993 |
Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event.
Topics: Aged; Aspirin; Cerebral Infarction; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemi | 1993 |
Late thrombolysis followed by antithrombotic treatment in acute myocardial infarction: effect of therapy evaluated with thallium-201 SPECT.
Topics: Aged; Coronary Circulation; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; E | 1993 |
[Use of high doses of atropine during dipyridamole echocardiography: safety and efficacy of the combined test].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angioplasty, Balloo | 1995 |
Correlation between dobutamine stress transesophageal echocardiography, thallium 201-dipyridamole scintigraphy and coronary angiography in the early detection of myocardial ischemia.
Topics: Adult; Aged; Dipyridamole; Dobutamine; Echocardiography, Transesophageal; Exercise Test; Female; Hum | 1996 |
Does stress echocardiography predict the site of future myocardial infarction? A large-scale multicenter study. EPIC (Echo Persantine International Cooperative) and EDIC (Echo Dobutamine International Cooperative) study groups.
Topics: Databases, Factual; Dipyridamole; Dobutamine; Echocardiography; Electrocardiography; Female; Follow- | 1996 |
Comparison of dobutamine stress echocardiography with dipyridamole stress echocardiography for detection of viable myocardium after myocardial infarction treated with thrombolysis.
Topics: Coronary Angiography; Dipyridamole; Dobutamine; Drug Administration Schedule; Echocardiography; Fema | 1996 |
Prediction of late cardiac events by dipyridamole thallium scintigraphy in patients with intermittent claudication and occult coronary artery disease.
Topics: Aged; Cardiac Catheterization; Coronary Disease; Dipyridamole; Female; Follow-Up Studies; Humans; In | 1996 |
Time course of impaired coronary flow reserve after reperfusion in patients with acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Flow Velocity; Cardiac Catheterization; Coronary Angiogr | 1996 |
Aspirin plus either dipyridamole or ticlopidine is effective in preventing recurrent myocardial infarction. Secondary Prevention Group.
Topics: Aged; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mid | 1997 |
Detection of significant residual stenosis of the infarct-related artery after thrombolysis by high-dose dipyridamole echocardiography test: is it detected often enough?
Topics: Aged; Coronary Disease; Dipyridamole; Echocardiography; Female; Humans; Male; Middle Aged; Myocardia | 1997 |
Dipyridamole thallium-201 imaging very early after uncomplicated acute myocardial infarction in patients treated with thrombolytic therapy.
Topics: Adult; Aged; Analysis of Variance; Coronary Angiography; Dipyridamole; Exercise Test; Female; Follow | 1997 |
The relative value of exercise-electrocardiography and dipyridamole stress echocardiography for risk stratification early after uncomplicated myocardial infarction. The EPIC (Echo Persantine International Cooperative) Study Group.
Topics: Cause of Death; Dipyridamole; Echocardiography; Electrocardiography; Exercise Test; Female; Follow-U | 1997 |
Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS).
Topics: Angina, Unstable; Blood Pressure; Coronary Circulation; Death, Sudden, Cardiac; Dipyridamole; Electr | 1997 |
Diagnostic and prognostic value of dipyridamole and dobutamine stress echocardiography in patients with Q-wave acute myocardial infarction.
Topics: Adult; Aged; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Female; Humans; Male; Middle | 1997 |
[Intracoronary dipyridamole reduces the incidence of acute coronary vessel occlusion in percutaneous transluminal coronary angioplasty--a prospective randomized study].
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Coro | 1997 |
The additive values of left ventricular function and extent of myocardium at risk to dipyridamole perfusion imaging for optimal risk stratification prior to vascular surgery.
Topics: Aged; Aged, 80 and over; Dipyridamole; Heart; Humans; Intraoperative Complications; Male; Middle Age | 1999 |
Early dipyridamole (99m)Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging.
Topics: Dipyridamole; Electrocardiography; Exercise Test; Female; Hemodynamics; Hospitalization; Humans; Mal | 1999 |
Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias : evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Arrhythmias, Cardiac; Cyc | 2000 |
Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trial.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Thrombosis; Coronar | 2000 |
Cardiac safety in the European Stroke Prevention Study 2 (ESPS2).
Topics: Angina Pectoris; Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Longitudinal Studies; My | 2001 |
[Does early high dosage dipyridamole in prevention of secondary stroke induce cardiac events?].
Topics: Administration, Oral; Angina Pectoris; Aspirin; Cause of Death; Cerebral Infarction; Delayed-Action | 2001 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Co | 1979 |
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Rela | 1975 |
Three large-scale clinical trials of aspirin in the USA.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therapy, Com | 1977 |
Preliminary study of effect of aspirin and dipyridamole on platelet adhesiveness and fibrinolytic activity in acute myocardial infarction.
Topics: Acute Disease; Aspirin; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Drug Evaluation; F | 1978 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; | 1978 |
[Clinico-statistical controlled evaluation of the anti-anginous and myocardiotropic activity of a new substance: 2-benzofuryl-p-chlorophenyl carbinol (Chloridarol)].
Topics: Angina Pectoris; Benzofurans; Benzyl Alcohols; Clinical Trials as Topic; Dipyridamole; Drug Evaluati | 1976 |
Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prospe | 1976 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Surviva | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
[Prognostic value of the dipyridamole-echocardiography test immediately after a non-complicated myocardial infarct: a large scale multicenter study. Echo Persantine Italian Cooperative Study].
Topics: Adult; Aged; Angina Pectoris; Dipyridamole; Echocardiography; Female; Follow-Up Studies; Humans; Mal | 1992 |
Multivariate clinical models and quantitative dipyridamole-thallium imaging to predict cardiac morbidity and death after vascular reconstruction.
Topics: Canada; Death, Sudden; Dipyridamole; Heart; Humans; Models, Cardiovascular; Multivariate Analysis; M | 1991 |
A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group.
Topics: Administration, Oral; Anticoagulants; Aspirin; Dipyridamole; Female; Heparin; Humans; Injections, In | 1991 |
Comparison of coronary angiographic features and oral dipyridamole thallium 201 tomography.
Topics: Adult; Aged; Angiography; Coronary Angiography; Dipyridamole; Female; Gated Blood-Pool Imaging; Huma | 1991 |
Secondary prevention of myocardial infarction in the first European Stroke Prevention Study.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Europe; Humans; Myocard | 1990 |
[Anticoagulantion and antiaggregation therapy in patients with unstableangina pectoris].
Topics: Angina, Unstable; Aspirin; Dipyridamole; Drug Therapy, Combination; Electrocardiography; Female; Hep | 1990 |
Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Therapy, Combina | 1990 |
Usefulness of aspirin plus dipyridamole in reducing left ventricular thrombus formation in anterior wall acute myocardial infarction.
Topics: Aspirin; Blood Coagulation; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Therap | 1989 |
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug | 1989 |
Prevention of coronary heart disease in practice. Implications of the results of recent clinical trials.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina, Unstable; Aspirin; Blood Platelets; Cholesterol; C | 1985 |
Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin.
Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Adult; Aged; Aspirin; Clinical Trials as Topic; Dig | 1986 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials a | 1986 |
Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Arte | 1987 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical | 1986 |
Antithrombotic agents in coronary artery disease.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disea | 1986 |
Aspirin for the prevention of coronary thrombosis: current facts and perspectives.
Topics: Angina, Unstable; Animals; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disea | 1986 |
VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis.
Topics: Amputation, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; | 1986 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Femal | 1985 |
[Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Fibrinolytic A | 1985 |
Secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Infar | 1985 |
V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics.
Topics: Amputation, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; | 1985 |
[Eicosanoids, myocardial ischemia and sudden death].
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Coronary Disease; Cyclooxygenase I | 1985 |
[Hemodynamic effects of dipyridamole (Persantin) following beta-blockade in coronary failure].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Cardiac Output; Cardiac Volume; Clinical Trials as Top | 1973 |
Controlled clinical trial of "Atromid" (androsterone with ethyl-p-chlorophenoxy-isobutyrate) and "Persantin" (dipyridamole) in cases of myocardial infarction.
Topics: Adult; Aged; Androsterone; Butyrates; Clinical Trials as Topic; Dipyridamole; Humans; Middle Aged; M | 1966 |
Dipyridamole: a controlled trial of its effect in acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Dipyridamole; Embolism; Female; Humans; Male; | 1968 |
389 other studies available for dipyridamole and Cardiovascular Stroke
| Article | Year |
|---|---|
Safety and Prognostic Value of Vasodilator Stress Cardiovascular Magnetic Resonance in Patients With Heart Failure and Reduced Ejection Fraction.
Topics: Aged; Contrast Media; Dipyridamole; Female; Heart Failure; Humans; Infusions, Intravenous; Longitudi | 2020 |
Non-contrast assessment of microvascular integrity using arterial spin labeled cardiovascular magnetic resonance in a porcine model of acute myocardial infarction.
Topics: Animals; Coronary Circulation; Coronary Vessels; Dipyridamole; Disease Models, Animal; Feasibility S | 2018 |
Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study.
Topics: Aged; Case-Control Studies; Cerebral Hemorrhage; Clopidogrel; Dipyridamole; Disease-Free Survival; D | 2019 |
Age- and Gender-Specific Prognostic Cutoff Values of Coronary Flow Velocity Reserve in Vasodilator Stress Echocardiography.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Dipyridamole; Echocardiography, Stress; Female; Fractio | 2019 |
Warranty periods for normal myocardial perfusion stress SPECT.
Topics: Aged; Coronary Artery Disease; Diabetes Complications; Dipyridamole; Exercise; Exercise Test; Female | 2015 |
Regular dipyridamole therapy produces sustained protection against cardiac ischemia-reperfusion injury: is it time to revisit PARIS?
Topics: Animals; Aspirin; Cardiotonic Agents; Dipyridamole; Drug Therapy, Combination; Guinea Pigs; Male; My | 2014 |
Prognostic value of dipyridamole stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a mid-term follow-up study.
Topics: Aged; Cardiovascular Diseases; Chest Pain; Contrast Media; Coronary Artery Disease; Dipyridamole; Ex | 2016 |
Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin.
Topics: Animals; Aspirin; CREB-Binding Protein; Dipyridamole; Dose-Response Relationship, Drug; Drug Interac | 2010 |
Stress and rest dynamic myocardial perfusion imaging by evaluation of complete time-attenuation curves with dual-source CT.
Topics: Adult; Aged; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Dipyridamole; Feasibilit | 2010 |
[Myocardial infarction after voluntary intoxication by drug interaction between dipyridamole and aspirin].
Topics: Aspirin; Dipyridamole; Drug Interactions; Humans; Male; Middle Aged; Myocardial Infarction; Suicide, | 2010 |
No-reflow: Still searching for that magic bullet.
Topics: Angioplasty, Balloon, Coronary; Coronary Circulation; Dipyridamole; Humans; Myocardial Infarction; N | 2010 |
Potential of delayed gadolinium enhancement magnetic resonance imaging for quantification of reverse remodeling of the peri-infarct zone in patients with ischemic cardiomyopathy treated with chronic vasodilator therapy: initial experience.
Topics: Adult; Aged; Cardiomyopathies; Contrast Media; Coronary Angiography; Coronary Circulation; Dipyridam | 2012 |
Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.
Topics: Aged; Death; Dipyridamole; Electrocardiography; Exercise Test; Female; Fractional Flow Reserve, Myoc | 2011 |
Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.
Topics: Aged; Death; Dipyridamole; Electrocardiography; Exercise Test; Female; Fractional Flow Reserve, Myoc | 2011 |
Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.
Topics: Aged; Death; Dipyridamole; Electrocardiography; Exercise Test; Female; Fractional Flow Reserve, Myoc | 2011 |
Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.
Topics: Aged; Death; Dipyridamole; Electrocardiography; Exercise Test; Female; Fractional Flow Reserve, Myoc | 2011 |
Prognostic implications of dipyridamole cardiac MR imaging: a prospective multicenter registry.
Topics: Aged; Artifacts; Case-Control Studies; Chest Pain; Chi-Square Distribution; Contrast Media; Dipyrida | 2012 |
Level of systolic blood pressure within the normal range and risk of recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Blood Pressure; | 2011 |
Level of systolic blood pressure within the normal range and risk of recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Blood Pressure; | 2011 |
Level of systolic blood pressure within the normal range and risk of recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Blood Pressure; | 2011 |
Level of systolic blood pressure within the normal range and risk of recurrent stroke.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Blood Pressure; | 2011 |
Myocardial contrast echocardiography for simultaneous assessment of function and perfusion in real time: a technique comes of age.
Topics: Coronary Artery Disease; Dipyridamole; Echocardiography; Exercise Test; Female; Humans; Male; Myocar | 2012 |
Comparative prediction of cardiac events by wall motion, wall motion plus coronary flow reserve, or myocardial perfusion analysis: a multicenter study of contrast stress echocardiography.
Topics: Acute Coronary Syndrome; Aged; Biomechanical Phenomena; Chi-Square Distribution; Contrast Media; Cor | 2013 |
High coronary artery calcium score affects clinical outcome despite normal stress myocardial perfusion imaging and normal left ventricular ejection fraction.
Topics: Adenosine; Aged; Coronary Circulation; Coronary Vessels; Diabetes Mellitus; Dipyridamole; Exercise T | 2013 |
[Prognostic value of early dipyridamole stress echocardiography in patients with first uncomplicated myocardial infraction].
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Dipyridamole; Echocardiography, | 2002 |
Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease.
Topics: Aged; Angina Pectoris; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic A | 2002 |
Usefulness of pharmacologic stress echocardiography for the long-term prognostic assessment of patients with typical versus atypical chest pain.
Topics: Age Factors; Aged; Angina Pectoris; Cardiotonic Agents; Chest Pain; Dipyridamole; Dobutamine; Echoca | 2003 |
Predischarge exercise electrocardiogram and stress echocardiography can predict long-term clinically driven revascularization following acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Dipyridamole; Echocardiography, Stress | 2003 |
[Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
Topics: Administration, Oral; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Bl | 2003 |
Clinical, exercise electrocardiographic, and pharmacologic stress echocardiographic findings for risk stratification of hypertensive patients with chest pain.
Topics: Cardiotonic Agents; Chest Pain; Dipyridamole; Dobutamine; Echocardiography; Electrocardiography; Exe | 2003 |
[Prognostic value of thallium 201 myocardial scintigraphy with dipyridamole before peripheral arterial surgery].
Topics: Aged; Dipyridamole; Female; Heart; Humans; Male; Myocardial Infarction; Myocardial Ischemia; Myocard | 2003 |
Usefulness of myocardial perfusion SPECT in patients with left bundle branch block and previous myocardial infarction.
Topics: Aged; Analysis of Variance; Bundle-Branch Block; Coronary Stenosis; Dipyridamole; Exercise Test; Fem | 2003 |
[Clinico-experipyrimido (5,4-d) pyrimidine].
Topics: Angina Pectoris; Dipyridamole; Heart Diseases; Humans; Intracranial Embolism; Intracranial Embolism | 1963 |
THE EFFECT OF 2, 6-BIS (DIETHANOLAMINO)-4,8-DIPIPERIDINE (PERSANTIN) ON THE PROTHROMBIN TIME.
Topics: Angina Pectoris; Dipyridamole; Heart Failure; Humans; Myocardial Infarction; Pharmacology; Phenindio | 1963 |
[REHABILITATION IN HEART DISEASE].
Topics: Acenocoumarol; Dipyridamole; Electrocardiography; Geriatrics; Heart Defects, Congenital; Heart Disea | 1963 |
[CORONARY SCLEROSIS IN THE INTRAVITAL CORONAROGRAM].
Topics: Angiography; Cardiac Surgical Procedures; Collateral Circulation; Coronary Disease; Coronary Vessels | 1964 |
NOCTURNAL ANGINA PECTORIS.
Topics: Angina Pectoris; Coronary Disease; Dipyridamole; Duodenal Obstruction; Heart Failure; Heart Valve Di | 1964 |
PERSANTIN-- A DOUBLE BLIND STUDY.
Topics: Biomedical Research; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy; Geriatrics; | 1964 |
[SHORT DIRECTIONS FOR THE TREATMENT OF A RECENT MYOCARDIAL INFARCT].
Topics: Anticoagulants; Antipsychotic Agents; Cardiac Glycosides; Chlorpromazine; Codeine; Dipyridamole; Dru | 1964 |
[FAVORABLE ELECTROCARDIOGRAPHIC MODIFICATIONS IN THE TREATMENT OF INFARCT WITH DIPYRIDAMOL (PERSANTIN) PHLEBOCLYSIS].
Topics: Dipyridamole; Drug Therapy; Electrocardiography; Humans; Injections, Intravenous; Myocardial Infarct | 1964 |
Validation of an updated approach to preoperative cardiac risk assessment in vascular surgery.
Topics: Aged; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Dobutamine; Echo | 2003 |
Identifying patients without favourable long-term outcome among those with medically stabilized unstable angina and a negative dipyridamole stress echocardiogram.
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Dipyridamole; Echocardiography, Stress; Female; Fo | 2004 |
Accuracy of dipyridamole myocardial contrast echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease early after acute myocardial infarction.
Topics: Aged; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Coronary Vessels; Dipyridamole; | 2004 |
Whole-heart dipyridamole stress first-pass myocardial perfusion MRI for the detection of coronary artery disease.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Dipyridamole; Echo-Planar Imaging; Female; Huma | 2004 |
Antiplatelet therapy.
Topics: Aged; Aspirin; Clopidogrel; Dipyridamole; Drug Interactions; Humans; Myocardial Infarction; Patient | 2004 |
Enhanced platelet aggregability in dogs following myocardial infarction.
Topics: Animals; Blood Platelets; Carrier Proteins; Collagen; Coronary Vessels; Dipyridamole; Disease Models | 1977 |
Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms.
Topics: Aged; Coronary Circulation; Dipyridamole; Electrocardiography; Exercise Test; Female; Heart Rate; Hu | 2005 |
Prognostic value of combined perfusion and function by stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging in patients with suspected or known coronary artery disease.
Topics: Aged; Angina, Unstable; Coronary Angiography; Coronary Disease; Dipyridamole; Exercise Test; Female; | 2005 |
The beneficial effect of insulin, glucose, and dipyridamole on regional left ventricular function early after acute myocardial infarction.
Topics: Dipyridamole; Drug Therapy, Combination; Echocardiography, Stress; Electrocardiography; Follow-Up St | 2005 |
Chronic myocardial infarction due to arteriosclerosis of coronary arteries followed by acute thromboembolism of caudal abdominal aorta in a cat.
Topics: Animals; Aorta, Abdominal; Benzazepines; Cat Diseases; Cats; Coronary Artery Disease; Diltiazem; Dip | 2005 |
Long-term survival of patients with chest pain syndrome and angiographically normal or near-normal coronary arteries: the additional prognostic value of dipyridamole echocardiography test (DET).
Topics: Coronary Angiography; Coronary Vessels; Dipyridamole; Echocardiography, Stress; Female; Humans; Male | 2005 |
Use of dipyridamole in patients with recent stroke or TIA.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Ischemic Attack, | 2005 |
Exercise- or dipyridamole-loaded QGS is useful to evaluate myocardial ischemia and viability in the patients with a history of Kawasaki disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Coronary Stenosis; Dipyridamole; Exercise Test; Female; | 2005 |
Incremental diagnostic value of ultrasonographic assessment of coronary flow reserve with high-dose dipyridamole in patients with acute coronary syndrome.
Topics: Aged; Angina, Unstable; Blood Flow Velocity; Coronary Circulation; Coronary Stenosis; Dipyridamole; | 2006 |
Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease.
Topics: Coronary Artery Disease; Diabetes Complications; Dipyridamole; Dobutamine; Echocardiography, Stress; | 2006 |
Myocardial perfusion imaging and cardiac events in a cohort of asymptomatic patients with diabetes living in southern France.
Topics: Aged; Angina Pectoris; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipyr | 2006 |
Depressed heart rate response to vasodilator stress for myocardial SPECT predicts mortality in patients after myocardial infarction.
Topics: Analysis of Variance; Dipyridamole; Exercise Test; Female; Follow-Up Studies; Heart Rate; Humans; Ka | 2006 |
Fractional flow reserve of infarct-related arteries identifies reversible defects on noninvasive myocardial perfusion imaging early after myocardial infarction.
Topics: Aged; Coronary Circulation; Coronary Vessels; Dipyridamole; Female; Humans; Male; Middle Aged; Myoca | 2006 |
Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease.
Topics: Aminophylline; Cardiotonic Agents; Contrast Media; Coronary Angiography; Coronary Artery Disease; Co | 2006 |
[Dipyridamole-induced regular R-R intervals in a case of old myocardial infarction with atrial fibrillation-flutter].
Topics: Atrial Fibrillation; Atrial Flutter; Dipyridamole; Electrocardiography; Heart; Heart Block; Humans; | 2006 |
Influence of ageing on perioperative cardiac risk in non-cardiac surgery.
Topics: Aged; Aged, 80 and over; Aging; Dipyridamole; Humans; Intraoperative Complications; Middle Aged; Mul | 2007 |
Are two tests always better than one?
Topics: Aminophylline; Cardiotonic Agents; Contrast Media; Coronary Angiography; Coronary Artery Disease; Co | 2007 |
The quantification of dipyridamole induced changes in regional deformation in normal, stunned or infarcted myocardium as measured by strain and strain rate: an experimental study.
Topics: Animals; Cardiotonic Agents; Coronary Circulation; Coronary Stenosis; Dipyridamole; Disease Models, | 2008 |
Prognostic value of coronary flow reserve in medically treated patients with left anterior descending coronary disease with stenosis 51% to 75% in diameter.
Topics: Adrenergic beta-Antagonists; Aged; Calcium Channel Blockers; Coronary Artery Disease; Coronary Circu | 2007 |
The additive prognostic value of wall motion abnormalities and coronary flow reserve during dipyridamole stress echo.
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Coronary Artery Disease; Coronary Circulation; Dea | 2008 |
Dipyridamole stress echocardiography stratifies outcomes of asymptomatic patients with recent myocardial revascularization.
Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery | 2008 |
Outcomes associated with combined antiplatelet and anticoagulant therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Coronary Artery Disea | 2008 |
[Antiplatelet treatment after acute and chronic ischemic heart and brain events is insufficient according to recommendations].
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Aspirin; | 2008 |
[Increased tolerance toward coronary occlusion through a pharmacologically increased vascular network].
Topics: Animals; Blood Pressure; Cardiac Catheterization; Collateral Circulation; Coronary Vessels; Dipyrida | 1966 |
Effects of dipyridamole on anastomotic blood flow in experimental myocardial infarction.
Topics: Animals; Blood Flow Velocity; Dipyridamole; Dogs; Myocardial Infarction; Xenon | 1967 |
Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
Topics: Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Recurrence; | 1980 |
[Infarction prophylaxis--prevention of the sudden heart death? An alternative].
Topics: Adrenergic beta-Antagonists; Anticoagulants; Aspirin; Dipyridamole; Female; Heart Arrest; Humans; Ma | 1982 |
Therapeutic interventions in acute myocardial infarction. Survey of the ACCP Section on Clinical Cardiology.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Calcium Channel Blocke | 1984 |
[Benefits and dangers of preventive thinking in medicine--prevention of thromboembolism].
Topics: Adult; Aspirin; Bandages; Blood Flow Velocity; Coumarins; Dextrans; Dihydroergotamine; Dipyridamole; | 1981 |
Antithrombotic treatment.
Topics: Ancrod; Aspirin; Cerebrovascular Disorders; Dextrans; Dipyridamole; Drug Administration Schedule; He | 1983 |
[Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
Topics: Adrenergic beta-Antagonists; Aged; Anticoagulants; Aspirin; Coumarins; Dicumarol; Dipyridamole; Fibr | 1984 |
Management of acute myocardial infarction with natural physiological agents.
Topics: Acute Disease; Adenosine; Animals; Carnitine; Collateral Circulation; Dipyridamole; Dogs; Epoprosten | 1983 |
[Effects of intracoronary injections of sodium tanshinone II-A sulfonate and dipyridamole on myocardial infarct size in acute ischemic dogs (author's transl)].
Topics: Animals; Cardiovascular Agents; Coronary Vessels; Dipyridamole; Dogs; Female; Furans; Male; Myocardi | 1981 |
[Stress studies with dipyridamole in patients with coronary heart disease in comparison to coronary angiography, myocardial scintigraphy and ergometry findings].
Topics: Angina Pectoris; Coronary Angiography; Coronary Circulation; Coronary Disease; Dipyridamole; Electro | 1984 |
[Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?].
Topics: Aspirin; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazo | 1983 |
Effects of cardiac contraction on segmental coronary resistances and collateral perfusion.
Topics: Animals; Blood Pressure; Chromonar; Collateral Circulation; Coronary Circulation; Coronary Vessels; | 1983 |
Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction.
Topics: Aged; Angina Pectoris; Coronary Circulation; Dipyridamole; Exercise Test; Female; Follow-Up Studies; | 1984 |
Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease.
Topics: Aged; Anticoagulants; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Humans | 1982 |
[Report on a successful orthotopic cardiac transplantation in Germany].
Topics: Adrenal Cortex Hormones; Adult; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporins; Dipyri | 1982 |
[Can non-invasive methods predict the existence of an anterior interventricular stenosis following postero-inferior infarction?].
Topics: Adult; Cholesterol; Coronary Angiography; Coronary Disease; Dipyridamole; Exercise Test; Female; Hea | 1982 |
[Present situation of therapy with platelet aggregation inhibitors].
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Middle Aged; | 1982 |
Capillary neoformation in the heart and skeletal muscle during dipyridamole--treatment and exercise.
Topics: Animals; Body Weight; Capillaries; Cell Division; Coronary Vessels; Dipyridamole; DNA Replication; F | 1982 |
[Two cases with the heart murmur originated from aortocoronary bypass: the diagnostic use of dipyridamole (author's transl)].
Topics: Coronary Artery Bypass; Dipyridamole; Female; Heart Auscultation; Heart Murmurs; Humans; Male; Middl | 1981 |
[Platelet function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 2. Secondary prevention].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Dipyridamole; Female; Humans; Ischemic Attack, Transient; M | 1982 |
The prophylactic effect of dipyridamole on the size of myocardial infarction following coronary artery occlusion.
Topics: Animals; Coronary Disease; Coronary Vessels; Dipyridamole; Female; Myocardial Infarction; Rats; Rats | 1982 |
[Experimental intramural myocardial infarction in the rat. A morphometrical method for a quantitative evaluation of the drug's influence].
Topics: Animals; Coronary Vessels; Dipyridamole; Female; Ligation; Myocardial Infarction; Propranolol; Rats; | 1982 |
[Enhancing hemodynamic effect of intraaortic balloon pumping (IABP) using cardiogenic agents in canine myocardial infarction].
Topics: Animals; Assisted Circulation; Dipyridamole; Dogs; Hemodynamics; Intra-Aortic Balloon Pumping; Isopr | 1982 |
[Thallium kinetics in ischemic heart diseases during dipyridamole administration--evaluation by successive administration of thallium].
Topics: Aged; Dipyridamole; Humans; Kinetics; Male; Middle Aged; Myocardial Infarction; Myocardium; Radioiso | 1982 |
[Thallium-201-myocardial imaging after high dose dipyridamole (author's transl)].
Topics: Coronary Disease; Coronary Vessels; Diagnosis, Differential; Dipyridamole; Female; Hemodynamics; Hum | 1981 |
Platelet adhesiveness: methodology for testing in humans.
Topics: Arterial Occlusive Diseases; Cell Survival; Densitometry; Diabetes Mellitus; Dipyridamole; Humans; I | 1981 |
[Clinical usefulness of thallium-201 myocardial scintigraphy with dipyridamole pharmacodynamic test in ischemic heart disease (author's transl)].
Topics: Angina Pectoris; Coronary Disease; Dipyridamole; Electrocardiography; Exercise Test; Humans; Myocard | 1981 |
Salvage of ischemic myocardium by dipyridamole in the conscious dog.
Topics: Animals; Arterial Occlusive Diseases; Coronary Disease; Coronary Vessels; Dipyridamole; Dogs; Hemody | 1981 |
A study on the noninvasive evaluation of coronary vasodilating drugs with Thallium-201 myocardial imagings.
Topics: Adult; Angina Pectoris; Cardiac Output; Coronary Circulation; Coronary Disease; Coronary Vessels; Di | 1981 |
[Platelet anti-aggregating therapy with dipyridamole in the prevention of early post-infarct angina].
Topics: Adult; Aged; Angina Pectoris; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction | 1981 |
Effectiveness of dipyridamole in reducing the size of experimental myocardial infarction.
Topics: Animals; Blood Pressure; Coronary Circulation; Dipyridamole; Dogs; Electrocardiography; Female; Hear | 1980 |
Antiplatelet drugs after myocardial infarction.
Topics: Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregati | 1980 |
Platelet aggregation after thrombolytic therapy.
Topics: Adult; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Aggregati | 1980 |
Studies of myocardial infarction.
Topics: Aspirin; Dipyridamole; Drug Combinations; Gastrointestinal Diseases; Humans; Myocardial Infarction; | 1980 |
Dipyridamole and infarct size.
Topics: Dipyridamole; Humans; Myocardial Infarction | 1980 |
[Effect of persantin on selected platelet functions in myocardial infarct].
Topics: Adult; Aged; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Adhesi | 1980 |
[Anti-platelet-aggregating action of dipyridamole administered by slow intravenous infusion].
Topics: Adult; Aged; Diabetes Mellitus; Dipyridamole; Female; Humans; Hypertension; Male; Middle Aged; Myoca | 1980 |
[Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Topics: Aspirin; Blood Platelet Disorders; Brain Ischemia; Clofibrate; Coronary Disease; Dipyridamole; Human | 1980 |
[Platelet hyperaggregation premonitory of myocardial infarct? A clinical case report].
Topics: Anticoagulants; Aspirin; Dipyridamole; Heart Block; Humans; Male; Middle Aged; Myocardial Infarction | 1981 |
Comparison of myocardial ischaemia in post-infarction patients with and without angina: assessment by dipyridamole 201T1 imaging.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Angiography; Dipyridamole; Female; Heart; | 1995 |
Significance of dipyridamole loading in ultrafast x-ray computed tomography for detection of myocardial ischemia. A study in patients with Kawasaki disease.
Topics: Adolescent; Adult; Blood Pressure; Child; Child, Preschool; Contrast Media; Dipyridamole; Female; He | 1995 |
[Identification of multivessel coronary disease using myocardial Thallium-201 and dipyridamole scintigraphy in acute myocardial infarction in the thrombolytic era].
Topics: Coronary Angiography; Coronary Disease; Dipyridamole; Evaluation Studies as Topic; Female; Humans; M | 1995 |
Long-term risk stratification with dipyridamole imaging.
Topics: Aged; Coronary Disease; Dipyridamole; Electrocardiography; Exercise Test; Female; Follow-Up Studies; | 1995 |
Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures.
Topics: Aged; Aorta, Abdominal; Carotid Arteries; Cohort Studies; Coronary Disease; Dipyridamole; Disease-Fr | 1995 |
An appraisal of dipyridamole thallium imaging-detected ischemia in Chinese following acute myocardial infarction.
Topics: Adult; Aged; Asian People; Coronary Angiography; Dipyridamole; Female; Humans; Male; Middle Aged; My | 1995 |
Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET.
Topics: Adult; Aged; Coronary Angiography; Coronary Circulation; Deoxyglucose; Dipyridamole; Female; Fluorin | 1995 |
Positive high-dose dipyridamole echocardiography test after acute myocardial infarction is an excellent predictor of cardiac events.
Topics: Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography; Female; Follow-Up Studies; H | 1995 |
[Quantitative evaluation of myocardial perfusion with ultrafast magnetic resonance tomography].
Topics: Adult; Aged; Animals; Blood Flow Velocity; Contrast Media; Coronary Circulation; Dipyridamole; Dogs; | 1994 |
Discordance of dual-isotope (hybrid) myocardial perfusion imaging results in patients who have undergone revascularization procedures.
Topics: Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Exercise Tes | 1994 |
Sex differences in perioperative and long-term cardiac event-free survival in vascular surgery patients. An analysis of clinical and scintigraphic variables.
Topics: Aged; Cohort Studies; Death, Sudden, Cardiac; Dipyridamole; Disease-Free Survival; Female; Heart; Hu | 1995 |
[Use of pharmacological-stress echocardiography].
Topics: Adenosine; Adenosine Triphosphate; Aged; Algorithms; Coronary Disease; Dipyridamole; Dobutamine; Ech | 1994 |
[Relationship between regional flow reserve supplied by the great saphenous vein graft and regional left ventricular wall motion: a Doppler guide wire study].
Topics: Adult; Aged; Analysis of Variance; Blood Flow Velocity; Coronary Artery Bypass; Coronary Circulation | 1995 |
Correlation of diagnostic accuracy of dipyridamole thallium-201 myocardial scintigraphy and clinical findings during stress.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Blood Pressure; Coronary Circulation; Coronary Disease; Di | 1994 |
Reduced coronary vasodilator function after myocardial infarction.
Topics: Coronary Vessels; Dipyridamole; Humans; Myocardial Infarction; Vasodilation | 1994 |
Dipyridamole first-pass radionuclide ventriculography: prediction of future cardiac events.
Topics: Aged; Coronary Disease; Dipyridamole; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans | 1994 |
[Identification of ischemic and/or viable myocardium in early post-infarction period using echocardiographic imaging technique. Comparison of 2 tests: echo-dipyridamole and echo-dobutamine].
Topics: Adult; Aged; Coronary Angiography; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Female | 1994 |
[Comparison of ergometer and dipyridamole echocardiography in patients with suspected coronary heart disease].
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography | 1994 |
Prophylactic myocardial revascularization based on dipyridamole-thallium scanning before peripheral vascular surgery.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Cause of Death; Combined Modality Thera | 1993 |
Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: feasibility, tolerability, safety and in-hospital prognostic value.
Topics: Aged; Coronary Angiography; Dipyridamole; Echocardiography; Feasibility Studies; Female; Follow-Up S | 1994 |
[Reversibility in perfusion scintigraphy after myocardial infarct: a comparison between the protocol of single-day rest-stress with 99mTc sestamibi and reinjection with thallium-201].
Topics: Adult; Aged; Chi-Square Distribution; Dipyridamole; Exercise Test; Female; Heart; Humans; Male; Midd | 1993 |
Fourier amplitude image circumferential profile analysis in the evaluation of the dipyridamole test.
Topics: Adult; Aged; Dipyridamole; Female; Fourier Analysis; Gated Blood-Pool Imaging; Humans; Male; Middle | 1993 |
[The usefulness of the echo-dipyridamole test in the early period after an uncomplicated acute myocardial infarct].
Topics: Adult; Aged; Dipyridamole; Echocardiography; Evaluation Studies as Topic; Female; Follow-Up Studies; | 1993 |
[Thallium-dipyridamole in acute myocardial infarction treated by thrombolysis: diagnostic and prognostic value].
Topics: Adult; Aged; Coronary Angiography; Dipyridamole; Exercise Test; Female; Follow-Up Studies; Humans; M | 1994 |
Quantitative demonstration of dipyridamole-induced coronary steal and alteration by angioplasty in man: analysis by simultaneous, continuous dual Doppler spectral flow velocity.
Topics: Adenosine; Aminophylline; Angioplasty, Balloon, Coronary; Blood Flow Velocity; Coronary Artery Disea | 1993 |
Digital dipyridamole stress echocardiography in silent ischemia after coronary artery bypass grafting and/or after healing of acute myocardial infarction.
Topics: Adult; Aged; Cineradiography; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Dipyri | 1993 |
Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implications in determining extent of myocardial salvage.
Topics: Animals; Coronary Circulation; Dipyridamole; Disease Models, Animal; Dogs; Echocardiography; Microsp | 1993 |
[Determination of myocardial risk on basis of the outcome of previous myocardial infarcts. Advantages of myocardial tomoscintigraphy using thallium with dipyridamole].
Topics: Adult; Aged; Dipyridamole; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Mid | 1993 |
Dipyridamole echocardiography evaluation of acute inferior myocardial infarction with concomitant anterior ST segment depression.
Topics: Adult; Aged; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography; Electrocardiogr | 1993 |
Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease.
Topics: Adult; Aged; Body Surface Area; Confounding Factors, Epidemiologic; Coronary Angiography; Coronary D | 1994 |
[Doppler echocardiography under dipyridamole after thrombolyzed early myocardial infarction. Comparison with coronarographic data].
Topics: Adult; Constriction, Pathologic; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiogra | 1993 |
An assessment of the positive predictive value and cost-effectiveness of dipyridamole myocardial scintigraphy in patients undergoing vascular surgery.
Topics: Aged; Algorithms; Cost-Benefit Analysis; Dipyridamole; Echocardiography; False Negative Reactions; F | 1994 |
Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast.
Topics: Animals; Autoradiography; Coronary Disease; Dipyridamole; Dobutamine; Dogs; Echocardiography; Heart | 1993 |
[Safety of the dipyramidole echocardiography test in elderly coronary disease patients].
Topics: Age Factors; Aged; Angina, Unstable; Coronary Disease; Dipyridamole; Dose-Response Relationship, Dru | 1993 |
Prognostic value of dipyridamole thallium scintigraphy in patients with coronary artery disease treated medically.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cardiac Catheterization; Coronary Disease; Dea | 1993 |
Extent of jeopardized viable myocardium determined by myocardial perfusion imaging best predicts perioperative cardiac events in patients undergoing noncardiac surgery.
Topics: Aged; Angina, Unstable; Cohort Studies; Death, Sudden, Cardiac; Diabetes Mellitus; Dipyridamole; Fem | 1993 |
Detection of viable tissue in healed infarcted myocardium by dipyridamole thallium-201 reinjection and regional wall motion studies.
Topics: Coronary Angiography; Dipyridamole; Heart; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardi | 1993 |
Dipyridamole thallium imaging in patients being considered for vascular procedures.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Angiography; Coro | 1993 |
Cardiac risk stratification using dipyridamole myocardial perfusion imaging and ambulatory ECG monitoring prior to vascular surgery.
Topics: Adult; Aged; Cause of Death; Coronary Circulation; Death, Sudden, Cardiac; Dipyridamole; Electrocard | 1993 |
Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram.
Topics: Adolescent; Child; Child, Preschool; Coronary Angiography; Coronary Circulation; Dipyridamole; Exerc | 1993 |
Noninvasive evaluation of total occlusion of infarct-related coronary artery after a first myocardial infarction.
Topics: Adult; Aged; Arterial Occlusive Diseases; Coronary Vessels; Dipyridamole; Evaluation Studies as Topi | 1993 |
Doppler determined aortic acceleration after dipyridamole in the prediction of coronary artery disease.
Topics: Acceleration; Adult; Aged; Aged, 80 and over; Aorta; Blood Flow Velocity; Coronary Angiography; Coro | 1995 |
Prediction of early cardiac morbidity and mortality following aorto-iliac reconstruction: comparison between clinical scoring systems, echocardiography and dipyridamole-thallium scanning.
Topics: Aged; Aged, 80 and over; Aortic Diseases; Arteriosclerosis; Cause of Death; Dipyridamole; Echocardio | 1995 |
Results of dipyridamole plus atropine echo stress test for the diagnosis of coronary artery disease.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Atropine; Blood Pressure; Coronary Angiography; Coronary Di | 1995 |
Left ventricular cavity size determined by preoperative dipyridamole thallium scintigraphy as a predictor of late cardiac events in vascular surgery patients.
Topics: Aged; Analysis of Variance; Coronary Disease; Dipyridamole; Heart Ventricles; Humans; Hypertrophy, L | 1996 |
Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: prognostic value for perioperative and late cardiac events.
Topics: Aged; Dipyridamole; Heart Failure; Humans; Intraoperative Complications; Male; Myocardial Infarction | 1996 |
Comparison of the diagnostic potential of four echocardiographic stress tests shortly after acute myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyridamole, and dobutamine-atropine.
Topics: Atropine; Cardiac Pacing, Artificial; Cardiotonic Agents; Constriction, Pathologic; Dipyridamole; Do | 1996 |
Prediction of in-hospital cardiac events using dipyridamole-thallium scintigraphy performed very early after acute myocardial infarction.
Topics: Aged; Aminophylline; Cardiotonic Agents; Coronary Angiography; Coronary Circulation; Dipyridamole; E | 1996 |
[Cardiological evaluation in the preparation for vascular surgery].
Topics: Adult; Cardiotonic Agents; Coronary Angiography; Coronary Disease; Dipyridamole; Dobutamine; Echocar | 1995 |
Relation between perfusion defects on stress technetium-99m sestamibi SPECT scintigraphy and the location of a subsequent acute myocardial infarction.
Topics: Aged; Databases, Factual; Dipyridamole; Electrocardiography; Exercise Test; Female; Heart; Humans; I | 1996 |
Cardiac complications in noncardiac surgery: value of dobutamine stress echocardiography versus dipyridamole thallium imaging.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiotonic Agents; Cohort Studies; Coronary Artery Bypass; Co | 1996 |
Residual myocardial perfusion in reversibly damaged myocardium by dipyridamole contrast echocardiography.
Topics: Aged; Albumins; Cell Survival; Contrast Media; Dipyridamole; Echocardiography; Female; Humans; Male; | 1996 |
[Detection of residual ischemia after acute anterior myocardial infarction using Thallium-201 SPECT].
Topics: Adult; Aged; Coronary Angiography; Dipyridamole; Electrocardiography; Evaluation Studies as Topic; E | 1996 |
Coronary reserve abnormalities in the infarcted myocardium. Assessment of myocardial viability immediately versus late after reflow by contrast echocardiography.
Topics: Adenosine; Animals; Coronary Circulation; Dipyridamole; Dogs; Echocardiography; Heart; Myocardial In | 1996 |
Myocardial viability in cases with persistent perfusion defects on the dipyridamole thallium-201 scintigram. A comparative study with autopsy findings.
Topics: Aged; Aged, 80 and over; Autopsy; Dipyridamole; Female; Heart; Humans; Male; Myocardial Infarction; | 1996 |
Dipyridamole technetium 99m sestamibi myocardial tomography for preoperative cardiac risk stratification before major or minor nonvascular surgery.
Topics: Aged; Angina, Unstable; Coronary Circulation; Coronary Disease; Death, Sudden, Cardiac; Dipyridamole | 1996 |
Cardiac complications in noncardiac surgery: relative value of resting two-dimensional echocardiography and dipyridamole thallium imaging.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Output, Low; Coronary Artery Bypass; Coronary Disease; | 1996 |
The usefulness of stress tests performed in the nuclear medicine department: mathematical methods to assess efficacy at various angiographic endpoints.
Topics: Angiography; Chest Pain; Coronary Disease; Dipyridamole; Exercise Test; Female; Heart; Humans; Male; | 1996 |
Cardiac assessment prior to vascular surgery: is dipyridamole-sestamibi necessary?
Topics: Age Factors; Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Arter | 1996 |
Usefulness of dipyridamole transesophageal echocardiography in the evaluation of myocardial ischemia and coronary artery flow.
Topics: Angina Pectoris; Coronary Angiography; Coronary Circulation; Dipyridamole; Echocardiography, Doppler | 1996 |
Prediction of infarction by stress echocardiography.
Topics: Dipyridamole; Dobutamine; Echocardiography; Humans; Myocardial Infarction; Predictive Value of Tests | 1997 |
[Combined use of bicycle ergometry test and echo-dipyridamole in stratification of risk after thrombolysed myocardial infarct].
Topics: Adult; Aged; Coronary Angiography; Data Interpretation, Statistical; Dipyridamole; Echocardiography; | 1996 |
Impaired coronary circulation in acute myocardial infarction: a dipyridamole-thallium-201 study.
Topics: Angioplasty, Balloon, Coronary; Coronary Circulation; Dipyridamole; Female; Heart; Humans; Male; Mid | 1997 |
Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events.
Topics: Aged; Cardiac Output, Low; Coronary Circulation; Coronary Disease; Coronary Vessels; Death, Sudden, | 1997 |
[Whole body distribution of Tc-99m-sestamibi after pharmacological stress with arbutamine and dipyridamole compared with resting conditions].
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Catecholamines; Coronary Disease; Dipyridamol | 1997 |
Relationship between coronary lesion morphology and inducible wall motion abnormalities.
Topics: Coronary Disease; Dipyridamole; Echocardiography; Humans; Myocardial Contraction; Myocardial Infarct | 1997 |
Impact of culprit lesion morphology on prevalence of provoked myocardial ischaemia in patients with old myocardial infarction. A dipyridamole stress echocardiography, exercise electrocardiography and angiographic study.
Topics: Adult; Aged; Coronary Angiography; Coronary Circulation; Dipyridamole; Echocardiography; Echocardiog | 1997 |
Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Cardiotonic Agents; Dipyridamole; Dogs; | 1997 |
Respiratory arrest during dipyridamole stress testing.
Topics: Cardiopulmonary Resuscitation; Coronary Vessels; Dipyridamole; Female; Humans; Middle Aged; Myocardi | 1997 |
Is coronary angiography necessary for vascular surgery patients who have positive results of dipyridamole thallium scans?
Topics: Case-Control Studies; Coronary Angiography; Coronary Disease; Dipyridamole; Female; Heart; Humans; M | 1997 |
Clinical comparison of circular versus noncircular acquisition using technetium-99m myocardial perfusion SPECT imaging.
Topics: Adrenergic beta-Agonists; Aged; Coronary Circulation; Coronary Disease; Coronary Vessels; Dipyridamo | 1997 |
Relevance of increased lung thallium uptake on stress imaging in patients with unstable angina and non-Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI)-IIIB Study.
Topics: Angina, Unstable; Body Weight; Cardiac Catheterization; Dipyridamole; Exercise Tolerance; Female; Fo | 1997 |
Relation of gender to physician use of test results and to the prognostic value of stress technetium 99m sestamibi myocardial single-photon emission computed tomography scintigraphy.
Topics: Angina Pectoris; Angina, Unstable; Cardiac Catheterization; Coronary Disease; Death, Sudden, Cardiac | 1997 |
[Mechanism of silent myocardial ischemia in elderly patients with coronary artery disease--assessment by dipyridamole thallium scintigraphy].
Topics: Aged; Aged, 80 and over; Coronary Angiography; Coronary Disease; Dipyridamole; Female; Heart; Humans | 1997 |
Ultra-early risk stratification after myocardial infarction via pharmacological stress echocardiography: the relative value of resting function, viability and myocardial ischemia.
Topics: Adrenergic beta-Agonists; Adult; Aged; Coronary Angiography; Data Interpretation, Statistical; Dipyr | 1997 |
[Echocardiography or stress scintigraphy with dipyridamole for the stratification of risk after acute myocardial infarction?].
Topics: Aged; Data Interpretation, Statistical; Dipyridamole; Echocardiography; Exercise Test; Female; Follo | 1997 |
[Usefulness of dipyridamole thallium scintigraphy in the diagnosis of coronary artery disease in elderly patients].
Topics: Adult; Aged; Aged, 80 and over; Coronary Angiography; Coronary Disease; Dipyridamole; Electrocardiog | 1997 |
Dipyridamole thallium-201 scintigraphy for early risk stratification of patients after uncomplicated myocardial infarction.
Topics: Aged; Dipyridamole; Female; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Myocardial Infarcti | 1997 |
Utility of stress single-photon emission computed tomography (SPECT) perfusion imaging in predicting outcome after coronary artery bypass grafting.
Topics: Adenosine; Aged; Angina Pectoris; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation | 1997 |
Mechanisms of limited maximum coronary flow in severe single-vessel coronary artery disease in humans due to vertical steal.
Topics: Aged; Blood Flow Velocity; Coronary Circulation; Dipyridamole; Exercise Test; Female; Humans; Male; | 1997 |
Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection.
Topics: Adenosine; Animals; Dipyridamole; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardi | 1998 |
Impact of chronic patency of infarct-related coronary artery on prevalence of myocardial ischemia during the pharmacologic and exercise stress test.
Topics: Blood Flow Velocity; Collateral Circulation; Coronary Angiography; Coronary Vessels; Dipyridamole; E | 1998 |
Noninvasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing.
Topics: Child; Child, Preschool; Dipyridamole; Exercise Test; Female; Humans; Infant; Male; Mucocutaneous Ly | 1998 |
[Prognostic value of dipyridamole echocardiography in 1st acute uncomplicated myocardial infarction].
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Bypass; Data Inte | 1998 |
[Assessment of exercise-induced silent myocardial ischemia by dipyridamole thallium imaging. (2). Its significance in Q wave myocardial infarction].
Topics: Aged; Coronary Angiography; Dipyridamole; Electrocardiography; Exercise Test; Female; Humans; Male; | 1998 |
Value of pharmacologic stress echocardiography in risk stratification of patients with single-vessel disease: a report from the Echo-Persantine and Echo-Dobutamine International Cooperative Studies.
Topics: Coronary Artery Bypass; Coronary Disease; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; | 1998 |
Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease.
Topics: Age of Onset; Angina, Unstable; Blood Pressure; Child; Coronary Angiography; Coronary Artery Bypass; | 1998 |
Dipyridamole stress echocardiography and exercise testing for risk stratification after uncomplicated myocardial infarction.
Topics: Aged; Dipyridamole; Echocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle | 1998 |
Prognostic value of dipyridamole thallium imaging after acute myocardial infarction in older patients.
Topics: Aged; Death, Sudden, Cardiac; Dipyridamole; Exercise Test; Female; Humans; Infusions, Intravenous; M | 1999 |
Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.
Topics: Activities of Daily Living; Aged; Analysis of Variance; Cardiovascular Diseases; Cholesterol; Choles | 1999 |
Role of dipyridamole myocardial scintigraphy in abdominal aortic aneurysm repair.
Topics: Aged; Angina Pectoris; Aortic Aneurysm, Abdominal; Dipyridamole; False Positive Reactions; Female; H | 1999 |
Stress echocardiography and exercise electrocardiography for risk stratification after non-Q-wave uncomplicated myocardial infarction.
Topics: Adult; Aged; Cardiotonic Agents; Dipyridamole; Dobutamine; Echocardiography; Electrocardiography; Ex | 1999 |
Risk stratification soon after acute infarction.
Topics: Dipyridamole; Exercise Test; Hospitalization; Humans; Myocardial Infarction; Risk Factors; Tomograph | 1999 |
Gated Tc-99m sestamibi SPECT versus stress-rest SPECT in detecting coronary artery disease: correlation with coronary angiography in patients without myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary | 1999 |
Valsartan and coronary haemodynamics in early post-myocardial infarction in rats.
Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Body Weigh | 1999 |
[The echo-stress test with dipyridamole-atropine on the 3rd-5th day of an uncomplicated acute myocardial infarct for risk stratification and early discharge].
Topics: Aged; Anti-Arrhythmia Agents; Atropine; Dipyridamole; Echocardiography; Electrocardiography; Exercis | 2000 |
Ischemic heart disease in black South African stroke patients.
Topics: Adult; Aged; Aged, 80 and over; Black People; Chest Pain; Comorbidity; Diabetes Mellitus; Dipyridamo | 2000 |
Outcome in patients with symptomatic occlusion of the internal carotid artery.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Carotid Artery, Internal; Carotid Stenosis; | 2000 |
Noninvasive risk stratification in women with uncomplicated acute myocardial infarction.
Topics: Aged; Cardiotonic Agents; Dipyridamole; Dobutamine; Echocardiography; Electrocardiography; Exercise | 2000 |
Dipyridamole administration at the end of an insufficient exercise Tc-99m MIBI SPECT improves detection of multivessel coronary artery disease in patients with previous myocardial infarction.
Topics: Cardiac Catheterization; Case-Control Studies; Coronary Disease; Dipyridamole; Exercise Test; Female | 2000 |
[Meaning of clinical and electrical positivity in the myocardial perfusion scintigraphy during the administration of dipyridamole].
Topics: Angina Pectoris; Convalescence; Coronary Angiography; Coronary Circulation; Coronary Disease; Dipyri | 2001 |
Myocardial flow reserve parametric map, assessed by first-pass MRI compartmental analysis at the chronic stage of infarction.
Topics: Aged; Collateral Circulation; Coronary Circulation; Dipyridamole; Exercise Test; Female; Humans; Hyp | 2001 |
Global myocardial blood flow and global flow reserve measurements by MRI and PET are comparable.
Topics: Adult; Collateral Circulation; Coronary Circulation; Dipyridamole; Exercise Test; Humans; Magnetic R | 2001 |
Incremental prognostic value of stress echocardiography as an adjunct to exercise electrocardiography after uncomplicated myocardial infarction.
Topics: Cardiotonic Agents; Dipyridamole; Dobutamine; Echocardiography; Exercise Test; Female; Humans; Male; | 2001 |
An abnormal dipyridamole thallium/sestamibi fails to predict long-term cardiac events in vascular surgery patients.
Topics: Aged; Aortic Diseases; Cause of Death; Dipyridamole; Female; Follow-Up Studies; Heart Failure; Human | 2001 |
[Utility of SPECT with 99m Tc-tetrofosmin and stimulus with dipyridamole in patients with permanent ventricular pacemakers].
Topics: Aged; Aged, 80 and over; Angina Pectoris; Arrhythmias, Cardiac; Cardiac Catheterization; Comorbidity | 2001 |
Is treatment with aspirin combined with dipyridamole really more cost-effective than aspirin alone?
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Cost-Benefit Analysis; Dipyridamole; D | 2001 |
Detection and management of concomitant coronary artery disease in patients undergoing thoracic aortic surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aorta, Thoracic; Aortic | 2001 |
Clinical impact of combination of scatter, attenuation correction, and depth-dependent resolution recovery for (201)Tl studies.
Topics: Coronary Circulation; Coronary Disease; Dipyridamole; Exercise Test; Humans; Image Processing, Compu | 2001 |
The role of myocardial perfusion scanning, heart rate variability and D-dimers in predicting the risk of perioperative cardiac complications after peripheral vascular surgery.
Topics: Aged; Coronary Circulation; Dipyridamole; Electrocardiography, Ambulatory; Endpoint Determination; H | 2001 |
Dipyridamole-atropine-induced myocardial infarction in a patient with patent epicardial coronary arteries.
Topics: Adult; Angioplasty, Balloon, Coronary; Atropine; Coronary Angiography; Coronary Disease; Dipyridamol | 2001 |
Stress-induced ST-segment elevation following myocardial infarction and its role in wall motion abnormality, myocardial ischemia and viability: comparison of response to exercise, dobutamine and dipyridamole.
Topics: Cardiotonic Agents; Cell Survival; Dipyridamole; Dobutamine; Electrocardiography; Exercise; Female; | 2001 |
Early dipyridamole stress myocardial SPECT to detect residual stenosis of infarct related artery: comparison with coronary angiography and fractional flow reserve.
Topics: Adult; Aged; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Dip | 2002 |
Uncomplicated non-Q wave myocardial infarction: long-term prognosis with a conservative echo-stress guided management strategy.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Bypass; Dipyridam | 2002 |
Exercise-electrocardiography and/or pharmacological stress echocardiography for non-invasive risk stratification early after uncomplicated myocardial infarction. A prospective international large scale multicentre study.
Topics: Aged; Cardiotonic Agents; Dipyridamole; Dobutamine; Echocardiography, Stress; Exercise Test; Female; | 2002 |
[Comparative statistical study of the treatment of myocardial infarct with anticoagulants and anti-aggregants].
Topics: Aged; Anticoagulants; Dicumarol; Dipyridamole; Drug Evaluation; Female; Heparin; Humans; Male; Middl | 1977 |
Effects of nitroglycerin and dipyridamole on acute myocardial infarction: a thermographic study in the dog.
Topics: Acute Disease; Animals; Coronary Circulation; Dipyridamole; Dogs; Hemodynamics; Myocardial Infarctio | 1979 |
[Metabolic shifts in acute period of myocardial infarct and the possibility of their correction with curantil].
Topics: Acute Disease; Adenine Nucleotides; Animals; Coronary Vessels; Dipyridamole; Dogs; Electron Transpor | 1979 |
[Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
Topics: Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Humans; Ischemic Attack, Transient; Myocard | 1979 |
[Platelet function in patients with acute myocardial infarct following administration of acetylsalicylic acid and dipyridamole].
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarct | 1979 |
[Antiplatelet drugs (author's transl)].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Female; Humans; Hydroxychloroquine; Ischemic Att | 1979 |
[Prevention and therapy with anticoagulants. Indications, experiences, results].
Topics: Anticoagulants; Aspirin; Blood Coagulation; Coumarins; Dipyridamole; Fibrinolysis; Heparin; Humans; | 1979 |
Pharmacological alterations of coronary collateral circulation; implication to the steal-phenomenon.
Topics: Animals; Blood Pressure; Chromonar; Collateral Circulation; Coronary Circulation; Dipyridamole; Dogs | 1978 |
[Platelet anti-aggregant and anticoagulant therapy in the secondary prevention of coronary disease. Preliminary note].
Topics: Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Drug Evaluation; Humans; Myocardial Infarct | 1977 |
Antiplatelet agents in coronary disease: are they of prophylactic value?
Topics: Angina Pectoris; Aspirin; Cardiopulmonary Bypass; Clofibrate; Coronary Disease; Dipyridamole; Fibrin | 1978 |
[Prevention of the myocardial damaging effect of isadrin by curantil].
Topics: Animals; Coronary Disease; Dipyridamole; Electrocardiography; Female; Isoproterenol; Male; Myocardia | 1978 |
Acute myocardial infarction with normal coronary arteries.
Topics: Acute Disease; Coronary Angiography; Coronary Vessels; Dipyridamole; Humans; Myocardial Infarction; | 1978 |
[Dipyridamole therapy in acute myocardial infarct].
Topics: Adult; Aged; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction | 1977 |
[Use of dipyridamol in the acute period of myocardial infarction].
Topics: Acute Disease; Adult; Aged; Dipyridamole; Humans; Middle Aged; Myocardial Infarction | 1977 |
Effect of drugs of platelets and complications of vascular disease.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clofibrate; Coronary Disease; | 1977 |
Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction.
Topics: Animals; Body Temperature; Coronary Circulation; Coronary Vessels; Dipyridamole; Dogs; Female; Hemod | 1976 |
Effects of acetylsalicylic acid, dipyridamole, and hydrocortisone on epinephrine-induced myocardial injury in dogs.
Topics: Acute Disease; Animals; Aspartate Aminotransferases; Aspirin; Calcium; Calcium Chloride; Cardiomyopa | 1976 |
Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications.
Topics: Adenosine; Adult; Aged; Angina Pectoris; Apyrase; Arterial Occlusive Diseases; Aspirin; Coronary Dis | 1976 |
[Experience with combined use of neurolepsy and vasodilator substances in the treatment of patients with acute myocardial infarct].
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Dipyridamole; Drop | 1976 |
[Myocardial blood flow and ventricular function in dependence on the size of myocardial infarct].
Topics: Animals; Collateral Circulation; Coronary Vessels; Dipyridamole; Dogs; Heart Ventricles; Myocardial | 1976 |
Are agents affecting platelet function clinically useful in patients with coronary artery disease?
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Clofibrate; Coro | 1976 |
The effect of dipyridamole on the coronary hemodynamics in man.
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Circulation; Coronary Disease; | 1975 |
[Hyperbaric oxygen and coronary dilator agents in experimental necrosis of the myocardium in rats].
Topics: Animals; Dipyridamole; Hyperbaric Oxygenation; Myocardial Infarction; Necrosis; Papaverine; Rats; Va | 1975 |
[Effect of intravenous administration of curantil on hemodynamics in patients with acute myocardial infarct].
Topics: Adult; Aged; Dipyridamole; Hemodynamics; Humans; Middle Aged; Myocardial Infarction | 1976 |
[Dipyridamole Tc-99m MIBI myocardial perfusion scintigraphy in patients with post-infarction chest pain symptom].
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Dipyridamole; Female; Heart; Humans; Male; Middl | 1992 |
[How to and why evaluate the ischemic risk after myocardial infarction?].
Topics: Coronary Angiography; Dipyridamole; Electrocardiography, Ambulatory; Exercise Test; Humans; Myocardi | 1992 |
[Assessment of prognosis of old myocardial infarction].
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Arter | 1992 |
Usefulness of dipyridamole-echocardiographic test to identify jeopardized myocardium after thrombolysis. Limited clinical predictivity of dipyridamole-echocardiographic test in convalescing acute myocardial infarction: correlation with coronary angiograph
Topics: Adult; Aged; Aged, 80 and over; Convalescence; Coronary Angiography; Dipyridamole; Echocardiography; | 1992 |
[Importance of late reversibility in the identification of myocardial viability at risk after myocardial infarction].
Topics: Adult; Aged; Dipyridamole; Echocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarctio | 1992 |
Prediction of late cardiac events by dipyridamole thallium imaging in patients undergoing elective vascular surgery.
Topics: Aged; Death, Sudden, Cardiac; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Postoperati | 1992 |
Dose and test for dipyridamole infusion and cardiac imaging early after uncomplicated acute myocardial infarction.
Topics: Angina Pectoris; Blood Pressure; Coronary Angiography; Coronary Disease; Coronary Vessels; Dipyridam | 1992 |
What is the optimum dose of dipyridamole for cardiac imaging?
Topics: Coronary Disease; Dipyridamole; Echocardiography; Electrocardiography; Humans; Hyperemia; Myocardial | 1992 |
Atrial fibrillation after intravenous dipyridamole for thallium imaging.
Topics: Atrial Fibrillation; Dipyridamole; Electrocardiography; Heart; Humans; Male; Middle Aged; Myocardial | 1992 |
Recombinant tissue-plasminogen activator (rt-PA) in acute myocardial infarction in the Chinese in Hong Kong.
Topics: Adult; Aged; Dipyridamole; Female; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Prospe | 1992 |
Recombinant tissue plasminogen activator in acute myocardial infarction in the Chinese in Hong Kong.
Topics: Adult; Aged; Asian People; Blood Coagulation Tests; Coronary Vessels; Dipyridamole; Female; Heparin; | 1992 |
Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning.
Topics: Adaptation, Physiological; Animals; Coronary Disease; Dipyridamole; Hemodynamics; Male; Myocardial I | 1992 |
Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest.
Topics: Coronary Angiography; Dipyridamole; Echocardiography; Electrocardiography; Female; Follow-Up Studies | 1992 |
Failure of negative dipyridamole thallium scans to predict perioperative myocardial ischaemia and infarction.
Topics: Aged; Coronary Disease; Creatine Kinase; Dipyridamole; Electrocardiography, Ambulatory; False Negati | 1992 |
Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: clinical and prognostic significance.
Topics: Adult; Aged; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography; Exercise Test; | 1992 |
Myocardial infarction secondary to dipyridamole overdose.
Topics: Dipyridamole; Drug Overdose; Female; Humans; Middle Aged; Myocardial Infarction | 1992 |
Prognostic value of dipyridamole thallium-201 imaging in elderly patients.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Female | 1992 |
Preoperative coronary artery disease risk stratification based on dipyridamole imaging and a simple three-step, three-segment model for patients undergoing noncardiac vascular surgery or major general surgery.
Topics: Aged; Coronary Circulation; Coronary Disease; Dipyridamole; Female; Heart; Humans; Male; Middle Aged | 1992 |
[Strategies for antiplatelet therapy-drug-fixed method and suppression-fixed method].
Topics: Aspirin; Cerebral Infarction; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Infarction | 1992 |
Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction.
Topics: Animals; Arginine; Blood Pressure; Coronary Circulation; Dipyridamole; Hemodynamics; Male; Myocardia | 1992 |
Outcome of noncardiac operations in patients with severe coronary artery disease successfully treated preoperatively with coronary angioplasty.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Coronary Disease; Dipyridamole; Female; Hum | 1992 |
[The usefulness of the echo-dipyridamole and exercise tests in risk stratification in patients with acute uncomplicated myocardial infarct after systemic thrombolysis].
Topics: Adult; Aged; Aged, 80 and over; Dipyridamole; Echocardiography; Evaluation Studies as Topic; Exercis | 1991 |
Prognosis following interventional therapy for acute myocardial infarction: utility of dipyridamole thallium scintigraphy.
Topics: Adult; Aged; Dipyridamole; Female; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Plasmino | 1991 |
Relation between the incidence of arrhythmias and ischemic ST-segment depression during dipyridamole electrocardiography test in patients with coronary artery disease.
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Dipyridamole; Electrocardiography; Female; Huma | 1991 |
Long-term prognostic value of a normal dipyridamole thallium-201 perfusion scan.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Cause of Death; Coronary Disease; Death, Sudden, Ca | 1991 |
[Early test of thallium dipyridamole after myocardial infarction: prognostic value and correlation with coronarography].
Topics: Adult; Aged; Coronary Angiography; Dipyridamole; Electrocardiography; Female; Humans; Male; Middle A | 1991 |
Dipyridamole echocardiography test. A new tool for detecting jeopardized myocardium after thrombolytic therapy.
Topics: Coronary Angiography; Dipyridamole; Echocardiography; Female; Humans; Male; Middle Aged; Myocardial | 1991 |
Dipyridamole 201Tl scintigraphy in the evaluation of prognosis after myocardial infarction.
Topics: Aged; Dipyridamole; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myoca | 1991 |
[The echo-dipyridamole test early after acute myocardial infarct: echocardiographic aspects and angiographic correlations].
Topics: Aged; Angiography; Coronary Angiography; Dipyridamole; Echocardiography; Electrocardiography; Female | 1991 |
[Thallium and echo- dipyridamole in the early selection of patients at risk after acute myocardial infarction. Which test? What dose?].
Topics: Adult; Aged; Coronary Angiography; Dipyridamole; Echocardiography; Female; Humans; Male; Middle Aged | 1991 |
[Prognostic stratification of non complicated acute myocardial infarct. Usefulness of the dipyridamole test with ecg-echo-thallium 201].
Topics: Adult; Aged; Dipyridamole; Echocardiography; Electrocardiography; Female; Humans; Male; Middle Aged; | 1991 |
[Prognostic value of echocardiography with high-dose dipyridamole after recent uncomplicated myocardial infarction].
Topics: Aged; Analysis of Variance; Chi-Square Distribution; Dipyridamole; Echocardiography; Exercise Test; | 1991 |
The relationship between chest pain during thallium-201 scintigraphy with dipyridamole and myocardial ischemia.
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Disease; Dipyridamole; Electrocardiogra | 1991 |
[Risk stratification after uncomplicated myocardial infarct: the usefulness of the echocardiographic-dipyridamole test].
Topics: Adult; Aged; Dipyridamole; Echocardiography; Electrocardiography; Exercise Test; Female; Follow-Up S | 1990 |
[The value of dipyridamole-technetium-99m carbomethoxyisopropylisonitrile (CPI) myocardial tomography imaging in diagnosing coronary artery disease].
Topics: Adult; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nitriles; Organotechn | 1990 |
[Cineventriculography with radionuclides and intravenous dipyridamole in the prognostic evaluation after acute myocardial infarction].
Topics: Coronary Angiography; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prognosis; Prospect | 1990 |
[Dipyridamole echocardiography test during the acute phase of lower myocardial infarction].
Topics: Aged; Coronary Angiography; Coronary Vessels; Dipyridamole; Echocardiography, Doppler; Humans; Middl | 1990 |
The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group.
Topics: Adult; Aged; Aminophylline; Bronchial Spasm; Chest Pain; Dipyridamole; Female; Headache; Heart; Hemo | 1990 |
Comparison of early exercise treadmill test and oral dipyridamole thallium-201 tomography for the identification of jeopardized myocardium in patients receiving thrombolytic therapy for acute Q-wave myocardial infarction.
Topics: Adult; Aged; Coronary Angiography; Dipyridamole; Electrocardiography; Exercise Test; Female; Humans; | 1990 |
Thallium-201 perfusion imaging with atrial pacing or dipyridamole stress testing for evaluation of cardiac risk prior to nonvascular surgery.
Topics: Aged; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Angiography; Coronary Disease; Dipyridam | 1990 |
Dipyridamole echocardiography: the bedside stress test for coronary artery disease.
Topics: Adult; Aged; Coronary Disease; Dipyridamole; Echocardiography; Female; Humans; Male; Middle Aged; My | 1990 |
Comparison of coronary angiography and early oral dipyridamole thallium-201 scintigraphy in patients receiving thrombolytic therapy for acute myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Angiography; Cardiac Catheterization; Coronary Angiography; Dipyridamo | 1990 |
[Dipyridamole-thallium 201 tomography following acute myocardial infarct: significance for stratifying cardiac risk factors].
Topics: Adult; Aged; Angina Pectoris; Cause of Death; Coronary Circulation; Coronary Disease; Dipyridamole; | 1990 |
Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipyridamole thallium-201 scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Diabete | 1990 |
Cardiac risk in vascular surgery. The oral dipyridamole-thallium stress test.
Topics: Administration, Oral; Dipyridamole; Humans; Myocardial Infarction; Postoperative Complications; Pros | 1990 |
Evaluation of coronary arterial disease by oral dipyridamole stress testing using 12-lead electrocardiography.
Topics: Administration, Oral; Adult; Aged; Coronary Disease; Dipyridamole; Electrocardiography; Exercise Tes | 1990 |
Assessment of post-infarction jeopardized myocardium by vasodilation--thallium-201 tomography: impact on risk stratification.
Topics: Adult; Cardiac Catheterization; Cineangiography; Coronary Disease; Dipyridamole; Female; Follow-Up S | 1990 |
Postoperative myocardial infarction and cardiac death. Predictive value of dipyridamole-thallium imaging and five clinical scoring systems based on multifactorial analysis.
Topics: Aged; Data Interpretation, Statistical; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial | 1990 |
Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events.
Topics: Coronary Disease; Dipyridamole; Electrocardiography; Hemodynamics; Hospitalization; Humans; Myocardi | 1990 |
Is dipyridamole-thallium imaging preferable to submaximal exercise thallium testing for risk stratification after thrombolysis?
Topics: Aged; Dipyridamole; Exercise Test; Heart; Humans; Male; Myocardial Infarction; Radionuclide Imaging; | 1990 |
Dipyridamole thallium 201 imaging. How safe is it?
Topics: Bronchial Spasm; Chest Pain; Coronary Disease; Dipyridamole; Electrocardiography; Humans; Myocardial | 1990 |
Acute myocardial infarction associated with intravenous dipyridamole for rubidium-82 PET imaging.
Topics: Dipyridamole; Humans; Myocardial Infarction; Rubidium Radioisotopes; Tomography, Emission-Computed | 1990 |
Perioperative and long-term prognostic value of intravenous dipyridamole thallium scintigraphy in patients with peripheral vascular disease.
Topics: Aged; Angiography; Coronary Angiography; Dipyridamole; Female; Follow-Up Studies; Humans; Injections | 1990 |
Plasma concentrations of platelet-specific proteins and serum thromboxane B2 production in response to treatment with dipyridamole. A pilot study of 27 post-myocardial infarction patients.
Topics: Adult; Aged; Beta-Globulins; beta-Thromboglobulin; Dipyridamole; Female; Humans; Male; Middle Aged; | 1985 |
Using body surface mapping to detect vulnerability to ventricular arrhythmias in patients with coronary artery disease.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Coronary Disease; Dipyridamole; Ele | 1987 |
Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
Topics: Adult; Aged; Aspirin; Beta-Globulins; beta-Thromboglobulin; Blood Platelets; Coronary Artery Bypass; | 1985 |
Prognostic importance of silent myocardial ischemia detected by intravenous dipyridamole thallium myocardial imaging in asymptomatic patients with coronary artery disease.
Topics: Aged; Coronary Disease; Dipyridamole; Female; Heart; Humans; Male; Middle Aged; Myocardial Infarctio | 1989 |
Prognostic utility of predischarge dipyridamole-thallium imaging compared to predischarge submaximal exercise electrocardiography and maximal exercise thallium imaging after uncomplicated acute myocardial infarction.
Topics: Dipyridamole; Electrocardiography; Exercise Test; Humans; Myocardial Infarction; Patient Discharge; | 1989 |
Exercise testing and dipyridamole echocardiography test before and 48 h after successful coronary angioplasty: prognostic implications.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiograp | 1989 |
[A case of severe cardiac failure due to myocardial stunning].
Topics: Coronary Angiography; Dipyridamole; Heart; Heart Failure; Humans; Middle Aged; Myocardial Infarction | 1989 |
[Thrombocyte function and the repair of myocardial infarct].
Topics: Aspirin; Blood Platelets; Dipyridamole; Female; Heart Function Tests; Humans; Hydroxyproline; Male; | 1989 |
Prognostic value of intravenous dipyridamole thallium scintigraphy after an acute myocardial ischemic event.
Topics: Aged; Angina Pectoris; Angina, Unstable; Dipyridamole; Electrocardiography; Follow-Up Studies; Human | 1989 |
[Myocardial scintigraphy using 201-thallium and 2-dimensional echocardiogram after dipyridamole infusion in the early evaluation of post-infarct residual ischemia].
Topics: Adult; Aged; Coronary Disease; Dipyridamole; Echocardiography; Female; Humans; Male; Middle Aged; My | 1989 |
High dose dipyridamole echocardiography early after uncomplicated acute myocardial infarction: correlation with exercise testing and coronary angiography.
Topics: Adult; Aged; Angiography; Coronary Angiography; Dipyridamole; Echocardiography; Electrocardiography; | 1989 |
Prognostic importance of dipyridamole-echocardiography test in coronary artery disease.
Topics: Actuarial Analysis; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography, Doppler; | 1989 |
[Prognostic meaning of the echo-dipyridamole test in recent non-Q myocardial infarct].
Topics: Adult; Aged; Coronary Disease; Dipyridamole; Echocardiography; Exercise Test; Female; Humans; Male; | 1989 |
Myocardial infarction after dipyridamole-assisted thallium-201 imaging.
Topics: Aged; Dipyridamole; Female; Heart; Humans; Myocardial Infarction; Radionuclide Imaging; Thallium Rad | 1989 |
Acute hemodynamic changes during intravenous dipyridamole thallium imaging early after infarction.
Topics: Aminophylline; Dipyridamole; Electrocardiography; Hemodynamics; Humans; Infusions, Intravenous; Leng | 1989 |
Clinical assessment of myocardial perfusion with thallium-201.
Topics: Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heart; Humans; Myocardial Infarction; Physical | 1989 |
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; | 1985 |
Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing single-photon emission computed tomography.
Topics: Cardiomegaly; Diagnosis, Differential; Dipyridamole; Echocardiography; Female; Heart; Humans; Hypert | 1988 |
Comparison of different pharmacological interventions on enzymatic parameters during acute myocardial infarction.
Topics: Adult; Aged; Clinical Enzyme Tests; Creatine Kinase; Dipyridamole; Female; Heart; Heparin; Humans; I | 1987 |
Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Combinatio | 1988 |
Clinical experience of percutaneous transluminal coronary angioplasty--technique and results.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease; | 1985 |
Dipyridamole-thallium 201 scintigraphy in the early post-infarction period. (Safety and accuracy in predicting the extent of coronary disease and future recurrence of angina in patients suffering from their first myocardial infarction).
Topics: Adult; Angina Pectoris; Dipyridamole; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myo | 1988 |
[Usefulness of positron emission tomography in the assessment of the effect of dipyridamole on regional myocardial blood flow].
Topics: Ammonia; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Humans; Myocardial Infarc | 1988 |
[Myocardial perfusion with 201-thallium tomography in the post-infarct phase: prognostic significance and 1-year follow-up].
Topics: Adult; Aged; Coronary Angiography; Dipyridamole; Electrocardiography; Humans; Middle Aged; Myocardia | 1988 |
[Dipyridamole-loading scintigraphy in patients with subendocardial infarction using single photon emission computed tomography].
Topics: Adult; Aged; Dipyridamole; Humans; Male; Myocardial Infarction; Thallium Radioisotopes; Tomography, | 1988 |
[Attempts at limiting necrotic areas in acute myocardial infarction by intravenous infusion of dipyridamole].
Topics: Adult; Aged; Creatine Kinase; Dipyridamole; Female; Humans; Infusions, Intravenous; Isoenzymes; Male | 1987 |
Short-term infarct vessel patency with aspirin and dipyridamole started 24 to 36 hours after intravenous streptokinase.
Topics: Angiography; Aspirin; Dipyridamole; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardi | 1988 |
Cardiac arrest during dipyridamole imaging.
Topics: Aged; Angina, Unstable; Dipyridamole; Female; Heart; Heart Arrest; Humans; Myocardial Infarction; Ra | 1988 |
Assessment by dipyridamole-thallium-201 myocardial scintigraphy of coronary risk before peripheral vascular surgery.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Carotid Artery, Internal; Coronary Disease; Dipyridamole; | 1988 |
[The significance of systolic time intervals in the dipyridamole test for the diagnosis of coronary disease].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Dipyridamole; Electrocardiography; Female; Heart Rat | 1988 |
[Significance of Tl-201 redistribution on infarcted region assessed by coronary sinus flow and lactate metabolism].
Topics: Aged; Coronary Circulation; Dipyridamole; Female; Heart Ventricles; Humans; Lactates; Male; Middle A | 1987 |
[Echocardiographic evaluation of the physiopathologic aspects of myocardial contraction in ischemic cardiopathy, in basal conditions and following provocation tests].
Topics: Adult; Constriction, Pathologic; Coronary Disease; Dipyridamole; Echocardiography; Humans; Male; Mid | 1987 |
Ameroid constriction of the proximal left circumflex coronary artery in swine. A model of limited coronary collateral circulation.
Topics: Animals; Aspirin; Collateral Circulation; Constriction; Coronary Circulation; Coronary Disease; Coro | 1987 |
[Effect of administration of hydrocortisone and dipyridamole (persantin) on plasma levels of prostaglandin E1 and F2 alpha in patients with myocardial infarction].
Topics: Adult; Aged; Dinoprost; Dipyridamole; Humans; Hydrocortisone; Middle Aged; Myocardial Infarction; Pr | 1987 |
[Localization and quantification of ischemic myocardial areas in the postinfarct phase by dipyridamole 201thallium emission computerized tomography].
Topics: Angina, Unstable; Coronary Circulation; Coronary Disease; Dipyridamole; Female; Humans; Male; Middle | 1986 |
[Reverse redistribution in dipyridamole-loading thallium-201 images using single photon emission computed tomography].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Diabetes Mellitus; Dipyridamole; Electrocardio | 1986 |
[Noninvasive identification of collateralized myocardium by 201 thallium tomography in vasodilation and redistribution].
Topics: Aged; Collateral Circulation; Coronary Circulation; Dipyridamole; Humans; Infusions, Intravenous; Mi | 1987 |
Myocardial perfusion studies: lessons from a decade of clinical use.
Topics: Coronary Disease; Coronary Vessels; Data Collection; Dipyridamole; Follow-Up Studies; Heart Rate; Hu | 1986 |
[The dipyridamole test in the 3d week after acute myocardial infarct].
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Circulation; Dipyridamole; Electrocardiography; Exercise | 1987 |
Dipyridamole-induced myocardial ischemia.
Topics: Coronary Disease; Dipyridamole; Humans; Myocardial Infarction | 1987 |
[Mode of action and clinical evaluation of platelet aggregation inhibitors].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Graft Occlusion, Vascular; Humans; Ketanserin; Myo | 1987 |
Platelet aggregation and atherosclerosis.
Topics: Arteriosclerosis; Aspirin; Dipyridamole; Electrocardiography; Humans; Male; Middle Aged; Myocardial | 1986 |
Non-invasive detection of coronary artery disease by body surface electrocardiographic mapping after dipyridamole infusion.
Topics: Adult; Aged; Blood Pressure; Coronary Disease; Dipyridamole; Electrocardiography; Exercise Test; Fem | 1986 |
Significance of perfusion studies in the detection of transient myocardial ischemia.
Topics: Angina Pectoris; Angina, Unstable; Coronary Disease; Coronary Vessels; Dipyridamole; Heart; Humans; | 1986 |
[Kurantil electrophoresis in treating patients who had a myocardial infarct].
Topics: Adult; Animals; Coronary Disease; Dipyridamole; Drug Evaluation; Drug Evaluation, Preclinical; Elect | 1986 |
Dipyridamole thallium 201 scintigraphy to detect coronary artery disease before abdominal aortic surgery.
Topics: Aged; Aorta, Abdominal; Coronary Disease; Dipyridamole; Electrocardiography; Female; Heart; Humans; | 1987 |
Noninvasive evaluation of cardiac risk before elective vascular surgery.
Topics: Aged; Coronary Angiography; Dipyridamole; Exercise Test; Female; Heart; Heart Function Tests; Humans | 1987 |
Early post-infarction angina: usefulness of dipyridamole-echocardiography test.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Circulation; Dipyridamole; Echocardiography; | 1986 |
[Status of glucose-insulin-potassium solutions in acute myocardial infarct].
Topics: Adult; Aged; Dipyridamole; Drug Combinations; Female; Glucose; Humans; Insulin; Male; Middle Aged; M | 1985 |
Prevention of cardiac complications in peripheral vascular surgery.
Topics: Angiography; Arrhythmias, Cardiac; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Electr | 1986 |
Use of experimental myocardial infarct to demonstrate arrhythmogenic activity of drugs.
Topics: Animals; Arrhythmias, Cardiac; Dipyridamole; Dogs; Electrocardiography; Female; Heart Rate; Male; My | 1985 |
High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial.
Topics: Adult; Aged; Aspirin; Coronary Angiography; Dipyridamole; Drug Evaluation; Female; Fibrin Fibrinogen | 1985 |
Does dipyridamole have antithrombotic potential?
Topics: Aspirin; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; P | 1985 |
White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction.
Topics: Adult; Aged; Aspirin; Cholesterol; Coronary Disease; Dipyridamole; Diuretics; Female; Hematocrit; Hu | 1985 |
[Non-homogenous irrigation of the myocardium and its importance in cardiac therapeutics].
Topics: Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Dipyridamole; Dogs; Lidofla | 1973 |
[Medicamentous prophylaxis of postoperative cardiovascular complications (author's transl)].
Topics: Aged; Cardiovascular Diseases; Digitalis Glycosides; Dipyridamole; Female; Humans; Male; Middle Aged | 1974 |
[Differential treatment of coronary heart disease].
Topics: Angina Pectoris; Aspirin; Cardiac Glycosides; Coronary Disease; Dipyridamole; Furosemide; Heparin; H | 1974 |
[Studies on myocardial metabolism in the ischemic heart. II. Studies by the electron spin resonance method].
Topics: Animals; Coronary Disease; Dipyridamole; Dogs; Electron Spin Resonance Spectroscopy; Epinephrine; Et | 1969 |
[Current problems in diagnosis and treatment of angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiography; Anticoagulants; Benzofurans; Coronary Ang | 1972 |
[Influence of vasodilation through dipyridamole on the extent of acute experimental infarct].
Topics: Acute Disease; Animals; Blood Flow Velocity; Blood Pressure; Coronary Circulation; Dipyridamole; Dog | 1974 |
[Long-term medicinal prevention in patients who have suffered myocardial infarction].
Topics: Anti-Arrhythmia Agents; Anticoagulants; Antihypertensive Agents; Clofibrate; Dipyridamole; Drug Ther | 1974 |
Failure of dipyridamole (Persantin) in reducing the infarct size following experimental coronary occlusion.
Topics: Animals; Aorta; Blood Flow Velocity; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary | 1972 |
Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregation.
Topics: Animals; Arteriosclerosis; Aspirin; Catecholamines; Dipyridamole; Dogs; Epinephrine; Heart; Myocardi | 1972 |
[Method of epicardial ECG registration].
Topics: Animals; Coronary Disease; Dipyridamole; Dogs; Electrocardiography; Heart; Isoproterenol; Ligation; | 1973 |
Drug-induced changes in blood flow in normal and ischaemic regions of the canine myocardium.
Topics: Amino Alcohols; Animals; Blood Pressure; Coronary Circulation; Coronary Vessels; Dipyridamole; Dogs; | 1973 |
Inhibition of platelet-induced thrombus formation.
Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Brain Diseases; Dipyridamole; Epinephrin | 1974 |
Increase in myocardial collateral capacity following drug-induced coronary vasodilatation. A preliminary report.
Topics: Animals; Blood Pressure; Collateral Circulation; Coronary Vessels; Dipyridamole; Dogs; Mercury; Myoc | 1969 |
Experimental myocardial infarction in the dog. Comparison of myocardial blood flow within, near, and distant from the infarct.
Topics: Animals; Blood Pressure; Cardiac Catheterization; Collateral Circulation; Coronary Vessels; Dipyrida | 1969 |
Effects of some coronary "vasodilators" on myocardial catecholamine.
Topics: Animals; Catecholamines; Dipyridamole; Dogs; Dopamine; Epinephrine; Ethylenediamines; Myocardial Inf | 1965 |
Drugs and myocardial blood flow.
Topics: Adult; Angina Pectoris; Animals; Coronary Vessels; Dipyridamole; Dogs; Humans; Male; Myocardial Infa | 1969 |
[Considerable reduction in infarct mortality in dogs after pretreatment with pyrimidopyrimidine].
Topics: Alanine Transaminase; Angiography; Animals; Aspartate Aminotransferases; Creatine Kinase; Dipyridamo | 1967 |
[Clinical and pharmacological properties of dipyridamole and trinitrin].
Topics: Angina Pectoris; Dipyridamole; Electrocardiography; Female; Humans; Male; Myocardial Infarction; Nit | 1967 |
[Experimental study on drugs for the treatment of myocardial infarction].
Topics: Angiography; Animals; Benzyl Compounds; Body Weight; Carboxylic Acids; Dipyridamole; Disease Models, | 1972 |
[Clinical physiopathological studies on myocardial oxygen metabolism. 3. Myocardial oxygen metabolism during administration of coronary dilators].
Topics: Adolescent; Adult; Aged; Benzoates; Benzofurans; Coronary Disease; Coumarins; Dipyridamole; Female; | 1971 |
[Clinical pathophysiological studies on coronary circulation. 3. The effects of so-called coronary vasodilator agents on coronary circulation in various diseases].
Topics: Adolescent; Adult; Aged; Benzoates; Benzofurans; Blood Flow Velocity; Blood Pressure; Coronary Disea | 1971 |
[The significance of the development of intercoronary collaterals for the myocardium].
Topics: Animals; Cattle; Collateral Circulation; Coronary Angiography; Coronary Disease; Coronary Vessel Ano | 1967 |
[Clinical effect of dipyridamole indicated by the prognosis of myocardial infarction].
Topics: Dipyridamole; Follow-Up Studies; Humans; Myocardial Infarction; Prognosis; Time Factors | 1969 |
[Clinical and electrocardiographic observations on the treatment of patients with myocardial infarct and coronary diseases by intravenous infusion of pyrimido-pyrimidine derivative in high doses].
Topics: Adolescent; Adult; Aged; Child; Coronary Disease; Dipyridamole; Electrocardiography; Female; Humans; | 1969 |
[Therapeutic results of intravenous perfusion of Persantin in myocardial infarct and severe angina pectoris: 30 cases].
Topics: Angina Pectoris; Dipyridamole; Humans; Injections, Intravenous; Myocardial Infarction; Perfusion | 1969 |
[Treatment of acute myocardial infarct using dipyridamole in continuous venoclysis].
Topics: Aged; Dipyridamole; Electrocardiography; Female; Humans; Injections, Intravenous; Male; Middle Aged; | 1970 |
[Infarct size and enzyme histochemical changes in the rat heart following long term treatment with dipyridamol (Persantin) and occlusion of the coronary arteries].
Topics: Aminosalicylic Acids; Animals; Coronary Vessels; Dipyridamole; Heart; Hydrogen; Hydrogen-Ion Concent | 1970 |
[Possibility of psychic disturbances following administration of persantin].
Topics: Acute Disease; Affective Symptoms; Dipyridamole; Humans; Male; Middle Aged; Myocardial Infarction | 1971 |
[Anomalies of platelet behavior at the time of myocardial infarct].
Topics: Adult; Blood Platelet Disorders; Dipyridamole; Humans; Middle Aged; Myocardial Infarction | 1967 |
On the factors which affect the immediate and long-term prognosis of myocardial infarction.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Blood Pressure; Diabetes Complications; Dipyridamole; Ele | 1967 |
[Clinical observations on the treatment of myocardial infarct with dipyridamole and polarizing solutions in intravenous administration].
Topics: Aged; Dipyridamole; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; P | 1968 |
[Experimental studies on selective coronary artery infusion].
Topics: Angiocardiography; Animals; Blood Pressure; Body Weight; Coloring Agents; Contrast Media; Coronary A | 1968 |
Dipyridamole in acute myocardial infarction.
Topics: Acute Disease; Dipyridamole; Humans; Injections, Intravenous; Myocardial Infarction | 1969 |
[Coronarographic findings before and after long-term oral therapy with coronary-specific drugs in man].
Topics: Angina Pectoris; Collateral Circulation; Coronary Angiography; Coronary Disease; Coronary Vessels; D | 1969 |
The effect of dipyridamole on irreversible platelet aggregation.
Topics: Anticoagulants; Blood Platelets; Cell Aggregation; Dipyridamole; Humans; Myocardial Infarction | 1969 |
[Prevention of acute ischemic cardiopathy in the surgical patient].
Topics: Adult; Aged; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Preoperative Ca | 1965 |
Unusual form of impending myocardial infarction in a premenopausal woman.
Topics: Adult; Anemia, Hypochromic; Angina Pectoris; Cholesterol; Diagnosis, Differential; Dipyridamole; Ele | 1965 |
[Clinical and electrocardiographical observations on the evolution of myocardial infarct treated with a derivative of pyrimido-pyrimidine (Persantin) in intravenous infusion].
Topics: Adult; Aged; Dipyridamole; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarc | 1966 |
[Emergency treatment of acute myocardial infarct by means of slow intravenous infusion of a derivative of pyrimido-(5,4-d)-pyrimidine (preparation RA8)].
Topics: Adult; Aged; Dipyridamole; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Infa | 1966 |
[Observations on the treatment of myocardial infarct with 2-6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-5,4-d)-pyrimidine (Persantin) in slow venous perfusion].
Topics: Adult; Aged; Dipyridamole; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Infa | 1966 |
[Dosage dependence of the development of coronary collaterals in the use of dilator agents].
Topics: Angina Pectoris; Angiocardiography; Animals; Collateral Circulation; Coronary Disease; Coronary Vess | 1966 |